Voya Financial (VOYA) 10-Q 3 Aug 23 2023 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - $ / shares	6 Months Ended
	Jun. 30, 2023	Jul. 28, 2023	May 01, 2020
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2023
Document Transition Report	false
Entity File Number	001-35897
Entity Registrant Name	Voya Financial, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	52-1222820
Entity Address, Address Line One	230 Park Avenue
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10169
City Area Code	212
Local Phone Number	309-8200
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		105,780,098
Common stock, par value (usd per share)	$ 0.01		$ 0.01
Entity Central Index Key	0001535929
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q2
Amendment Flag	false
Common Stock, $.01 par value
Entity Information [Line Items]
Title of 12(b) Security	Common Stock, $.01 par value
Trading Symbol	VOYA
Security Exchange Name	NYSE
Depositary Shares, each representing a 1/40th
Entity Information [Line Items]
Title of 12(b) Security	Depositary Shares, each representing a 1/40th
Trading Symbol	VOYAPrB
Security Exchange Name	NYSE

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Jun. 30, 2023	Dec. 31, 2022
Investments:
Short-term investments under securities loan agreements, including collateral delivered	$ 1,089	$ 1,179
Accrued investment income	417	425
Premiums Receivable And Reinsurance Recoverables, Including Reinsurance Premium Paid	12,131	12,426
Deferred policy acquisition costs and Value of business acquired	2,304	2,363
Deferred income taxes	2,161	2,223
Goodwill	646	327
Other Intangible Assets, Net	908	631
Assets held in separate accounts	88,851	80,174
Total assets	154,616	146,606
Liabilities:
Future policy benefits	9,653	9,719
Contract owner account balances	40,930	42,455
Payables under securities loan and repurchase agreements, including collateral held	1,301	1,302
Short-term debt	143	141
Long-term debt	2,095	2,094
Derivatives	400	389
Liabilities related to separate accounts	88,851	80,174
Total liabilities	149,088	141,609
Commitments and Contingencies (Note 17)
Mezzanine equity:
Redeemable noncontrolling interest	171	166
Shareholders' equity:
Preferred stock ($0.01 par value per share; $625 aggregate liquidation preference as of 2023 and 2022 respectively)	0	0
Common stock ($0.01 par value per share; 900,000,000 shares authorized; 109,286,448 and 97,789,852 shares issued as of 2023 and 2022, respectively; 105,720,303 and 97,186,970 shares outstanding as of 2023 and 2022, respectively)	1	1
Treasury stock (at cost; 3,566,145 and 602,882 shares as of 2023 and 2022, respectively)	(248)	(39)
Additional paid-in capital	6,695	6,643
Accumulated other comprehensive income (loss)	(2,791)	(3,055)
Retained earnings (deficit):
Unappropriated	40	(201)
Total Voya Financial, Inc. shareholders' equity	3,697	3,349
Noncontrolling interest	1,660	1,482
Total shareholders' equity	5,357	4,831
Total liabilities, mezzanine equity and shareholders' equity	154,616	146,606
Consolidated Entity, Excluding Consolidated VIE
Investments:
Fixed maturities, available-for-sale, at fair value (amortized cost of $28,812 as of 2023 and $30,202 as of 2022; net of allowance for credit losses of $16 as of 2023 and $12 as of 2022)	25,955	27,044
Fixed maturities, at fair value using the fair value option	2,090	2,151
Equity securities, at fair value	309	336
Short-term investments	49	356
Mortgage loans on real estate, net	5,339	5,427
Policy loans	358	363
Limited partnerships/corporations	1,800	1,781
Derivatives	444	422
Other investments	69	68
Securities pledged (amortized cost of $1,266 as of 2023 and $1,303 as of 2022)	1,148	1,162
Total investments	37,561	39,110
Cash and cash equivalents	1,195	919
Other assets (net of allowance for credit losses of $1 as of 2023 and 2022)	2,626	2,625
Liabilities:
Other liabilities	2,994	2,901
VIEs
Investments:
Limited partnerships/corporations	3,120	2,802
Cash and cash equivalents	154	88
Other assets (net of allowance for credit losses of $1 as of 2023 and 2022)	21	21
Financing Receivable, after Allowance for Credit Loss	1,432	1,293
Liabilities:
Other liabilities	1,390	1,200
Collateralized loan obligations notes, at fair value using the fair value option	$ 1,331	$ 1,234

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Jun. 30, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Fixed maturities, amortized cost	$ 28,812	$ 30,202
Fixed maturities, allowance for credit losses	16	12
Mortgage loans, allowance for credit losses	27	18
Securities pledged, amortized costs	1,266	1,303
Premium receivable and reinsurance recoverable, allowance for credit losses	26	$ 32
Other assets, allowance for credit losses	1
Preferred stock, par value (usd per share)		$ 0.01
Preferred stock, aggregate liquidation preference	$ 625
Common stock, par value (usd per share)	$ 0.01
Common stock, shares outstanding (in shares)	900,000,000
Common stock, shares issued (in shares)	109,286,448	97,789,852
Common stock, shares outstanding (in shares)	105,720,303	97,186,970
Treasury stock (in shares)	3,566,145	602,882

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Revenues:
Net investment income	$ 545	$ 581	$ 1,090	$ 1,211
Fee income	474	413	938	846
Premiums	677	597	1,362	1,205
Net gains (losses)	(56)	(226)	(72)	(514)
Other revenue	86	44	164	84
Income (loss) related to CIEs:
Net investment income	145	115	224	198
Total revenues	1,871	1,524	3,706	3,030
Benefits and expenses:
Policyholder benefits	438	411	948	822
Interest credited to contract owner account balances	244	243	485	476
Operating expenses	770	605	1,606	1,237
Net amortization of Deferred policy acquisition costs and Value of business acquired	57	62	116	124
Interest expense	39	33	71	73
Operating expenses related to CIEs:
Interest expense	55	13	71	19
Other expense	5	5	5	5
Total benefits and expenses	1,608	1,372	3,302	2,756
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Total	263	152	404	274
Income tax expense (benefit)	28	9	40	20
Net income (loss)	235	143	364	254
Less: Net income (loss) attributable to noncontrolling interest	77	75	123	118
Net income (loss) available to Voya Financial, Inc.	158	68	241	136
Less: Preferred stock dividends	4	4	18	18
Net income (loss) available to Voya Financial, Inc.'s common shareholders	$ 154	$ 64	$ 223	$ 118
Net income (loss) available to Voya Financial, Inc.'s common shareholders per common share:
Basic (usd per share)	$ 1.50	$ 0.62	$ 2.22	$ 1.13
Diluted (usd per share)	$ 1.41	$ 0.57	$ 2.03	$ 1.03

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 235	$ 143	$ 364	$ 254
AOCI, Liability for Future Policy Benefit, Expected Future Policy Benefit, before Tax	28	92	30	196
Other comprehensive income (loss), before tax:
Unrealized gains (losses) on securities	(339)	(2,479)	304	(5,072)
Other Comprehensive Income (Loss), before Tax, Total	(311)	(2,387)	334	(4,876)
Income tax expense (benefit) related to items of other comprehensive income (loss)	(65)	(502)	70	(1,024)
Other Comprehensive Income (Loss), Net of Tax, Total	(246)	(1,885)	264	(3,852)
Comprehensive income (loss)	(11)	(1,742)	628	(3,598)
Less: Comprehensive income (loss) attributable to noncontrolling interest and redeemable noncontrolling interest	77	75	123	118
Comprehensive income (loss) attributable to Voya Financial, Inc.	$ (88)	$ (1,817)	$ 505	$ (3,716)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($) $ in Millions	Total	Previously Reported	Total Voya Financial, Inc. Shareholders' Equity	Total Voya Financial, Inc. Shareholders' Equity Previously Reported	Common Stock	Common Stock Previously Reported	Additional Paid-In Capital	Additional Paid-In Capital Previously Reported	Accumulated Other Comprehensive Income (Loss)	Accumulated Other Comprehensive Income (Loss) Previously Reported	Retained Earnings (Deficit), Unappropriated	Noncontrolling Interest	Noncontrolling Interest Previously Reported	Treasury Stock, Common	Treasury Stock, Common Previously Reported
Beginning balance at Dec. 31, 2021		$ 9,668		$ 8,100		$ 1		$ 7,542		$ 1,807	$ (1,170)		$ 1,568		$ (80)
Comprehensive income (loss):
Net income (loss)	$ 254		$ 136		$ 0		$ 0		$ 0		136	$ 118		$ 0
Other comprehensive income (loss), after tax	(3,852)		(3,852)		0		0		(3,852)		0	0		0
Comprehensive income (loss)	(3,598)		(3,716)
Less: Comprehensive income (loss) attributable to noncontrolling interest and redeemable noncontrolling interest	118											118
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Nonredeemable Noncontrolling Interest	(3,598)
Common stock issuance	2		2		0		2		0		0	0		0
Common stock acquired - Share repurchase	(750)		(750)		0		50		0		0	0		(700)
Dividends on preferred stock	(18)		(18)		0		(18)		0		0	0		0
Dividends on common stock	(41)		(41)		0		(41)		0		0	0		0
Share-based compensation	24		24		0		65		0		0	0		(41)
Contributions from (Distributions to) noncontrolling interest, net	11		0		0		0		0		0	11		0
Ending Balance at Jun. 30, 2022	5,298		3,601		1		7,500		(2,045)		(1,034)	1,697		(821)
Beginning balance at Mar. 31, 2022		7,184		5,678		1		7,504		(160)	(1,102)		1,506		(565)
Comprehensive income (loss):
Net income (loss)	143		68		0		0		0		68	75		0
Other comprehensive income (loss), after tax	(1,885)		(1,885)		0		0		(1,885)		0	0		0
Comprehensive income (loss)	(1,742)		(1,817)
Less: Comprehensive income (loss) attributable to noncontrolling interest and redeemable noncontrolling interest	75											75
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Nonredeemable Noncontrolling Interest	(1,742)
Common stock acquired - Share repurchase	(250)		(250)		0		(5)		0		0	0		(255)
Dividends on preferred stock	(4)		(4)		0		(4)		0		0	0		0
Dividends on common stock	(20)		(20)		0		(20)		0		0	0		0
Share-based compensation	14		14		0		15		0		0	0		(1)
Contributions from (Distributions to) noncontrolling interest, net	116		0		0		0		0		0	116		0
Ending Balance at Jun. 30, 2022	5,298		3,601		1		7,500		(2,045)		(1,034)	1,697		(821)
Increase (Decrease) in Temporary Equity [Roll Forward]
Redeemable noncontrolling interest	166
Beginning balance at Dec. 31, 2022	4,831	4,831		3,349		1		6,643		(3,055)	(201)		1,482		(39)
Comprehensive income (loss):
Net income (loss)	353		241		0		0		0		241	112		0
Net income (loss)	364
Other comprehensive income (loss), after tax	264		264		0		0		264		0	0		0
Comprehensive income (loss)	628		505
Less: Comprehensive income (loss) attributable to noncontrolling interest and redeemable noncontrolling interest	123											112
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Nonredeemable Noncontrolling Interest	617
Common stock acquired - Share repurchase	(162)		(162)		0		0		0		0			(162)
Dividends on preferred stock	(18)		(18)		0		(18)		0		0			0
Dividends on common stock	(41)		(41)		0		(41)		0		0			0
Share-based compensation	64		64		0		111		0		0			(47)
Contributions from (Distributions to) noncontrolling interest, net	66		0		0		0		0		0	66		0
Ending Balance at Jun. 30, 2023	5,357		3,697		1		6,695		(2,791)		40	1,660		(248)
Increase (Decrease) in Temporary Equity [Roll Forward]
Temporary Equity, Net Income	11
Temporary Equity, Other Changes	(6)
Temporary Equity, Comprehensive Income (Loss)	11
Redeemable noncontrolling interest	166
Beginning balance at Mar. 31, 2023		$ 5,521		$ 3,954		$ 1		$ 6,693		$ (2,545)	(118)		$ 1,567		$ (77)
Comprehensive income (loss):
Net income (loss)	226		158		0		0		0		158	68		0
Net income (loss)	235
Other comprehensive income (loss), after tax	(246)		(246)		0		0		(246)		0	0		0
Comprehensive income (loss)	(11)		(88)
Less: Comprehensive income (loss) attributable to noncontrolling interest and redeemable noncontrolling interest	77											68
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Nonredeemable Noncontrolling Interest	(20)
Common stock acquired - Share repurchase	(162)		(162)		0		0		0		0	0		(162)
Dividends on preferred stock	(4)		(4)		0		(4)		0		0	0		0
Dividends on common stock	(21)		(21)		0		(21)		0		0	0		0
Share-based compensation	18		18		0		27		0		0	0		(9)
Contributions from (Distributions to) noncontrolling interest, net	25		0		0		0		0		0	25		0
Ending Balance at Jun. 30, 2023	5,357		$ 3,697		$ 1		$ 6,695		$ (2,791)		$ 40	$ 1,660		$ (248)
Increase (Decrease) in Temporary Equity [Roll Forward]
Temporary Equity, Net Income	9
Temporary Equity, Other Changes	(4)
Temporary Equity, Comprehensive Income (Loss)	9
Redeemable noncontrolling interest	$ 171

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Cash Flows from Operating Activities:
Net cash provided by operating activities	$ 871	$ 715
Proceeds from the sale, maturity, disposal or redemption of:
Fixed maturities	4,351	3,454
Equity securities	28	0
Mortgage loans on real estate	351	545
Limited partnerships/corporations	75	127
Acquisition of:
Fixed maturities	(2,971)	(4,613)
Equity securities	(25)	0
Mortgage loans on real estate	(272)	(330)
Limited partnerships/corporations	(79)	(177)
Short-term investments, net	307	61
Derivatives, net	30	116
Sales from CIEs	456	578
Purchases within CIEs	(623)	(1,426)
Collateral received (delivered), net	88	23
Receipts on deposit asset contracts	141	60
Payments for business acquisitions, net of cash acquired	(534)	(2)
Net cash provided by (used in) investing activities	(54)	10
Net cash provided by (used in) investing activities	1,269	(1,574)
Cash Flows from Financing Activities:
Deposits received for investment contracts	1,247	3,548
Maturities and withdrawals from investment contracts	(3,046)	(3,112)
Proceeds from issuance of long-term debt	388	0
Repayments of long-term debt, including current maturities	(398)	(215)
Borrowings of CIEs	226	959
Repayments of borrowings of CIEs	(305)	(309)
Contributions from (distributions to) participants in CIEs, net	367	322
Proceeds from issuance of common stock, net	0	2
Common stock acquired - Share repurchase	(162)	(750)
Dividends paid on preferred stock	(18)	(18)
Dividends paid on common stock (includes $2 of dividend equivalent payments in 2023)	(43)	(41)
Other, net	(54)	(61)
Net cash provided by (used in) financing activities	(1,798)	325
Net increase (decrease) in cash and cash equivalents, including cash in CIEs	342	(534)
Cash and cash equivalents, including cash in CIEs, beginning of period	1,007	1,573
Cash and cash equivalents, including cash in CIEs, end of period	1,349	$ 1,039
Condensed Financial Statements, Captions [Line Items]
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Total	1,349
Consolidated Entity, Excluding Consolidated VIE
Condensed Financial Statements, Captions [Line Items]
Cash and cash equivalents	1,195
VIEs
Condensed Financial Statements, Captions [Line Items]
Cash and cash equivalents	$ 154

Business, Basis of Presentation

Business, Basis of Presentation and Significant Accounting Policies	6 Months Ended
	Jun. 30, 2023
Accounting Policies [Abstract]
Business Description and Basis of Presentation	1. Business, Basis of Presentation and Significant Accounting Policies Business Voya Financial, Inc. and its subsidiaries (collectively, the "Company") is a financial services organization that offers a broad range of retirement services, investment management services, mutual funds, group insurance and supplemental health products primarily in the United States. P roducts and services are provided by the Company through three segments: Wealth Solutions, Health Solutions and Investment Management . Activities not directly related to the Company's segments and certain run-off activities that are not meaningful to the Company's business strategy are included within Corporate. See the Segments Note to these Condensed Consolidated Financial Statements. On July 25, 2022, the Company completed a series of transactions pursuant to a Combination Agreement dated as of June 13, 2022 (the "AllianzGI Agreement") with Voya Investment Management LLC ("Voya IM") and VIM Holdings LLC ("VIM Holdings"), both indirect subsidiaries of the Company, Allianz SE ("Allianz") and Allianz Global Investors U.S. LLC ("AllianzGI"), an indirect subsidiary of Allianz, which combined Voya IM with assets and teams comprising specified transferred strategies managed by AllianzGI. The transaction increases the international scale and distribution of the Company’s investment products and provides diverse investment strategies that meet the needs of a larger and more global client base. Under the terms of the AllianzGI Agreement, AllianzGI transferred to VIM Holdings the rights to certain assets and liabilities related to specified investment teams and strategies and the associated assets under management (the "AllianzGI Transferred Business"). The Company transferred all of the limited liability company interests in Voya IM to VIM Holdings and in exchange, received a 76% economic stake in VIM Holdings. Pursuant to the Amended and Restated Limited Liability Company Agreement of VIM Holdings entered into at the closing date ("A&R VIM Holdings Operating Agreement"), the Company now holds, indirectly, a 76% economic stake in VIM Holdings and Allianz holds, indirectly, a 24% economic stake in VIM Holdings. In accordance with the A&R VIM Holdings Operating Agreement, the Company has full operational control of VIM Holdings, Voya IM and the transferred assets and investment teams. The AllianzGI Agreement was executed for noncash consideration and accounted for under the acquisition method of accounting. Accordingly, the purchase price was allocated to the assets acquired and liabilities assumed based upon their estimated fair values as of the closing date. The 24% economic stake in VIM Holdings shares is reflected on the Condensed Consolidated Balance Sheets under Redeemable noncontrolling interests within Mezzanine equity. On November 1, 2022, Voya Investment Management Alternative Assets, LLC ("VIMAA"), one of the Company’s indirect subsidiaries, acquired all of the issued and outstanding equity interests of Czech Asset Management, L.P., a private credit asset manager dedicated to the U.S. middle market pursuant to a sales and purchase agreement ("SPA") entered into on August 1, 2022 with Czech Management GP, LLC, and Czech Holdings, LLC. The purchase consideration for the acquisition included cash paid upon close and contingent consideration that is based on revenues that will be earned during the earnout period and capital raised in the underlying funds and is subject to conditions as defined in the SPA. The acquisition expands VIMAA's private and leveraged credit business. On January 24, 2023, the Company acquired all outstanding shares of Benefitfocus, Inc. ("Benefitfocus"), pursuant to an agreement and plan of merger (the "Merger Agreement") entered into on November 1, 2022. The acquisition expands the Company’s capacity to meet the growing demand for comprehensive benefits and savings solutions and increases its ability to deliver innovative solutions for employers and health plans. The total purchase consideration for the acquisition was $595, of which $583 was paid in cash ($558 paid by the Company and $25 of the cash acquired was used to fund the transaction). Net assets acquired as part of this transaction included cash of $49, goodwill of $319, intangible assets of $275, deferred tax assets of $45 and assumed lease liabilities of $91. This represents the best estimate of fair value of net assets acquired at the transaction date and will continue to be revised during the remeasurement period as further information becomes available. Intangible assets primarily include customer relationships of $190 with a useful life of 15 years, and software of $70 with a useful life of 5 years. The estimated amortization expense of the acquired intangible assets for the next five years is approximately $29 annually. The revenues, expenses, assets and liabilities of the business acquired are reported in the Health Solutions segment. On August 1, 2023, the Company acquired all remaining equity interest in VFI SLK Global Services Private Limited ("VFISLK") currently held by SLK Software Private Limited ("SLK"). VFISLK is a private limited company in India formed pursuant to a joint venture agreement between the Company and SLK on August 1, 2019, with the purpose of providing technology and business operations services to the Company. As a result of the acquisition, VFISLK has become a wholly owned subsidiary of the Company and provides the Company with improved strategic and operational flexibility. An upfront payment of approximately $50 was made at closing. The Company is in the process of determining the fair value of the identifiable assets and liabilities assumed. As such, an estimate of the financial impact of the acquisition cannot be currently made. Basis of Presentation The accompanying Condensed Consolidated Financial Statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States ("U.S. GAAP") and are unaudited. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the Condensed Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. Those estimates are inherently subject to change and actual results could differ from those estimates, and the differences may be material to the Condensed Consolidated Financial Statements. The Condensed Consolidated Financial Statements include the accounts of Voya Financial, Inc. and its subsidiaries, as well as other voting interest entities ("VOEs") and variable interest entities ("VIEs") in which the Company has a controlling financial interest. See the Consolidated and Nonconsolidated Investment Entities Note to these Condensed Consolidated Financial Statements. Intercompany transactions and balances have been eliminated. The accompanying Condensed Consolidated Financial Statements are unaudited and reflect adjustments (including normal, recurring adjustments) necessary to present fairly the financial position, results of operations, and cash flows for the interim periods presented in conformity with U.S. GAAP. Interim results are not necessarily indicative of full year performance. Certain reclassifications have been made to prior-period amounts to conform to current-period reporting classifications. These reclassifications had no impact on Net income (loss) or Total shareholders’ equity. As a result of the modified retrospective adoption methodology for Accounting Standards Update ("ASU") 2018-12, Targeted Improvements to the Accounting for Long-Duration Contracts ("ASU 2018-12"), adjustments have been made to the December 31, 2022 audited Consolidated Financial Statements included in the Company's Annual Report on Form 10-K , filed with the SEC. Certain of these adjustments are included below in the Adoption of New Pronouncements - Long-Duration Contracts section, in accordance with the transition disclosure requirements of ASU 2018-12, and are unaudited. These interim Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and related notes included in the Company's Annual Report on Form 10-K . Significant Accounting Policies Effective January 1, 2023, the Company adopted ASU 2018-12, as amended. As a result, the Company made changes to the following significant accounting policies: Estimates and Assumptions Upon adoption of ASU 2018-12, deferred policy acquisition costs ("DAC") and value of business acquired ("VOBA") were no longer considered significant estimates by the Company, as the amortization methodology is no longer subject to a significant degree of variability and does not require a high degree of judgment. Deferred Policy Acquisition Costs and Value of Business Acquired DAC represents policy acquisition costs that have been capitalized and are subject to amortization. Capitalized costs are incremental, direct costs of contract acquisition and certain other costs related directly to successful acquisition activities. Such costs consist principally of commissions, underwriting, sales and contract issuance and processing expenses directly related to the successful acquisition of new and renewal business. Indirect or unsuccessful acquisition costs, maintenance, product development and overhead expenses are charged to expense as incurred. VOBA represents the outstanding value of in-force business acquired and is subject to amortization. The value is based on the present value of estimated net cash flows embedded in the insurance contracts at the time of the acquisition and increased for subsequent deferrable expenses on purchased policies. DAC/VOBA amortization is recorded in Net amortization of Deferred policy acquisition costs and Value of business acquired in the Condensed Consolidated Statements of Operations. Amortization Methodologies The Company amortizes DAC/VOBA related to certain traditional life insurance contracts, certain accident and health insurance contracts, and deferred annuity contracts on a constant level basis over the expected term of the related contracts. Contracts are grouped for amortization purposes by product or market type and issue year cohort using assumptions on a basis consistent with those used in estimating the associated liability or other related balance, where applicable. The principal assumption deemed critical to the DAC/VOBA amortization is the estimated contract term, which incorporates mortality and persistency, and represents management’s best estimate of future outcome. The Company periodically reviews this assumption against actual experience and, based on additional information that becomes available, updates the assumption. Changes in contract term estimates are reflected prospectively in amortization expense as of the beginning of the reporting period in which the change is made. VOBA is subject to recoverability testing; DAC is not. The Company performs testing to assess the recoverability of VOBA on an annual basis, or more frequently if circumstances indicate that a potential loss recognition issue exists. If VOBA is not deemed recoverable, charges will be applied against the VOBA balance before an additional reserve is established. Future Policy Benefits Future Policy Benefits The Company establishes and carries actuarially-determined reserves that are calculated to meet its future obligations, including estimates of unpaid claims and claims that the Company believes have been incurred but have not yet been reported as of the balance sheet date. • Reserves for long-duration traditional life insurance contracts (term insurance, participating and non-participating whole life insurance and traditional group life insurance) and accident and health insurance represent the present value of future benefits to be paid to or on behalf of contract owners and related expenses, less the present value of future net premiums. • Reserves for payout contracts with life contingencies are equal to the present value of future payments. Principal assumptions used to establish liabilities for future policy benefits include interest rate, mortality, morbidity, policy lapse, contract renewal, payment of subsequent premiums or deposits by the contract owner, retirement, inflation, and benefit utilization. Other than interest rate assumptions, these assumptions are based on Company experience and periodically reviewed against industry standards. The Company reviews these assumptions at least annually and updates them if necessary. In addition to assumption updates, the Company adjusts reserves for actual experience in the period in which the experience occurs. Changes in, or deviations from, the assumptions used can significantly affect the Company's reserve levels and related results of operations. Remeasurements of the reserves as a result of assumption updates and adjustments for actual experience are recognized in Policyholder benefits in the Condensed Consolidated Statements of Operations. Interest rates used in discounting the reserves are based on an upper-medium grade (low-credit-risk) fixed-income instrument yield derived from observable market data. A 30-year forward rate is used for periods beyond the last observable market point. Reserves are remeasured quarterly to reflect changes in the discount rate, with the resulting change recorded in Accumulated other comprehensive income ("AOCI"). Locked-in interest rates used to determine interest accretion on reserves for new contracts sold after January 1, 2021 are based on the upper-medium grade (low-credit-risk) fixed-income instrument yield applicable at the time the contract was issued. Locked-in interest accretion rates for contracts in-force as of the January 1, 2021 transition date for ASU 2018-12 are based on the locked-in interest rates in effect for those contracts immediately before the transition date. Interest accretion is recorded in Policyholder benefits on the Condensed Consolidated Statements of Operations. Product Guarantees and Additional Reserves The Company calculates additional reserve liabilities for certain universal life-type products and certain variable annuity guaranteed benefits and variable funding products. The Company periodically evaluates its estimates and adjusts the additional liability balance, with a related charge or credit to benefit expense, if actual experience or other evidence suggests that earlier assumptions should be revised. Changes in, or deviations from, the assumptions used can significantly affect the Company's reserve levels and related results of operations. Universal and Variable Universal Life : The Company establishes additional reserves on universal life ("UL") and variable universal life ("VUL") contracts, primarily related to secondary guarantees and paid-up guarantees, for the portion of contract assessments received in early years that will be used to compensate the Company for benefits provided in later years. These reserves are calculated by estimating the expected value of benefits payable and recognizing those benefits ratably over the accumulation period based on total expected assessments, using interest rates consistent with the underlying contracts' interest crediting rates. Included are contracts where the Company contractually guaranteed a death benefit even when there is insufficient value to cover monthly mortality and expense charges, whereas otherwise the contract would typically lapse ("no lapse guarantee"), and other provisions that would produce expected gains from the insurance benefit function followed by losses from that function in later years. Additional reserves for UL and VUL contracts are recorded in Future policy benefits on the Condensed Consolidated Balance Sheets. Stabilizer and MCG : Guaranteed credited rates give rise to an embedded derivative in the stabilizer ("Stabilizer") products and a stand-alone derivative for managed custody guarantee products ("MCG"). These derivatives are measured at estimated fair value and recorded in Contract owner account balances. Changes in estimated fair value that are not related to attributed fees collected or payments made are reported in Net gains (losses) in the Condensed Consolidated Statements of Operations. The estimated fair value of the Stabilizer embedded derivative and MCG stand-alone derivative is determined based on the present value of projected future claims, minus the present value of future guaranteed premiums. At inception of the contract, the Company projects a guaranteed premium to be equal to the present value of the projected future claims. The income associated with the contracts is projected using actuarial and capital market assumptions, including benefits and related contract charges, over the anticipated life of the related contracts. The cash flow estimates are projected under multiple capital market scenarios using observable risk-free rates and other best estimate assumptions. The liabilities for the Stabilizer embedded derivative and the MCG stand-alone derivative include a risk margin to capture uncertainties related to policyholder behavior assumptions. The margin represents additional compensation a market participant would require to assume these risks. The discount rate used to determine the fair value of the liabilities for the Stabilizer embedded derivative and the MCG stand-alone derivative includes an adjustment to reflect the risk that these obligations will not be fulfilled ("nonperformance risk"). Reinsurance The Company utilizes reinsurance agreements in most aspects of its insurance business to reduce its exposure to large losses. Such reinsurance permits recovery of a portion of losses from reinsurers, although it does not discharge the primary liability of the Company as direct insurer of the risks reinsured. For each of its reinsurance agreements, the Company determines whether the agreement provides indemnification against loss or liability relating to insurance risk. The Company reviews contractual features, particularly those that may limit the amount of insurance risk to which the reinsurer is subject or features that delay the timely reimbursement of claims. The assumptions used to account for both long and short-duration reinsurance agreements are consistent with those used for the underlying contracts, with the exception of the interest accretion rate on reinsurance recoverable assets associated with in-force business reinsured. Ceded Future policy benefits and Contract owner account balances are reported gross on the Condensed Consolidated Balance Sheets. Long-duration : For reinsurance of long-duration contracts that transfer significant insurance risk, the difference, if any, between the amounts paid and benefits received related to the underlying contracts is included in the expected net cost of reinsurance, which is recorded in Premiums receivable and reinsurance recoverable or Other liabilities, as appropriate, on the Condensed Consolidated Balance Sheets. Short-duration : For prospective reinsurance of short-duration contracts that meet the criteria for reinsurance accounting, amounts paid are recorded as ceded premiums and ceded unearned premiums and are reflected as a component of Premiums in the Condensed Consolidated Statements of Operations and Other assets on the Condensed Consolidated Balance Sheets, respectively. Ceded unearned premiums are amortized through premiums over the remaining contract period in proportion to the amount of protection provided. For retroactive reinsurance of short-duration contracts that meet the criteria for reinsurance accounting, amounts paid in excess of the related insurance liabilities ceded are recognized immediately as a loss. Any gains on such retroactive agreements are deferred in Other liabilities and amortized over the remaining life of the underlying contracts. Accounting for reinsurance requires use of assumptions and estimates, particularly related to the future performance of the underlying business and the potential impact of counterparty credit risks. The Company reviews assumptions used to establish assets and liabilities relating to ceded and assumed reinsurance at least annually and updates them if necessary. In addition to the assumption updates, the Company adjusts these assets or liabilities for actual experience in the period in which the experience occurs. The Company also evaluates the financial strength of potential reinsurers and continually monitors the financial condition of reinsurers. Reinsurance recoverable balances are reported net of the allowance for credit losses on the Company’s Condensed Consolidated Balance Sheets. Management estimates the credit loss allowance balance using a factor-based method of probability of default and loss given default which incorporates relevant available information, from internal and external sources, relating to past events, current conditions, and reasonable and supportable forecasts. Included in the factor-based method are the consideration of capital market factors, counterparty financial information and ratings, and reinsurance agreement-specific risk characteristics such as collateral type, collateral size, and covenant strength. The allowance for credit losses is a valuation account that is deducted from the reinsurance recoverable balance to present the net amount expected to be collected on the reinsurance recoverable. The change in the allowance for credit losses is recorded in Policyholder benefits in the Condensed Consolidated Statements of Operations. Current reinsurance recoverable balances deemed probable of recovery and payable balances under reinsurance agreements are included in Premium receivable and reinsurance recoverable and Other liabilities, respectively. Such assets and liabilities relating to reinsurance agreements with the same reinsurer are recorded net on the Condensed Consolidated Balance Sheets if a right of offset exists within the reinsurance agreement. Premiums, Fee income and Policyholder benefits are reported net of reinsurance ceded. The Company has entered into coinsurance funds withheld reinsurance arrangements that contain embedded derivatives for which carrying value is estimated based on the change in the fair value of the assets supporting the funds withheld payable under the agreements. Significant accounting policies that were unchanged from those included in the Company’s December 31, 2022 Annual Report on Form 10-K as a result of the adoption of ASU 2018-12 have not been repeated. These policies include Internal Replacements, Contract Owner Account Balances, and Separate Accounts. Adoption of New Pronouncements Long-Duration Contracts The following section provides a description of the Company's adoption of ASU 2018-12 issued by the Financial Accounting Standards Board ("FASB") and the impact of the adoption on the Company's financial statements: This standard, issued in August 2018, changes the measurement and disclosures of insurance liabilities and DAC for long-duration contracts issued by insurers. In addition to expanded disclosures, the standard’s requirements include: • Annual review and, if necessary, update of cash flow assumptions used to measure the liability for future policy benefits for nonparticipating traditional and limited payment insurance contracts, measured on a retrospective catch-up basis and recognized in the period the update is made. The rate used is required to be updated quarterly, with related changes in the liability recorded in AOCI. • Fair value measurement of contract guarantee features qualifying as Market Risk Benefits ("MRB"), with changes in fair value recognized in the Statements of Operations. Changes in the instrument-specific credit risk will be recorded in AOCI. • Amortization of DAC on a constant level basis over the expected term of the contracts, without reference to revenue or profitability. An accounting election may be made to apply the DAC requirements to VOBA. • Insurance entities may make an accounting policy election to exclude contracts from application of the requirements in ASU 2018-12 when those contracts have been derecognized because of a sale or disposal of a legal entity before the effective date of ASU 2018-12. The Company adopted ASU 2018-12 on January 1, 2023, on a modified retrospective basis for the liability for future policy benefits and DAC and on a full retrospective basis for MRBs. The January 1, 2021 transition impact increased Total shareholders’ equity. This increase was primarily driven by the removal of DAC/VOBA and Premium deficiency reserve adjustment balances, and partially offset by the impact of remeasurement of Future policy benefits and Reinsurance recoverable using the discount rate at January 1, 2021. Total shareholders’ equity was also impacted by the establishment of MRB liabilities related to guaranteed minimum benefits on certain deferred annuity contracts. The Company elected the option to exclude contracts reported as discontinued operations in 2021. Disclosures and post-transition comparative information have been restated to conform to the requirements of ASU 2018-12. The following tables provide additional information related to the transition adjustments: DAC VOBA Wealth Solutions Deferred and Individual Annuities Businesses Exited (1) Balance, December 31, 2020 $ 119 $ 1,186 $ 70 Adjustment for removal of related balances in AOCI 571 104 635 Balance, January 1, 2021 $ 690 $ 1,290 $ 705 Liability for Future Policy Benefits Health Solutions Group (2) Health Solutions Voluntary (3) Businesses Exited (1) Balance, December 31, 2020 $ 822 $ 188 $ 5,448 Adjustment for reversal of related balances in AOCI — — (386) Adjustment for loss contracts under the modified retrospective approach 7 3 3 Effect of remeasurement of liability at current discount rate 118 83 1,362 Balance, January 1, 2021 $ 947 $ 274 $ 6,427 (1) Includes long duration retail individual life and annuity business exited via reinsurance (2) Includes long duration employee-sponsored group life and health products (3) Includes long duration employee-paid whole life products The following table presents information on transition adjustments, net of tax, related to the adoption of ASU 2018-12 for retained earnings and AOCI to arrive at the opening balances as of January 1, 2021: Total Shareholders' equity December 31, 2020 $ 11,178 AOCI Reversal of AOCI adjustments 1,328 Effect of remeasurement of liability at current discount rate (1,065) Total AOCI adjustments $ 263 Retained Earnings Establishment of MRBs $ (132) Other adjustments 27 Total Retained earnings $ (105) Total adjustment for the adoption of ASU 2018-12 $ 158 Total Shareholders' equity January 1, 2021 $ 11,336 The following table provides a description of the Company’s adoption of other new ASUs issued by the FASB and the impact of adoption on the Company’s financial statements: Standard Description of Requirements Effective Date and Transition Provisions Effect on the Financial Statements or Other Significant Matters ASU 2022-02, Troubled Debt Restructurings ("TDRs") and Vintage Disclosures This standard, issued in March 2022, eliminates the accounting guidance on troubled debt restructurings for creditors, requires enhanced disclosures for creditors about loan modifications when a borrower is experiencing financial difficulty, and requires public business entities to include current-period gross write-offs in the vintage disclosure tables. January 1, 2023 on a prospective basis. Adoption of the ASU did not have an impact on the Company's financial condition, results of operations, or cash flows. Required disclosure changes have been included in the Investments (excluding Consolidated Investment Entities) Note to these Condensed Consolidated Financial Statements . ASU 2020-04, Reference Rate Reform This standard, issued in March 2020, provides temporary optional expedients and exceptions for applying U.S. GAAP principles to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments were effective as of March 12, 2020, the issuance date of the ASU. An entity may elect to apply the amendments prospectively through December 31, 2024. The Company has elected to apply the expedient provided in ASU 2020-04 for qualifying contract modifications. To date, adoption of the guidance has not had a material impact on the Company’s financial condition and results of operations. The Company will continue to evaluate the impacts of reference rate reform on contract modifications and hedging relationships as transition progresses. Future Adoption of Accounting Pronouncements The following table provides a description of future adoptions of new accounting standards that may have an impact on the Company's financial statements when adopted: Standard Description of Requirements Effective Date and Transition Provisions Effect on the Financial Statements or Other Significant Matters ASU 2022-03, Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions This standard, issued in June 2022, clarifies that contractual restrictions on equity security sales are not considered part of the security unit of account and, therefore, are not considered in measuring fair value. In addition, the restrictions cannot be recognized and measured as separate units of account. Disclosures on such restrictions are also required. The amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, and are required to be applied prospectively, with any adjustments from the adoption recognized in earnings and disclosed. The Company is currently in the process of determining the impact of adoption of the provisions of ASU 2022-03.

Investments (excluding Consolid

Investments (excluding Consolidated Investment Entities)	6 Months Ended
	Jun. 30, 2023
Investments, Debt and Equity Securities [Abstract]
Investments (excluding Consolidated Investment Entities)	50% - 60% >60% - 70% >70% - 80% >80% and above Total 2023 $ 78 $ 168 $ — $ — $ — $ 246 2022 250 330 69 — — 649 2021 242 248 212 — — 702 2020 158 161 9 10 — 338 2019 229 82 28 — — 339 2018 159 38 5 — — 202 2017 and prior 2,489 396 5 — — 2,890 Total $ 3,605 $ 1,423 $ 328 $ 10 $ — $ 5,366 As of December 31, 2022 Loan-to-Value Ratios Year of Origination 0% - 50% >50% - 60% >60% - 70% >70% - 80% >80% and above Total 2022 $ 250 $ 320 $ 65 $ — $ — $ 635 2021 240 272 255 10 — 777 2020 119 209 25 10 — 363 2019 227 94 29 — — 350 2018 163 41 2 — — 206 2017 and prior 2,606 482 26 — — 3,114 Total $ 3,605 $ 1,418 $ 402 $ 20 $ — $ 5,445 The following tables present commercial mortgage loans by year of origination and DSC ratio as of the dates indicated. The information is updated as of June 30, 2023 and December 31, 2022, respectively. As of June 30, 2023 Debt Service Coverage Ratios Year of Origination >1.5x >1.25x - 1.5x >1.0x - 1.25x <1.0x Total* 2023 $ 70 $ 93 $ 83 $ — $ 246 2022 245 82 210 112 649 2021 256 21 62 363 702 2020 242 27 5 64 338 2019 186 39 107 7 339 2018 123 24 55 — 202 2017 and prior 2,078 362 211 239 2,890 Total $ 3,200 $ 648 $ 733 $ 785 $ 5,366 *No commercial mortgage loans were secured by land or construction loans As of December 31, 2022 Debt Service Coverage Ratios Year of Origination >1.5x >1.25x - 1.5x >1.0x - 1.25x <1.0x Total* 2022 $ 331 $ 100 $ 181 $ 23 $ 635 2021 273 33 269 202 777 2020 259 11 11 82 363 2019 222 54 67 7 350 2018 128 27 51 — 206 2017 and prior 2,172 454 226 262 3,114 Total $ 3,385 $ 679 $ 805 $ 576 $ 5,445 *No commercial mortgage loans were secured by land or construction loans The following tables present the commercial mortgage loans by year of origination and U.S. region as of the dates indicated. The information is updated as of June 30, 2023 and December 31, 2022, respectively. As of June 30, 2023 U.S. Region Year of Origination Pacific South Atlantic Middle Atlantic West South Central Mountain East North Central New England West North Central East South Central Total 2023 $ 21 $ 48 $ 5 $ 97 $ 11 $ 32 $ 3 $ 26 $ 3 $ 246 2022 140 130 48 99 113 93 5 1 20 649 2021 99 63 128 146 112 95 9 49 1 702 2020 74 160 18 10 12 40 — 7 17 338 2019 53 102 10 75 46 5 14 13 21 339 2018 49 60 53 10 14 10 — 6 — 202 2017 and prior 743 593 736 195 207 201 48 142 25 2,890 Total $ 1,179 $ 1,156 $ 998 $ 632 $ 515 $ 476 $ 79 $ 244 $ 87 $ 5,366 As of December 31, 2022 U.S. Region Year of Origination Pacific South Atlantic Middle Atlantic West South Central Mountain East North Central New England West North Central East South Central Total 2022 $ 140 $ 129 $ 48 $ 98 $ 114 $ 82 $ 4 $ 1 $ 19 $ 635 2021 99 72 134 143 112 138 9 48 22 777 2020 74 170 18 16 12 39 — 7 27 363 2019 58 106 10 77 46 5 14 13 21 350 2018 50 62 55 10 14 10 — 5 — 206 2017 and prior 777 623 759 248 227 257 49 149 25 3,114 Total $ 1,198 $ 1,162 $ 1,024 $ 592 $ 525 $ 531 $ 76 $ 223 $ 114 $ 5,445 The following tables present the commercial mortgage loans by year of origination and property type as of the dates indicated. The information is updated as of June 30, 2023 and December 31, 2022, respectively. As of June 30, 2023 Property Type Year of Origination Retail Industrial Apartments Office Hotel/Motel Other Mixed Use Total 2023 $ 93 $ 108 $ 26 $ 19 $ — $ — $ — $ 246 2022 79 265 251 34 10 10 — 649 2021 37 153 360 125 — 18 9 702 2020 58 60 77 143 — — — 338 2019 45 83 163 36 12 — — 339 2018 36 82 55 12 — 17 — 202 2017 and prior 806 700 632 485 67 150 50 2,890 Total $ 1,154 $ 1,451 $ 1,564 $ 854 $ 89 $ 195 $ 59 $ 5,366 As of December 31, 2022 Property Type Year of Origination Retail Industrial Apartments Office Hotel/Motel Other Mixed Use Total 2022 $ 79 $ 255 $ 247 $ 34 $ 10 $ 10 $ — $ 635 2021 37 168 420 125 — 18 9 777 2020 58 61 93 151 — — — 363 2019 46 85 165 40 14 — — 350 2018 37 84 56 12 — 17 — 206 2017 and prior 888 757 679 513 69 156 52 3,114 Total $ 1,145 $ 1,410 $ 1,660 $ 875 $ 93 $ 201 $ 61 $ 5,445 The following table summarizes the activity in the allowance for losses for commercial mortgage loans for the periods indicated: June 30, 2023 December 31, 2022 Allowance for credit losses, beginning of period $ 18 $ 15 Credit losses on mortgage loans for which credit losses were not previously recorded 1 3 Increase (decrease) on mortgage loans with allowance recorded in previous period 8 — Provision for expected credit losses 27 18 Write-offs — — Recoveries of amounts previously written-off — — Allowance for credit losses, end of period $ 27 $ 18 The following table presents past due commercial mortgage loans as of the dates indicated: June 30, 2023 December 31, 2022 Delinquency: Current $ 5,366 $ 5,445 30-59 days past due — — 60-89 days past due — — Greater than 90 days past due — — Total $ 5,366 $ 5,445 Commercial mortgage loans are placed on non-accrual status when 90 days in arrears if the Company has concerns regarding the collectability of future payments, or if a loan has matured without being paid off or extended. As of June 30, 2023, and December 31, 2022, the Company had no commercial mortgage loan in non-accrual status. There was no interest income recognized on loans in non-accrual status for the six months ended June 30, 2023 and year ended December 31, 2022. Net Investment Income The following table summarizes Net investment income for the periods indicated: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Fixed maturities $ 440 $ 495 $ 898 $ 974 Equity securities 7 5 14 9 Mortgage loans on real estate 62 60 123 119 Policy loans 5 5 11 11 Short-term investments and cash equivalents 9 2 18 3 Limited partnerships and other 40 29 62 125 Gross investment income 563 596 1,126 1,241 Less: Investment expenses 18 15 36 30 Net investment income $ 545 $ 581 $ 1,090 $ 1,211 As of June 30, 2023, the Company had $17 of investments in fixed maturities that did not produce net investment income. As of December 31, 2022, the Company had $11 investments in fixed maturities that did not produce net investment income. Fixed maturities are moved to a non-accrual status when the investment defaults. Interest income on fixed maturities is recorded when earned using an effective yield method, giving effect to amortization of premiums and accretion of discounts. Such interest income is recorded in Net investment income in the Condensed Consolidated Statements of Operations. Net Gains (Losses) Net gains (losses) comprise the difference between the amortized cost of investments and proceeds from sale and redemption, as well as losses incurred due to the credit-related and intent-related impairment of investments. Net gains (losses) are also primarily generated from changes in fair value of embedded derivatives within products and fixed maturities, changes in fair value of fixed maturities recorded at FVO and changes in fair value including accruals on derivative instruments, except for effective cash flow hedges. Net gains (losses) also include changes in fair value of equity securities. The cost of the investments on disposal is generally determined based on first-in-first-out ("FIFO") methodology. Net gains (losses) were as follows for the periods indicated: Three Months Ended June 30, 2023 2022 Fixed maturities, available-for-sale, including securities pledged $ (18) $ (6) Fixed maturities, at fair value option (144) (245) Equity securities, at fair value (1) (24) Derivatives 119 32 Embedded derivatives - fixed maturities (2) (2) Other derivatives, net — 12 Standalone derivatives — — Managed custody guarantees — 1 Mortgage loans (10) 1 Other investments — 5 Net gains (losses) $ (56) $ (226) Six Months Ended June 30, 2023 2022 Fixed maturities, available-for-sale, including securities pledged $ (17) $ (79) Fixed maturities, at fair value option (108) (550) Equity securities, at fair value (3) (32) Derivatives 65 126 Embedded derivatives - fixed maturities (1) (6) Other derivatives, net — 17 Standalone derivatives — 1 Managed custody guarantees 3 (2) Mortgage Loans (10) 5 Other investments (1) 6 Net gains (losses) $ (72) $ (514) Proceeds from the sale of fixed maturities, available-for-sale and equity securities and the related gross realized gains and losses, before tax, were as follows for the periods indicated: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Proceeds on sales $ 2,331 $ 971 $ 3,637 $ 2,220 Gross gains 23 15 43 30 Gross losses 30 12 55 44 " id="sjs-B4" xml:space="preserve">Investments (excluding Consolidated Investment Entities) Fixed Maturities Available-for-sale and fair value option ("FVO") fixed maturities were as follows as of June 30, 2023: Amortized Cost Gross Unrealized Capital Gains Gross Unrealized Capital Losses Embedded Derivatives (2) Fair Value Allowance for credit losses Fixed maturities: U.S. Treasuries $ 434 $ 9 $ 18 $ — $ 425 $ — U.S. Government agencies and authorities 54 3 1 — 56 — State, municipalities and political subdivisions 931 1 110 — 822 — U.S. corporate public securities 8,845 116 1,082 — 7,878 1 U.S. corporate private securities 5,113 27 405 — 4,735 — Foreign corporate public securities and foreign governments (1) 3,081 28 336 — 2,767 6 Foreign corporate private securities (1) 3,092 18 193 — 2,915 2 Residential mortgage-backed securities 3,870 33 277 2 3,628 — Commercial mortgage-backed securities 4,326 1 644 — 3,676 7 Other asset-backed securities 2,422 6 137 — 2,291 — Total fixed maturities, including securities pledged 32,168 242 3,203 2 29,193 16 Less: Securities pledged 1,266 — 118 — 1,148 — Total fixed maturities $ 30,902 $ 242 $ 3,085 $ 2 $ 28,045 $ 16 (1) Primarily U.S. dollar denominated. (2) Embedded derivatives within fixed maturity securities are reported with the host investment. The changes in fair value of embedded derivatives are reported in Net gains (losses) in the Condensed Consolidated Statements of Operations. Available-for-sale and FVO fixed maturities were as follows as of December 31, 2022: Amortized Cost Gross Unrealized Capital Gains Gross Unrealized Capital Losses Embedded Derivatives (2) Fair Value Allowance for credit losses Fixed maturities: U.S. Treasuries $ 590 $ 12 $ 21 $ — $ 581 $ — U.S. Government agencies and authorities 58 3 2 — 59 — State, municipalities and political subdivisions 978 1 134 — 845 — U.S. corporate public securities 9,343 97 1,239 — 8,201 — U.S. corporate private securities 5,087 14 409 — 4,692 — Foreign corporate public securities and foreign governments (1) 3,343 18 403 — 2,949 9 Foreign corporate private securities (1) 3,254 7 225 — 3,034 2 Residential mortgage-backed securities 4,230 34 290 3 3,977 — Commercial mortgage-backed securities 4,466 2 585 — 3,883 — Other asset-backed securities 2,307 3 173 — 2,136 1 Total fixed maturities, including securities pledged 33,656 191 3,481 3 30,357 12 Less: Securities pledged 1,303 3 144 — 1,162 — Total fixed maturities $ 32,353 $ 188 $ 3,337 $ 3 $ 29,195 $ 12 (1) Primarily U.S. dollar denominated. (2) Embedded derivatives within fixed maturity securities are reported with the host investment. The changes in fair value of embedded derivatives are reported in Net gains (losses) in the Condensed Consolidated Statements of Operations. The amortized cost and fair value of fixed maturities, including securities pledged, as of June 30, 2023, are shown below by contractual maturity. Actual maturities may differ from contractual maturities as securities may be restructured, called or prepaid. Mortgage-backed securities ("MBS") and Other asset-backed securities ("ABS") are shown separately because they are not due at a single maturity date. Amortized Fair Due to mature: One year or less $ 650 $ 643 After one year through five years 4,054 3,844 After five years through ten years 4,126 3,887 After ten years 12,720 11,224 Mortgage-backed securities 8,196 7,304 Other asset-backed securities 2,422 2,291 Fixed maturities, including securities pledged $ 32,168 $ 29,193 As of June 30, 2023 and December 31, 2022, the Company did not have any investments in a single issuer, other than obligations of the U.S. Government and government agencies, with a carrying value in excess of 10% of the Company’s Total shareholders' equity. The following tables present the composition of the U.S. and foreign corporate securities within the fixed maturity portfolio by industry category as of the dates indicated: Amortized Gross Gross Fair June 30, 2023 Communications $ 1,202 $ 26 $ 114 $ 1,114 Financial 3,982 42 452 3,572 Industrial and other companies 7,824 44 824 7,044 Energy 1,987 43 139 1,891 Utilities 3,547 24 332 3,239 Transportation 1,101 7 105 1,003 Total $ 19,643 $ 186 $ 1,966 $ 17,863 December 31, 2022 Communications $ 1,156 $ 16 $ 130 $ 1,042 Financial 4,153 31 491 3,693 Industrial and other companies 8,379 26 953 7,452 Energy 1,979 39 160 1,858 Utilities 3,664 21 355 3,330 Transportation 1,165 2 128 1,039 Total $ 20,496 $ 135 $ 2,217 $ 18,414 The Company invests in various categories of collateralized mortgage obligations (CMOs), including CMOs that are not agency-backed, that are subject to different degrees of risk from changes in interest rates and defaults. The principal risks inherent in holding CMOs are prepayment and extension risks related to significant decreases and increases in interest rates resulting in the prepayment of principal from the underlying mortgages, either earlier or later than originally anticipated. As of June 30, 2023 and December 31, 2022, approximately 47.5% and 41.6%, respectively, of the Company's CMO holdings, were invested in the above mentioned types of CMOs such as interest-only or principal-only strips, that are subject to more prepayment and extension risk than traditional CMOs. Public corporate fixed maturity securities are distinguished from private corporate fixed maturity securities based upon the manner in which they are transacted. Public corporate fixed maturity securities are issued initially through market intermediaries on a registered basis or pursuant to Rule 144A under the Securities Act of 1933 (the "Securities Act") and are traded on the secondary market through brokers acting as principal. Private corporate fixed maturity securities are originally issued by borrowers directly to investors pursuant to Section 4(a)(2) of the Securities Act, and are traded in the secondary market directly with counterparties, either without the participation of a broker or in agency transactions. Repurchase Agreements As of June 30, 2023 and December 31, 2022, the Company did not have any securities pledged in dollar rolls or reverse repurchase agreements. As of June 30, 2023, the carrying value of securities pledged and obligation to repay loans related to repurchase agreement transactions were $116 and included in Securities pledged and Payables under securities loan and repurchase agreements, including collateral held on the Condensed Consolidated Balance Sheets. As of December 31, 2022, the carrying value of securities pledged and obligation to repay loans related to repurchase agreement transactions was $113. Securities pledged related to repurchase agreements are comprised of other asset-backed securities. Securities Pledged The Company engages in securities lending whereby the initial collateral is required at a rate of 102% of the market value of the loaned securities. The lending agent retains the collateral and invests it in high quality liquid assets on behalf of the Company. The market value of the loaned securities is monitored on a daily basis with additional collateral obtained or refunded as the market value of the loaned securities fluctuates. The lending agent indemnifies the Company against losses resulting from the failure of a counterparty to return securities pledged where collateral is insufficient to cover the loss. As of June 30, 2023 and December 31, 2022, the fair value of loaned securities was $857 and $907, respectively, and is included in Securities pledged on the Condensed Consolidated Balance Sheets. If cash is received as collateral, the lending agent retains the cash collateral and invests it in short-term liquid assets on behalf of the Company. As of June 30, 2023 and December 31, 2022, cash collateral retained by the lending agent and invested in short-term liquid assets on the Company's behalf was $704 and $807, respectively, and is recorded in Short-term investments under securities loan agreements, including collateral delivered on the Condensed Consolidated Balance Sheets. As of June 30, 2023 and December 31, 2022, liabilities to return collateral of $704 and $807, respectively, are included in Payables under securities loan and repurchase agreements, including collateral held on the Condensed Consolidated Balance Sheets. The Company accepts non-cash collateral in the form of securities. The securities retained as collateral by the lending agent may not be sold or re-pledged, except in the event of default, and are not reflected on the Company’s Condensed Consolidated Balance Sheets. This collateral generally consists of U.S. Treasury, U.S. Government agency securities and MBS pools. As of June 30, 2023 and December 31, 2022, the fair value of securities retained as collateral by the lending agent on the Company’s behalf was $180 and $135, respectively. The following table presents borrowings under securities lending transactions by asset class from cash collateral invested and non-cash collateral as of the dates indicated: June 30, 2023 December 31, 2022 U.S. Treasuries $ 41 $ 53 U.S. corporate public securities 576 604 Short-term investments 1 — Foreign corporate public securities and foreign governments 266 285 Total $ 884 $ 942 The Company's securities lending activities are conducted on an overnight basis, and all securities loaned can be recalled at any time. The Company does not offset assets and liabilities associated with its securities lending program. Allowance for credit losses The following table presents a rollforward of the allowance for credit losses on available-for-sale fixed maturity securities for the periods presented: Six Months Ended June 30, 2023 U.S. corporate public securities Commercial mortgage-backed securities Foreign corporate public securities and foreign governments Foreign corporate private securities Other asset-backed securities Total Balance as of January 1 $ — $ — $ 9 $ 2 $ 1 $ 12 Credit losses on securities for which credit losses were not previously recorded 1 7 — — — 8 Reductions for securities sold during the period — — (2) — — (2) Increase (decrease) on securities with allowance recorded in previous period — — (1) — (1) (2) Balance as of June 30 $ 1 $ 7 $ 6 $ 2 $ — $ 16 Year Ended December 31, 2022 Residential mortgage-backed securities Foreign Foreign corporate private securities Other asset-backed securities Total Balance as of January 1 $ 1 $ — $ 56 $ 1 $ 58 Credit losses on securities for which credit losses were not previously recorded — 9 — — 9 Reductions for securities sold during the period — — (57) — (57) Increase (decrease) on securities with allowance recorded in previous period (1) — 3 — 2 Balance as of December 31 $ — $ 9 $ 2 $ 1 $ 12 Unrealized Capital Losses The following table presents available-for-sale fixed maturities, including securities pledged, for which an allowance for credit losses has not been recorded by market sector and duration as of June 30, 2023: Twelve Months or Less More Than Twelve Total Fair Value Unrealized Capital Losses Number of securities Fair Value Unrealized Capital Losses Number of securities Fair Value Unrealized Capital Losses Number of securities U.S. Treasuries $ 202 $ 5 24 $ 63 $ 13 14 $ 265 $ 18 38 U.S. Government agencies and authorities 14 — * 1 3 1 1 17 1 2 State, municipalities and political subdivisions 191 10 80 587 100 216 778 110 296 U.S. corporate public securities 1,723 89 305 4,266 993 1,011 5,989 1,082 1,316 U.S. corporate private securities 1,272 55 127 2,597 350 276 3,869 405 403 Foreign corporate public securities and foreign governments 552 19 97 1,588 317 334 2,140 336 431 Foreign corporate private securities 1,051 33 74 1,497 160 133 2,548 193 207 Residential mortgage-backed 585 31 236 1,146 246 545 1,731 277 781 Commercial mortgage-backed 492 46 79 3,046 598 550 3,538 644 629 Other asset-backed 192 7 44 1,745 130 467 1,937 137 511 Total $ 6,274 $ 295 1,067 $ 16,538 $ 2,908 3,547 $ 22,812 $ 3,203 4,614 *Less than $1 The Company concluded that an allowance for credit losses was unnecessary for these securities because the unrealized losses are interest rate related. The following table presents available-for-sale fixed maturities, including securities pledged, for which an allowance for credit losses has not been recorded by market sector and duration as of December 31, 2022: Twelve Months or Less More Than Twelve Total Fair Value Unrealized Capital Losses Number of securities Fair Value Unrealized Capital Losses Number of securities Fair Value Unrealized Capital Losses Number of securities U.S. Treasuries $ 197 $ 19 19 $ 9 $ 2 7 $ 206 $ 21 26 U.S. Government agencies and authorities 21 2 2 — — — 21 2 2 State, municipalities and political subdivisions 751 121 284 30 13 17 781 134 301 U.S. corporate public securities 5,479 792 1,054 1,137 447 347 6,616 1,239 1,401 U.S. corporate private securities 3,569 322 375 458 87 32 4,027 409 407 Foreign corporate public securities and foreign governments 2,050 260 371 391 143 97 2,441 403 468 Foreign corporate private securities 2,728 211 217 65 14 6 2,793 225 223 Residential mortgage-backed 1,538 128 536 562 162 283 2,100 290 819 Commercial mortgage-backed 2,628 390 441 1,133 195 207 3,761 585 648 Other asset-backed 1,430 104 334 578 69 191 2,008 173 525 Total $ 20,391 $ 2,349 3,633 $ 4,363 $ 1,132 1,187 $ 24,754 $ 3,481 4,820 Based on the Company's quarterly evaluation of its securities in an unrealized loss position, described below, the Company concluded that these securities were not impaired as of June 30, 2023. The Company does not intend to sell the investments and it is not more likely than not that the Company will be required to sell the investments before recovery of their amortized cost bases. Gross unrealized capital losses on fixed maturities, including securities pledged, decreased $278 from $3,481 to $3,203 for the six months ended June 30, 2023. The decrease in unrealized losses was driven by tighter credit spreads. As of June 30, 2023, $834 of the total $3,203 of gross unrealized losses were from 603 available-for-sale fixed maturity securities with an unrealized loss position of 20% or more of amortized cost for 12 months or greater. Evaluating Securities for Impairments The Company performs a regular evaluation, on a security-by-security basis, of its available-for-sale securities holdings, including fixed maturity securities, in accordance with its impairment policy in order to evaluate whether such investments are impaired. The following table identifies the Company's intent impairments included in the Condensed Consolidated Statements of Operations, excluding impairments included in Other comprehensive income (loss) by type for the periods indicated: Three Months Ended June 30, 2023 2022 Impairment No. of Impairment No. of Residential mortgage-backed $ 2 34 $ 2 17 Commercial mortgage-backed 5 3 — * 1 Total $ 7 37 $ 2 18 *Less than $1 Six Months Ended June 30, 2023 2022 Impairment No. of Impairment No. of Residential mortgage-backed $ 2 36 $ 9 27 Commercial mortgage-backed 5 3 — * 1 Total $ 7 39 $ 9 28 *Less than $1 The Company may sell securities during the period in which fair value has declined below amortized cost for fixed maturities. In certain situations, new factors, including changes in the business environment, can change the Company’s previous intent to continue holding a security. Accordingly, these factors may lead the Company to record additional intent related capital losses. Debt Restructuring Upon the adoption of ASU 2022-02 as of January 1, 2023, the Company no longer identifies certain debt modifications as troubled debt restructuring, but instead evaluates all debt modifications to determine whether a modification results in a new loan or a continuation of an existing loan. Disclosures are required for loan modifications with borrowers experiencing financial difficulty. For the three and six months ended June 30, 2023, the Company had no material debt modifications that require such disclosure. Mortgage Loans on Real Estate The Company diversifies its commercial mortgage loan portfolio by geographic region and property type to reduce concentration risk. The Company manages risk when originating commercial mortgage loans by generally lending only up to 75% of the estimated fair value of the underlying real estate. Subsequently, the Company continuously evaluates mortgage loans based on relevant current information including a review of loan-specific performance, property characteristics and market trends. Loan performance is monitored on a loan specific basis through the review of submitted appraisals, operating statements, rent revenues and annual inspection reports, among other items. This review ensures properties are performing at a consistent and acceptable level to secure the debt. The components to evaluate debt service coverage are received and reviewed at least annually to determine the level of risk. Loan-to-value ("LTV") and debt service coverage ("DSC") ratios are measures commonly used to assess the risk and quality of mortgage loans. The LTV ratio, calculated at time of origination, is expressed as a percentage of the amount of the loan relative to the value of the underlying property. A LTV ratio in excess of 100% indicates the unpaid loan amount exceeds the underlying collateral. The DSC ratio, based upon the most recently received financial statements, is expressed as a percentage of the amount of a property’s net income to its debt service payments. A DSC ratio of less than 1.0 indicates that a property’s operations do not generate sufficient income to cover debt payments. These ratios are utilized as part of the review process described above. The following tables present commercial mortgage loans by year of origination and LTV ratio as of the dates indicated. The information is updated as of June 30, 2023 and December 31, 2022, respectively. As of June 30, 2023 Loan-to-Value Ratios Year of Origination 0% - 50% >50% - 60% >60% - 70% >70% - 80% >80% and above Total 2023 $ 78 $ 168 $ — $ — $ — $ 246 2022 250 330 69 — — 649 2021 242 248 212 — — 702 2020 158 161 9 10 — 338 2019 229 82 28 — — 339 2018 159 38 5 — — 202 2017 and prior 2,489 396 5 — — 2,890 Total $ 3,605 $ 1,423 $ 328 $ 10 $ — $ 5,366 As of December 31, 2022 Loan-to-Value Ratios Year of Origination 0% - 50% >50% - 60% >60% - 70% >70% - 80% >80% and above Total 2022 $ 250 $ 320 $ 65 $ — $ — $ 635 2021 240 272 255 10 — 777 2020 119 209 25 10 — 363 2019 227 94 29 — — 350 2018 163 41 2 — — 206 2017 and prior 2,606 482 26 — — 3,114 Total $ 3,605 $ 1,418 $ 402 $ 20 $ — $ 5,445 The following tables present commercial mortgage loans by year of origination and DSC ratio as of the dates indicated. The information is updated as of June 30, 2023 and December 31, 2022, respectively. As of June 30, 2023 Debt Service Coverage Ratios Year of Origination >1.5x >1.25x - 1.5x >1.0x - 1.25x <1.0x Total* 2023 $ 70 $ 93 $ 83 $ — $ 246 2022 245 82 210 112 649 2021 256 21 62 363 702 2020 242 27 5 64 338 2019 186 39 107 7 339 2018 123 24 55 — 202 2017 and prior 2,078 362 211 239 2,890 Total $ 3,200 $ 648 $ 733 $ 785 $ 5,366 *No commercial mortgage loans were secured by land or construction loans As of December 31, 2022 Debt Service Coverage Ratios Year of Origination >1.5x >1.25x - 1.5x >1.0x - 1.25x <1.0x Total* 2022 $ 331 $ 100 $ 181 $ 23 $ 635 2021 273 33 269 202 777 2020 259 11 11 82 363 2019 222 54 67 7 350 2018 128 27 51 — 206 2017 and prior 2,172 454 226 262 3,114 Total $ 3,385 $ 679 $ 805 $ 576 $ 5,445 *No commercial mortgage loans were secured by land or construction loans The following tables present the commercial mortgage loans by year of origination and U.S. region as of the dates indicated. The information is updated as of June 30, 2023 and December 31, 2022, respectively. As of June 30, 2023 U.S. Region Year of Origination Pacific South Atlantic Middle Atlantic West South Central Mountain East North Central New England West North Central East South Central Total 2023 $ 21 $ 48 $ 5 $ 97 $ 11 $ 32 $ 3 $ 26 $ 3 $ 246 2022 140 130 48 99 113 93 5 1 20 649 2021 99 63 128 146 112 95 9 49 1 702 2020 74 160 18 10 12 40 — 7 17 338 2019 53 102 10 75 46 5 14 13 21 339 2018 49 60 53 10 14 10 — 6 — 202 2017 and prior 743 593 736 195 207 201 48 142 25 2,890 Total $ 1,179 $ 1,156 $ 998 $ 632 $ 515 $ 476 $ 79 $ 244 $ 87 $ 5,366 As of December 31, 2022 U.S. Region Year of Origination Pacific South Atlantic Middle Atlantic West South Central Mountain East North Central New England West North Central East South Central Total 2022 $ 140 $ 129 $ 48 $ 98 $ 114 $ 82 $ 4 $ 1 $ 19 $ 635 2021 99 72 134 143 112 138 9 48 22 777 2020 74 170 18 16 12 39 — 7 27 363 2019 58 106 10 77 46 5 14 13 21 350 2018 50 62 55 10 14 10 — 5 — 206 2017 and prior 777 623 759 248 227 257 49 149 25 3,114 Total $ 1,198 $ 1,162 $ 1,024 $ 592 $ 525 $ 531 $ 76 $ 223 $ 114 $ 5,445 The following tables present the commercial mortgage loans by year of origination and property type as of the dates indicated. The information is updated as of June 30, 2023 and December 31, 2022, respectively. As of June 30, 2023 Property Type Year of Origination Retail Industrial Apartments Office Hotel/Motel Other Mixed Use Total 2023 $ 93 $ 108 $ 26 $ 19 $ — $ — $ — $ 246 2022 79 265 251 34 10 10 — 649 2021 37 153 360 125 — 18 9 702 2020 58 60 77 143 — — — 338 2019 45 83 163 36 12 — — 339 2018 36 82 55 12 — 17 — 202 2017 and prior 806 700 632 485 67 150 50 2,890 Total $ 1,154 $ 1,451 $ 1,564 $ 854 $ 89 $ 195 $ 59 $ 5,366 As of December 31, 2022 Property Type Year of Origination Retail Industrial Apartments Office Hotel/Motel Other Mixed Use Total 2022 $ 79 $ 255 $ 247 $ 34 $ 10 $ 10 $ — $ 635 2021 37 168 420 125 — 18 9 777 2020 58 61 93 151 — — — 363 2019 46 85 165 40 14 — — 350 2018 37 84 56 12 — 17 — 206 2017 and prior 888 757 679 513 69 156 52 3,114 Total $ 1,145 $ 1,410 $ 1,660 $ 875 $ 93 $ 201 $ 61 $ 5,445 The following table summarizes the activity in the allowance for losses for commercial mortgage loans for the periods indicated: June 30, 2023 December 31, 2022 Allowance for credit losses, beginning of period $ 18 $ 15 Credit losses on mortgage loans for which credit losses were not previously recorded 1 3 Increase (decrease) on mortgage loans with allowance recorded in previous period 8 — Provision for expected credit losses 27 18 Write-offs — — Recoveries of amounts previously written-off — — Allowance for credit losses, end of period $ 27 $ 18 The following table presents past due commercial mortgage loans as of the dates indicated: June 30, 2023 December 31, 2022 Delinquency: Current $ 5,366 $ 5,445 30-59 days past due — — 60-89 days past due — — Greater than 90 days past due — — Total $ 5,366 $ 5,445 Commercial mortgage loans are placed on non-accrual status when 90 days in arrears if the Company has concerns regarding the collectability of future payments, or if a loan has matured without being paid off or extended. As of June 30, 2023, and December 31, 2022, the Company had no commercial mortgage loan in non-accrual status. There was no interest income recognized on loans in non-accrual status for the six months ended June 30, 2023 and year ended December 31, 2022. Net Investment Income The following table summarizes Net investment income for the periods indicated: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Fixed maturities $ 440 $ 495 $ 898 $ 974 Equity securities 7 5 14 9 Mortgage loans on real estate 62 60 123 119 Policy loans 5 5 11 11 Short-term investments and cash equivalents 9 2 18 3 Limited partnerships and other 40 29 62 125 Gross investment income 563 596 1,126 1,241 Less: Investment expenses 18 15 36 30 Net investment income $ 545 $ 581 $ 1,090 $ 1,211 As of June 30, 2023, the Company had $17 of investments in fixed maturities that did not produce net investment income. As of December 31, 2022, the Company had $11 investments in fixed maturities that did not produce net investment income. Fixed maturities are moved to a non-accrual status when the investment defaults. Interest income on fixed maturities is recorded when earned using an effective yield method, giving effect to amortization of premiums and accretion of discounts. Such interest income is recorded in Net investment income in the Condensed Consolidated Statements of Operations. Net Gains (Losses) Net gains (losses) comprise the difference between the amortized cost of investments and proceeds from sale and redemption, as well as losses incurred due to the credit-related and intent-related impairment of investments. Net gains (losses) are also primarily generated from changes in fair value of embedded derivatives within products and fixed maturities, changes in fair value of fixed maturities recorded at FVO and changes in fair value including accruals on derivative instruments, except for effective cash flow hedges. Net gains (losses) also include changes in fair value of equity securities. The cost of the investments on disposal is generally determined based on first-in-first-out ("FIFO") methodology. Net gains (losses) were as follows for the periods indicated: Three Months Ended June 30, 2023 2022 Fixed maturities, available-for-sale, including securities pledged $ (18) $ (6) Fixed maturities, at fair value option (144) (245) Equity securities, at fair value (1) (24) Derivatives 119 32 Embedded derivatives - fixed maturities (2) (2) Other derivatives, net — 12 Standalone derivatives — — Managed custody guarantees — 1 Mortgage loans (10) 1 Other investments — 5 Net gains (losses) $ (56) $ (226) Six Months Ended June 30, 2023 2022 Fixed maturities, available-for-sale, including securities pledged $ (17) $ (79) Fixed maturities, at fair value option (108) (550) Equity securities, at fair value (3) (32) Derivatives 65 126 Embedded derivatives - fixed maturities (1) (6) Other derivatives, net — 17 Standalone derivatives — 1 Managed custody guarantees 3 (2) Mortgage Loans (10) 5 Other investments (1) 6 Net gains (losses) $ (72) $ (514) Proceeds from the sale of fixed maturities, available-for-sale and equity securities and the related gross realized gains and losses, before tax, were as follows for the periods indicated: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Proceeds on sales $ 2,331 $ 971 $ 3,637 $ 2,220 Gross gains 23 15 43 30 Gross losses 30 12 55 44

Derivative Financial Instrument

Derivative Financial Instruments	6 Months Ended
	Jun. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Derivative Financial Instruments The Company primarily enters into the following types of derivatives: Interest rate swaps: Interest rate swaps are used by the Company primarily to reduce market risks from changes in interest rates and to alter interest rate exposure arising from mismatches between assets and/or liabilities. Interest rate swaps are also used to hedge the interest rate risk associated with the value of assets it owns or in an anticipation of acquiring them. Using interest rate swaps, the Company agrees with another party to exchange, at specified intervals, the difference between fixed rate and floating rate interest payments, calculated by reference to an agreed upon notional principal amount. These transactions are entered into pursuant to master agreements that provide for a single net payment to be made to/from the counterparty at each due date. The Company utilizes these contracts in qualifying hedging relationships as well as non-qualifying hedging relationships. Foreign exchange swaps: The Company uses foreign exchange or currency swaps to reduce the risk of change in the value, yield or cash flows associated with certain foreign denominated invested assets. Foreign exchange swaps represent contracts that require the exchange of foreign currency cash flows against U.S. dollar cash flows at regular periods, typically quarterly or semi-annually. The Company utilizes these contracts in qualifying hedging relationships as well as non-qualifying hedging relationships. Total return swaps: The Company uses total return swaps as a hedge of interest related risks within various Legacy Annuity and Retirement products. Total return swaps are also used as a hedge of other corporate liabilities. Using total return swaps, the Company agrees with another party to exchange, at specified intervals, the difference between the economic performance of assets or a market index and a fixed or variable funding multiplied by reference to an agreed upon notional amount. No cash is exchanged at the onset of the contracts. Cash is paid and received over the life of the contract based upon the terms of the swaps. The Company utilized these contracts in non-qualifying hedging relationships. Futures: Futures contracts are used to hedge against a decrease in certain equity indices. Such decreases may correlate to a decrease in variable annuity account values which would increase the possibility of the Company incurring an expense for guaranteed benefits in excess of account values. The Company also uses interest rate futures contracts to hedge its exposure to market risks due to changes in interest rates. The Company enters into exchange traded futures with regulated futures commissions that are members of the exchange. The Company also posts initial and variation margins, with the exchange, on a daily basis. The Company utilizes exchange-traded futures in non-qualifying hedging relationships. The Company may also use futures contracts as a hedge against an increase in certain equity indices. Embedded derivatives: The Company also invests in certain fixed maturity instruments and has issued certain products that contain embedded derivatives for which market value is at least partially determined by, among other things, levels of or changes in domestic and/or foreign interest rates (short-term or long-term), exchange rates, prepayment rates, equity rates or credit ratings/spreads. In addition, the Company has entered into coinsurance with funds withheld arrangements, which contain embedded derivatives. The notional amounts and fair values of derivatives were as follows as of the dates indicated: June 30, 2023 December 31, 2022 Notional Asset Liability Notional Asset Liability Derivatives: Qualifying for hedge accounting (1) Fair value hedges: Foreign exchange contracts $ 103 $ 1 $ — $ 81 $ — $ 6 Cash flow hedges: Interest rate contracts 44 — — 22 — — Foreign exchange contracts 745 54 3 718 71 2 Derivatives: Non-qualifying for hedge accounting (1) Interest rate contracts 27,506 374 390 18,304 341 376 Foreign exchange contracts 249 4 1 160 9 2 Equity contracts 255 11 2 248 1 1 Credit contracts 177 — 4 174 — 2 Embedded derivatives and Managed custody guarantees: Within fixed maturity investments (2) N/A 2 — N/A 3 — Within reinsurance agreements (4) N/A 78 47 N/A 95 46 Managed custody guarantees (3) N/A — 3 N/A — 6 Total $ 524 $ 450 $ 520 $ 441 (1) Open derivative contracts are reported as Derivatives assets or liabilities on the Condensed Consolidated Balance Sheets at fair value. (2) Included in Fixed maturities, available-for-sale, at fair value on the Condensed Consolidated Balance Sheets. (3) Included in Contract owner account balances on the Condensed Consolidated Balance Sheets. (4) Included in Other liabilities, Other assets and Premium receivable and reinsurance recoverable on the Condensed Consolidated Balance Sheets. N/A - Not applicable The Company utilizes derivative contracts mainly to hedge exposure to variability in cash flows, interest rate risk, credit risk, foreign exchange risk and equity market risk. The majority of derivatives used by the Company are designated as product hedges, which hedge the exposure arising from insurance liabilities or guarantees embedded in the contracts the Company offers through various product lines. The Company also uses derivatives contracts to hedge its exposure to various risks associated with the investment portfolio. The Company also uses credit default swaps coupled with other investments in order to produce the investment characteristics of otherwise permissible investments. Based on the notional amounts, a substantial portion of the Company’s derivative positions was not designated or did not qualify for hedge accounting as part of a hedging relationship as outlined in ASC Topic 815 as of June 30, 2023 and December 31, 2022. Although the Company has not elected to net its derivative exposures, the notional amounts and fair values of Over-The-Counter ("OTC") and cleared derivatives excluding exchange traded contracts are presented in the tables below as of the dates indicated: June 30, 2023 Notional Amount Asset Fair Value Liability Fair Value Credit contracts $ 177 $ — $ 4 Equity contracts 225 11 2 Foreign exchange contracts 1,097 59 4 Interest rate contracts 24,444 374 389 444 399 Counterparty netting (1) (341) (341) Cash collateral netting (1) (96) (52) Securities collateral netting (1) (5) (5) Net receivables/payables $ 2 $ 1 (1) Represents the netting of receivable balances with payable balances, net of collateral, for the same counterparty under eligible netting agreements. December 31, 2022 Notional Amount Asset Fair Value Liability Fair Value Credit contracts $ 174 $ — $ 2 Equity contracts 201 1 1 Foreign exchange contracts 959 80 10 Interest rate contracts 13,328 339 376 420 389 Counterparty netting (1) (295) (295) Cash collateral netting (1) (64) (88) Securities collateral netting (1) (6) (1) Net receivables/payables $ 55 $ 5 (1) Represents the netting of receivable balances with payable balances, net of collateral, for the same counterparty under eligible netting agreements. Collateral Under the terms of the OTC Derivative International Swaps and Derivatives Association, Inc. ("ISDA") agreements, the Company may receive from, or deliver to, counterparties collateral to assure that terms of the ISDA agreements will be met with regard to the Credit Support Annex ("CSA"). The terms of the CSA call for the Company to pay interest on any cash received equal to the Federal Funds rate. To the extent cash collateral is received and delivered, it is included in Payables under securities loan and repurchase agreements, including collateral held and Short-term investments under securities loan agreements, including collateral delivered, respectively, on the Condensed Consolidated Balance Sheets and is reinvested in short-term investments. Collateral held is used in accordance with the CSA to satisfy any obligations. Investment grade bonds owned by the Company are the source of noncash collateral posted, which is reported in Securities pledged on the Condensed Consolidated Balance Sheets. As of June 30, 2023, the Company held $98 and pledged $55 of net cash collateral related to OTC derivative contracts and cleared derivative contracts, respectively. As of December 31, 2022, the Company held $56 and pledged $79 of net cash collateral related to OTC derivative contracts and cleared derivative contracts, respectively. In addition, as of June 30, 2023, the Company delivered $175 of securities and held $6 of securities as collateral. As of December 31, 2022, the Company delivered $142 of securities and held $7 of securities as collateral. The location and effect of derivatives qualifying for hedge accounting on the Condensed Consolidated Statements of Operations and Condensed Consolidated Statements of Comprehensive Income are as follows for the periods indicated: Three Months Ended June 30, 2023 2022 Interest Rate Contracts Foreign Exchange Contracts Interest Rate Contracts Foreign Exchange Contracts Derivatives: Qualifying for hedge accounting Location of Gain (Loss) Reclassified from Accumulated Other Comprehensive Income into Income Net investment income Net investment income and Net gains/(losses) Net investment income Net investment income and Net gains/(losses) Amount of Gain (Loss) Recognized in Other Comprehensive Income $ — $ (6) $ (1) $ 55 Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Income — 2 — 2 Six Months Ended June 30, 2023 2022 Interest Rate Contracts Foreign Exchange Contracts Interest Rate Contracts Foreign Exchange Contracts Derivatives: Qualifying for hedge accounting Location of Gain (Loss) Reclassified from Accumulated Other Comprehensive Income into Income Net investment income Net investment income and Net gains/(losses) Net investment income Net investment income and Net gains/(losses) Amount of Gain (Loss) Recognized in Other Comprehensive Income $ — $ (18) $ (2) $ 62 Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Income — 5 — 5 The location and amount of gain (loss) recognized in the Condensed Consolidated Statements of Operations for derivatives qualifying for hedge accounting are as follows for the periods indicated: Three Months Ended June 30, 2023 2022 Net investment income Net gains/(losses) Net investment income Net gains/(losses) Total amounts of line items presented in the statements of operations in which the effects of fair value or cash flow hedges are recorded $ 545 $ (56) $ 581 $ (226) Derivatives: Qualifying for hedge accounting Fair value hedges: Foreign exchange contracts: Hedged items — — — (5) Derivatives designated as hedging instruments (1) — — — 6 Cash flow hedges: Foreign exchange contracts: Gain (loss) reclassified from accumulated other comprehensive income into income 2 — 2 — Six Months Ended June 30, 2023 2022 Net investment income Net gains/(losses) Net investment income Net gains/(losses) Total amounts of line items presented in the statements of operations in which the effects of fair value or cash flow hedges are recorded $ 1,090 $ (72) $ 1,211 $ (514) Derivatives: Qualifying for hedge accounting Fair value hedges: Foreign exchange contracts: Hedged items — 2 — (7) Derivatives designated as hedging instruments (1) — (1) — 8 Cash flow hedges: Foreign exchange contracts: Gain (loss) reclassified from accumulated other comprehensive income into income 5 — 5 — (1) For the three months ended June 30, 2023, an immaterial amount of the change in derivative instruments designated and qualifying as fair value hedges was excluded from the assessment of hedge effectiveness and recognized currently in earning. For the six months ended June 30, 2023, $1 of the change in derivative instruments designated and qualifying as fair value hedges was excluded from the assessment of hedge effectiveness and recognized currently in earning. For the three and six months ended June 30, 2022, $1 of the change in derivative instruments designated and qualifying as fair value hedges was excluded from the assessment of hedge effectiveness and recognized currently in earning. The location and effect of derivatives not designated as hedging instruments on the Condensed Consolidated Statements of Operations are as follows for the periods indicated: Location of Gain (Loss) on Derivative Three Months Ended June 30, 2023 2022 Derivatives: Non-qualifying for hedge accounting Interest rate contracts Net gains (losses) $ 114 $ 52 Foreign exchange contracts Net gains (losses) — (1) Equity contracts Net gains (losses) 5 (20) Credit contracts Net gains (losses) — (4) Embedded derivatives and Managed custody guarantees: Within fixed maturity investments Net gains (losses) (2) (2) Within reinsurance agreements (1) Policyholder benefits 8 84 Managed custody guarantees Net gains (losses) — 1 Total $ 125 $ 110 Location of Gain (Loss) on Derivative Six Months Ended June 30, 2023 2022 Derivatives: Non-qualifying for hedge accounting Interest rate contracts Net gains (losses) $ 58 $ 152 Foreign exchange contracts Net gains (losses) 1 (2) Equity contracts Net gains (losses) 8 (28) Credit contracts Net gains (losses) (1) (4) Embedded derivatives and Managed custody guarantees: Within fixed maturity investments Net gains (losses) (1) (6) Within reinsurance agreements (1) Policyholder benefits (18) 176 Managed custody guarantees Net gains (losses) 3 (2) Total $ 50 $ 286 (1) For the three and six months ended June 30, 2023, the amount excludes immaterial gains (losses) from standalone derivatives that were recognized in Net gains (losses). For the three months ended June 30, 2022, no gains (losses) from standalone derivatives were recognized. For the six months ended June 30, 2022, the amount excluded gains (losses) of $1 from standalone derivatives recognized in Net gains (losses).

Fair Value Measurements (exclud

Fair Value Measurements (excluding Consolidated Investment Entities)	6 Months Ended
	Jun. 30, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements (excluding Consolidated Investment Entities)	Fair Value Measurements (excluding Consolidated Investment Entities) Fair Value Measurement The following table presents the Company's hierarchy for its assets and liabilities measured at fair value on a recurring basis as of June 30, 2023: Level 1 Level 2 Level 3 Total Assets: Fixed maturities, including securities pledged: U.S. Treasuries $ 367 $ 58 $ — $ 425 U.S. Government agencies and authorities — 55 1 56 State, municipalities and political subdivisions — 822 — 822 U.S. corporate public securities — 7,858 20 7,878 U.S. corporate private securities — 3,003 1,732 4,735 Foreign corporate public securities and foreign governments (1) — 2,767 — 2,767 Foreign corporate private securities (1) — 2,502 413 2,915 Residential mortgage-backed securities — 3,571 57 3,628 Commercial mortgage-backed securities — 3,676 — 3,676 Other asset-backed securities — 2,246 45 2,291 Total fixed maturities, including securities pledged 367 26,558 2,268 29,193 Equity securities 117 — 192 309 Derivatives: Interest rate contracts — 374 — 374 Foreign exchange contracts — 59 — 59 Equity contracts — 11 — 11 Embedded derivative on reinsurance — 78 — 78 Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements 2,297 36 — 2,333 Assets held in separate accounts 83,005 5,502 344 88,851 Total assets $ 85,786 $ 32,618 $ 2,804 $ 121,208 Percentage of Level to total 71 % 27 % 2 % 100 % Liabilities: Contingent consideration $ — $ — $ 112 $ 112 Stabilizer and MCGs — — 3 3 Derivatives: Interest rate contracts 4 386 — 390 Foreign exchange contracts — 4 — 4 Equity contracts — 2 — 2 Credit contracts — 4 — 4 Embedded derivative on reinsurance — (11) (2) 58 (3) 47 Total liabilities $ 4 $ 385 $ 173 $ 562 (1) Primarily U.S. dollar denominated. (2) The Company classifies the embedded derivative within liabilities given the underlying nature of the balance and the right-of-offset. (3) Represents the standalone derivative. The following table presents the Company's hierarchy for its assets and liabilities measured at fair value on a recurring basis as of December 31, 2022: Level 1 Level 2 Level 3 Total Assets: Fixed maturities, including securities pledged: U.S. Treasuries $ 433 $ 148 $ — $ 581 U.S. Government agencies and authorities — 58 1 59 State, municipalities and political subdivisions — 845 — 845 U.S. corporate public securities — 8,181 20 8,201 U.S. corporate private securities — 2,891 1,801 4,692 Foreign corporate public securities and foreign governments (1) — 2,946 3 2,949 Foreign corporate private securities (1) — 2,602 432 3,034 Residential mortgage-backed securities — 3,949 28 3,977 Commercial mortgage-backed securities — 3,883 — 3,883 Other asset-backed securities — 2,072 64 2,136 Total fixed maturities, including securities pledged 433 27,575 2,349 30,357 Equity securities 140 — 196 336 Derivatives: Interest rate contracts 2 339 — 341 Foreign exchange contracts — 80 — 80 Equity contracts — 1 — 1 Embedded derivative on reinsurance — 95 — 95 Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements 2,430 24 — 2,454 Assets held in separate accounts 74,600 5,227 347 80,174 Total assets $ 77,605 $ 33,341 $ 2,892 $ 113,838 Percentage of Level to total 68 % 29 % 3 % 100 % Liabilities: Contingent consideration $ — $ — $ 112 $ 112 Stabilizer and MCGs — — 6 6 Derivatives: Interest rate contracts 3 373 — 376 Foreign exchange contracts — 10 — 10 Equity contracts — 1 — 1 Credit contracts — 2 — 2 Embedded derivative on reinsurance — (12) (2) 58 (3) 46 Total liabilities $ 3 $ 374 $ 176 $ 553 (1) Primarily U.S. dollar denominated. (2) The Company classifies the embedded derivative within liabilities given the underlying nature of the balance and the right-of-offset. (3) Represents the standalone derivative. Valuation of Financial Assets and Liabilities at Fair Value Certain assets and liabilities are measured at estimated fair value on the Company's Consolidated Balance Sheets. The Company defines fair value as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The exit price and the transaction (or entry) price will be the same at initial recognition in many circumstances. However, in certain cases, the transaction price may not represent fair value. The fair value of a liability is based on the amount that would be paid to transfer a liability to a third-party with an equal credit standing. Fair value is required to be a market-based measurement that is determined based on a hypothetical transaction at the measurement date, from a market participant’s perspective. The Company considers three broad valuation approaches when a quoted price is unavailable: (i) the market approach, (ii) the income approach and (iii) the cost approach. The Company determines the most appropriate valuation technique to use, given the instrument being measured and the availability of sufficient inputs. The Company prioritizes the inputs to fair valuation approaches and allows for the use of unobservable inputs to the extent that observable inputs are not available. The Company utilizes a number of valuation methodologies to determine the fair values of its financial assets and liabilities in conformity with the concepts of exit price and the fair value hierarchy as prescribed in ASC Topic 820. Valuations are obtained from third-party commercial pricing services, brokers and industry-standard, vendor-provided software that models the value based on market observable inputs. The valuations obtained from third-party commercial pricing services are non-binding. The Company reviews the assumptions and inputs used by third-party commercial pricing services for each reporting period in order to determine an appropriate fair value hierarchy level. The documentation and analysis obtained from third-party commercial pricing services are reviewed by the Company, including in-depth validation procedures confirming the observability of inputs. The valuations are reviewed and validated monthly through the internal valuation committee price variance review, comparisons to internal pricing models, back testing to recent trades or monitoring of trading volumes. When available, the fair value of the Company's financial assets and liabilities are based on quoted prices of identical assets in active markets and therefore, reflected in Level 1. The valuation approaches and key inputs for each category of assets or liabilities that are classified within Level 2 and Level 3 of the fair value hierarchy are presented below. For fixed maturities classified as Level 2 assets, fair values are determined using a matrix-based market approach, based on prices obtained from third-party commercial pricing services and the Company’s matrix and analytics-based pricing models, which in each case incorporate a variety of market observable information as valuation inputs. The market observable inputs used for these fair value measurements, by fixed maturity asset class, are as follows: U.S. Treasuries: Fair value is determined using third-party commercial pricing services, with the primary inputs being stripped interest and principal U.S. Treasury yield curves that represent a U.S. Treasury zero-coupon curve. U.S. government agencies and authorities, State, municipalities and political subdivisions: Fair value is determined using third-party commercial pricing services, with the primary inputs being U.S. Treasury yield curves, trades of comparable securities, credit spreads off benchmark yields and issuer ratings. U.S. corporate public securities, Foreign corporate public securities and foreign governments: Fair value is determined using third-party commercial pricing services, with the primary inputs being benchmark yields, trades of comparable securities, issuer ratings, bids and credit spreads off benchmark yields. U.S. corporate private securities and Foreign corporate private securities: Fair values are determined using a matrix and analytics-based pricing model. The model incorporates the current level of risk-free interest rates, current corporate credit spreads, credit quality of the issuer and cash flow characteristics of the security. The model also considers a liquidity spread, the value of any collateral, the capital structure of the issuer, the presence of guarantees, and prices and quotes for comparably rated publicly traded securities. RMBS, CMBS and ABS: Fair value is determined using third-party commercial pricing services, with the primary inputs being credit spreads off benchmark yields, prepayment speed assumptions, current and forecasted loss severity, debt service coverage ratios, collateral type, payment priority within tranche and the vintage of the loans underlying the security. Generally, the Company does not obtain more than one vendor price from pricing services per instrument. The Company uses a hierarchy process in which prices are obtained from a primary vendor and, if that vendor is unable to provide the price, the next vendor in the hierarchy is contacted until a price is obtained or it is determined that a price cannot be obtained from a commercial pricing service. When a price cannot be obtained from a commercial pricing service, independent broker quotes are solicited. Securities priced using independent broker quotes are classified as Level 3. Fair values of privately placed bonds are determined primarily using a matrix-based pricing model and are generally classified as Level 2 assets. The model considers the current level of risk-free interest rates, current corporate spreads, the credit quality of the issuer and cash flow characteristics of the security. Also considered are factors such as the net worth of the borrower, the value of collateral, the capital structure of the borrower, the presence of guarantees and the Company’s evaluation of the borrower’s ability to compete in its relevant market. Using this data, the model generates estimated market values, which the Company considers reflective of the fair value of each privately placed bond. Equity securities: Level 2 and Level 3 equity securities, typically private equities or equity securities not traded on an exchange, are valued by other sources such as analytics or brokers. Derivatives: Derivatives are carried at fair value, which is determined using the Company’s derivative accounting system in conjunction with observable key financial data from third-party sources, such as yield curves, exchange rates, S&P 500 Index prices, London Interbank Offered Rates ("LIBOR"), Overnight Index Swap ("OIS") rates, and Secured Overnight Financing Rate ("SOFR"). The Company uses SOFR discounting for valuations of interest rate derivatives; however, certain legacy positions may continue to be discounted on OIS. The Company uses OIS for valuations of collateralized interest rate derivatives, which are obtained from third-party sources. For those derivatives that are unable to be valued by the accounting system, the Company typically utilizes values established by third-party brokers. Counterparty credit risk is considered and incorporated in the Company’s valuation process through counterparty credit rating requirements and monitoring of overall exposure. It is the Company’s policy to transact only with investment grade counterparties with a credit rating of A- or better. The Company’s nonperformance risk is also considered and incorporated in the Company’s valuation process. The Company also has certain credit default swaps and options that are priced by third party vendors or by using models that primarily use market observable inputs, but contain inputs that are not observable to market participants, which have been classified as Level 3. The remaining derivative instruments are valued based on market observable inputs and are classified as Level 2. Contingent consideration: The fair value of the contingent consideration liability associated with the Company’s acquisitions uses unobservable inputs and as such are reported as Level 3. Unobservable inputs include projected revenues, duration of earnouts and other metrics as well as discount rate. Changes in the fair value of the contingent consideration are recorded in Operating expenses in the Company’s Condensed Consolidated Statements of Operations. The Company records reserves for Stabilizer and MCG contracts containing guaranteed credited rates. The guarantee is treated as an embedded derivative or a stand-alone derivative (depending on the underlying product) and is required to be reported at fair value. The estimated fair value is determined based on the present value of projected future claims, minus the present value of future guaranteed premiums. At inception of the contract, the Company projects a guaranteed premium to be equal to the present value of the projected future claims. The income associated with the contracts is projected using relevant actuarial and capital market assumptions, including benefits and related contract charges, over the anticipated life of the related contracts. The cash flow estimates are projected under multiple capital market scenarios using observable risk-free rates and other best estimate assumptions. These derivatives are classified as Level 3 liabilities. The discount rate used to determine the fair value of the Company's Stabilizer embedded derivative liabilities and the stand-alone derivative for MCG includes an adjustment to reflect the risk that these obligations will not be fulfilled ("nonperformance risk"). The nonperformance risk adjustment incorporates a blend of observable, similarly rated peer holding company credit spreads, adjusted to reflect the credit quality of the individual insurance subsidiary that issued the guarantee, as well as an adjustment to reflect the non-default spreads and the priority and recovery rates of policyholder claims. Embedded derivatives on reinsurance: The carrying value of embedded derivatives is estimated based upon the change in the fair value of the assets supporting the funds withheld payable under reinsurance agreements. The fair value of the embedded derivative is based on market observable inputs and is classified as Level 2. The remaining derivative instruments are classified as Level 3 and are estimated using the income approach. The fair value is calculated by estimating future cash flows for a certain discrete projection period, estimating the terminal value, if appropriate, and discounting these amounts to present value at a rate of return that considers the relative risk of the cash flows and the time value of money. Level 3 Financial Instruments The fair values of certain assets and liabilities are determined using prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement (i.e., Level 3 as defined by ASC Topic 820), including but not limited to liquidity spreads for investments within markets deemed not currently active. These valuations, whether derived internally or obtained from a third-party, use critical assumptions that are not widely available to estimate market participant expectations in valuing the asset or liability. In addition, the Company has determined, for certain financial instruments, an active market is such a significant input to determine fair value that the presence of an inactive market may lead to classification in Level 3. In light of the methodologies employed to obtain the fair values of financial assets and liabilities classified as Level 3, additional information is presented below. The following tables summarize the change in fair value of the Company's Level 3 assets and liabilities and transfers in and out of Level 3 for the periods indicated: Three Months Ended June 30, 2023 Fair Value as of April 1 Realized/Unrealized Purchases Issuances Sales Settlements Transfers Transfers Fair Value as of June 30 Change In (3) Change In Unrealized Gains (Losses) Included in OCI (3) Net OCI Fixed maturities, including securities pledged: U.S. Government agencies and authorities $ 1 $ — $ — $ — $ — $ — $ — $ — $ — $ 1 $ — $ — U.S. corporate public securities 21 — (1) — — — — — — 20 — — U.S. corporate private securities 1,800 — (29) 20 — (3) (56) — — 1,732 — (29) Foreign corporate private securities (1) 441 1 — 19 — — (93) 45 — 413 1 — Residential mortgage-backed securities 56 (3) — 4 — — — — — 57 (3) — Other asset-backed securities 77 — — 4 — — (1) — (35) 45 — — Total fixed maturities, including securities pledged 2,396 (2) (30) 47 — (3) (150) 45 (35) 2,268 (2) (29) Equity securities, at fair value 192 — — — — — — — — 192 — — Contingent consideration (112) — — — — — — — — (112) — — Stabilizer and MCGs (2) (3) — — — — — — — — (3) — — Embedded derivatives on reinsurance (58) — — — — — — — — (58) — — Assets held in separate accounts (4) 349 (8) — 7 — (7) — 3 — 344 — — (1) Primarily U.S. dollar denominated. (2) All gains and losses on Level 3 liabilities are classified as realized gains (losses) for the purpose of this disclosure because it is impracticable to track realized and unrealized gains (losses) separately on a contract by contract basis. These amounts are included in Net gains (losses) in the Condensed Consolidated Statements of Operations. (3) For financial instruments still held as of June 30 amounts are included in Net investment income and Net gains (losses) in the Condensed Consolidated Statements of Operations or Unrealized gains (losses) on securities in the Condensed Consolidated Statements of Comprehensive Income. (4) The investment income and realized gains (losses) and change in unrealized gains (losses) included in net income for separate account assets are offset by an equal amount for separate account liabilities, which results in a net zero impact on Net income (loss) for the Company. Six Months Ended June 30, 2023 Fair Value as of January 1 Realized/Unrealized Purchases Issuances Sales Settlements Transfers Transfers Fair Value as of June 30 Change In (3) Change In Unrealized Gains (Losses) Included in OCI (3) Net OCI Fixed maturities, including securities pledged: U.S. Government agencies and authorities $ 1 $ — $ — $ — $ — $ — $ — $ — $ — $ 1 $ — $ — U.S. corporate public securities 20 — — — — — — — — 20 — — U.S. corporate private securities 1,801 — 6 61 — (3) (133) — — 1,732 1 5 Foreign corporate public securities and foreign governments (1) 3 — — — — — — — (3) — — — Foreign corporate private securities (1) 432 3 7 75 — — (181) 77 — 413 3 6 Residential mortgage-backed securities 28 (3) — 32 — — — — — 57 (3) — Other asset-backed securities 64 — — 4 — — (1) — (22) 45 — — Total fixed maturities, including securities pledged 2,349 — 13 172 — (3) (315) 77 (25) 2,268 1 11 Equity securities, at fair value 196 (4) — — — — — — — 192 (3) — Contingent consideration (112) — — — — — — — — (112) — — Stabilizer and MCGs (2) (6) 4 — — (1) — — — — (3) — — Embedded derivatives on reinsurance (58) — — — — — — — — (58) — — Assets held in separate accounts (4) 347 (4) — 7 — (9) — 3 — 344 — — (1) Primarily U.S. dollar denominated. (2) All gains and losses on Level 3 liabilities are classified as realized gains (losses) for the purpose of this disclosure because it is impracticable to track realized and unrealized gains (losses) separately on a contract by contract basis. These amounts are included in Net gains (losses) in the Condensed Consolidated Statements of Operations. (3) For financial instruments still held as of June 30 amounts are included in Net investment income and Net gains (losses) in the Condensed Consolidated Statements of Operations or Unrealized gains (losses) on securities in the Condensed Consolidated Statements of Comprehensive Income. (4) The investment income and realized gains (losses) and change in unrealized gains (losses) included in net income for separate account assets are offset by an equal amount for separate account liabilities, which results in a net zero impact on Net income (loss) for the Company. Three Months Ended June 30, 2022 Fair Value as of April 1 Realized/Unrealized Purchases Issuances Sales Settlements Transfers Transfers Fair Value as of June 30 Change In (3) Change In Unrealized Gains (Losses) Included in OCI (3) Net OCI Fixed maturities, including securities pledged: U.S. corporate public securities $ 71 $ — $ (1) $ 1 $ — $ — $ — $ — $ (52) $ 19 $ — $ 1 U.S. corporate private securities 1,925 (1) (134) 89 — — (58) — (41) 1,780 (1) (133) Foreign corporate public securities and foreign governments (1) 11 — — 4 — — — — (11) 4 — — Foreign corporate private securities (1) 496 (3) (7) 51 — — (15) — (119) 403 (4) (7) Residential mortgage-backed securities 45 (6) — 2 — — (9) 1 (2) 31 (6) — Other asset-backed securities 49 — (2) 35 — — (5) — (14) 63 — (2) Total fixed maturities, including securities pledged 2,597 (10) (144) 182 — — (87) 1 (239) 2,300 (11) (143) Equity securities, at fair value 203 (17) — 26 — — — — (9) 203 (17) — Contingent consideration (11) — — — — — — — — (11) — — Stabilizer and MCGs (2) (15) 11 — — — — — — — (4) — — Embedded derivatives on (86) — — — — — — — — (86) — — Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements 8 — — — — — (8) — — — — — Assets held in separate accounts (4) 334 (12) — 67 — (3) — — (37) 349 — — (1) Primarily U.S. dollar denominated. (2) All gains and losses on Level 3 liabilities are classified as realized gains (losses) for the purpose of this disclosure because it is impracticable to track realized and unrealized gains (losses) separately on a contract by contract basis. These amounts are included in Net gains (losses) in the Condensed Consolidated Statements of Operations. (3) For financial instruments still held as of June 30, amounts are included in Net investment income and Net gains (losses) in the Condensed Consolidated Statements of Operations or Unrealized gains (losses) on securities in the Condensed Consolidated Statements of Comprehensive Income. (4) The investment income and realized gains (losses) and change in unrealized gains (losses) included in net income for separate account assets are offset by an equal amount for separate account liabilities, which results in a net zero impact on Net income (loss) for the Company. Six Months Ended June 30, 2022 Fair Value as of January 1 Realized/Unrealized Purchases Issuances Sales Settlements Transfers Transfers Fair Value as of June 30 Change In (3) Change In Unrealized Gains (Losses) Included in OCI (3) Net OCI Fixed maturities, including securities pledged: U.S. corporate public securities $ 16 $ — $ (1) $ 5 $ — $ — $ — $ — $ (1) $ 19 $ — $ (1) U.S. corporate private securities 1,910 (2) (277) 158 — — (120) 121 (10) 1,780 (2) (276) Foreign corporate public securities and foreign governments (1) — — — 4 — — — — — 4 — — Foreign corporate private securities (1) 353 (22) (31) 97 — — (28) 148 (114) 403 (4) (31) Residential mortgage-backed securities 43 (15) — 4 — — — 1 (2) 31 (15) — Other asset-backed securities 44 — (4) 39 — (10) (6) — — 63 — (4) Total fixed maturities, including securities pledged 2,366 (39) (313) 307 — (10) (154) 270 (127) 2,300 (21) (312) Equity securities, at fair value 203 (26) — 26 — — — — — 203 (26) — Contingent consideration (11) — — — — — — — — (11) — — Stabilizer and MCGs (2) (20) 17 — — (1) — — — — (4) — — Embedded derivatives on reinsurance (87) 1 — — — — — — — (86) — — Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements — — — 8 — — (8) — — — — — Assets held in separate accounts (4) 316 (26) — 132 — (4) — 6 (75) 349 — — (1) Primarily U.S. dollar denominated. (2) All gains and losses on Level 3 liabilities are classified as realized gains (losses) for the purpose of this disclosure because it is impracticable to track realized and unrealized gains (losses) separately on a contract by contract basis. These amounts are included in Net gains (losses) in the Condensed Consolidated Statements of Operations. (3) For financial instruments still held as of June 30 amounts are included in Net investment income and Net gains (losses) in the Condensed Consolidated Statements of Operations or Unrealized gains (losses) on securities in the Condensed Consolidated Statements of Comprehensive Income. (4) The investment income and realized gains (losses) and change in unrealized gains (losses) included in net income for separate account assets are offset by an equal amount for separate account liabilities, which results in a net zero impact on Net income (loss) for the Company. For the three and six months ended June 30, 2023 and 2022, the transfers in and out of Level 3 for fixed maturities were due to the variation in inputs relied upon for valuation each quarter. Securities that are primarily valued using independent broker quotes when prices are not available from one of the commercial pricing services are reflected as transfers into Level 3. When securities are valued using more widely available information, the securities are transferred out of Level 3 and into Level 1 or 2, as appropriate. Significant Unobservable Inputs The Company's Level 3 fair value measurements of its fixed maturities, equity securities and equity and credit derivative contracts are primarily based on broker quotes for which the quantitative detail of the unobservable inputs is neither provided nor reasonably corroborated, thus negating the ability to perform a sensitivity analysis. The Company performs a review of broker quotes by performing a monthly price variance comparison and back tests broker quotes to recent trade prices. Other Financial Instruments The following disclosures are made in accordance with the requirements of ASC Topic 825 which requires disclosure of fair value information about financial instruments, whether or not recognized at fair value on the Condensed Consolidated Balance Sheets. ASC Topic 825 excludes certain financial instruments, including insurance contracts and all nonfinancial instruments from its disclosure requirements. Accordingly, the aggregate fair value amounts presented do not represent the underlying value of the Company. The carrying values and estimated fair values of the Company's financial instruments as of the dates indicated: June 30, 2023 December 31, 2022 Carrying Fair Carrying Fair Assets: Fixed maturities, including securities pledged $ 29,193 $ 29,193 $ 30,357 $ 30,357 Equity securities 309 309 336 336 Mortgage loans on real estate 5,366 4,998 5,445 5,149 Policy loans 358 358 363 363 Cash, cash equivalents, short-term investments and short-term investments under securities loan agreements 2,333 2,333 2,454 2,454 Derivatives 444 444 422 422 Embedded derivatives on reinsurance 78 78 95 95 Other investments 69 69 68 68 Assets held in separate accounts 88,851 88,851 80,174 80,174 Liabilities: Investment contract liabilities: Funding agreements without fixed maturities and deferred annuities (1) $ 34,335 $ 35,615 $ 35,707 $ 36,385 Funding agreements with fixed maturities 1,290 1,298 1,285 1,281 Supplementary contracts, immediate annuities and other 673 614 727 636 Stabilizer and MCGs 3 3 6 6 Derivatives 400 400 389 389 Embedded derivative on reinsurance 47 47 46 46 Short-term debt 143 143 141 142 Long-term debt 2,095 1,941 2,094 1,935 (1) Certain amounts included in Funding agreements without fixed maturities and deferred annuities are also reflected within the Stabilizer and MCGs section of the table above. The following table presents the classifications of financial instruments which are not carried at fair value on the Condensed Consolidated Balance Sheets: Financial Instrument Classification Mortgage loans on real estate Level 3 Policy loans Level 2 Other investments Level 2 Funding agreements without fixed maturities and deferred annuities Level 3 Funding agreements with fixed maturities Level 2 Supplementary contracts and immediate annuities Level 3 Short-term debt and Long-term debt Level 2

Deferred Policy Acquisition Cos

Deferred Policy Acquisition Costs and Value of Business Acquired	6 Months Ended
	Jun. 30, 2023
Deferred Policy Acquisition Costs and Present Value of Future Insurance Profits, Net [Abstract]
Deferred Policy Acquisition Costs and Value of Business Acquired	Deferred Policy Acquisition Costs and Value of Business Acquired The following tables present a rollforward of DAC and VOBA for the periods indicated: DAC VOBA Wealth Solutions Deferred and Individual Annuities Businesses exited Balance as of January 1, 2022 $ 691 $ 1,158 $ 473 Deferrals of commissions and expenses 59 — 5 Amortization expense (59) (115) (39) Balance as of December 31, 2022 $ 691 $ 1,043 $ 439 Deferrals of commissions and expenses 29 — 2 Amortization expense (28) (53) (19) Balance as of June 30, 2023 $ 692 $ 990 $ 422 The following table shows a reconciliation of DAC and VOBA balances to the Condensed Consolidated Balance Sheets for the periods indicated: June 30, 2023 December 31, 2022 DAC: Wealth Solutions Deferred and Individual Annuities $ 692 $ 691 Businesses exited 990 1,043 Other 200 190 VOBA 422 439 Total $ 2,304 $ 2,363

Financial Services, Insurance,

Financial Services, Insurance, ASU 2018-12 Transition	6 Months Ended
	Jun. 30, 2023
Reserves for Future Policy Benefits and Contract Owner Balances [Abstract]
Liability for Future Policy Benefits and Unpaid Claims Disclosure	Reserves for Future Policy Benefits and Contract Owner Account Balances The balances and changes in the liability for future policy benefits for Health Solutions Group, Health Solutions Voluntary and Businesses Exited are presented in the tables below for the periods indicated: Health Solutions Group Health Solutions Voluntary Businesses Exited June 30, 2023 December 31, 2022 June 30, 2023 December 31, 2022 June 30, 2023 December 31, 2022 Present Value of Expected Net Premiums: Balance at January 1 $ 77 $ 93 $ 97 $ 105 $ 4,244 $ 5,634 Beginning balance at original discount rate 84 85 100 92 4,128 4,226 Effect of change in cash flow assumptions — (7) — — — (69) Effect of actual variances from expected experience 12 23 5 20 (37) 86 Adjusted balance at January 1 96 101 105 112 4,091 4,243 Interest accrual 1 2 2 4 112 230 Net premiums collected (1) (11) (19) (8) (16) (161) (345) Ending balance at original discount rate 86 84 99 100 4,042 4,128 Effects of changes in discount rate assumptions (6) (7) (3) (3) 153 116 Balance at end of period $ 80 $ 77 $ 96 $ 97 $ 4,195 $ 4,244 Present Value of Expected Future Policy Benefits: Balance at January 1 $ 881 $ 1,048 $ 285 $ 359 $ 8,639 $ 11,444 Beginning balance at original discount rate 913 952 294 290 8,644 9,079 Effect of change in cash flow assumptions 4 (43) (1) (2) — (77) Effect of actual variances from expected experience (2) (27) 5 11 (41) (52) Adjusted balance at January 1 915 882 298 299 8,603 8,950 Issuances 68 139 — — 9 13 Interest accrual 12 25 7 14 220 458 Benefit payments (64) (133) (11) (19) (388) (777) Ending balance at original discount rate 931 913 294 294 8,444 8,644 Effects of changes in discount rate assumptions (34) (32) (5) (9) 51 (5) Balance at end of period $ 897 $ 881 $ 289 $ 285 $ 8,495 $ 8,639 Net liability for future policy benefits $ 816 $ 804 $ 193 $ 188 $ 4,300 $ 4,395 Less: Reinsurance recoverable 299 283 — — 4,412 4,411 Net liability for future policy benefits, after reinsurance recoverable $ 517 $ 521 $ 193 $ 188 $ (112) $ (16) (1) Net Premiums collected represent the portion of gross premiums collected from policyholders that is used to fund expected benefit payments. The reconciliation of the net liability for future policy benefits to the liability for future policy benefits in the Condensed Consolidated Balance Sheets is presented below: June 30, 2023 December 31, 2022 Health Solutions Group $ 816 $ 804 Health Solutions Voluntary 193 188 Businesses Exited - Future policy benefits 4,300 4,395 Businesses Exited – Additional liability 2,074 2,107 Other 2,270 2,225 Total $ 9,653 $ 9,719 The amount of undiscounted expected gross premiums and future benefit payments is presented in the table below: June 30, 2023 December 31, 2022 Undiscounted Discounted Undiscounted Discounted Health Solutions Group Expected future benefit payments $ 1,160 $ 931 $ 1,141 $ 913 Expected future gross premiums 288 231 286 231 Health Solutions Voluntary Expected future benefit payments 589 294 588 294 Expected future gross premiums 308 205 307 205 The following table presents a rollforward of the additional reserve liability for Businesses exited for the periods indicated: Businesses exited June 30, 2023 December 31, 2022 Balance at beginning of period $ 2,107 $ 1,715 Effect of change in cash flow assumptions — 540 Effect of actual variances from expected experience (58) 15 Adjusted balance at January 1 2,049 2,270 Interest accrual 43 80 Excess Benefits (209) (427) Assessments 191 184 Balance at end of period 2,074 2,107 Less: Reinsurance recoverable 2,021 2,054 Net additional liability, after reinsurance recoverable $ 53 $ 53 The following table presents the weighted average duration of the liability for future policy benefits and the weighted average interest rates for the periods indicated: Health Solutions Group Health Solutions Voluntary Businesses Exited June 30, 2023 December 31, 2022 June 30, 2023 December 31, 2022 June 30, 2023 December 31, 2022 Weighted average duration (in years) (1) 7 7 14 14 8 8 Interest accretion rate 4.0 % 4.1 % 5.3 % 5.3 % 4.9 % 5.0 % Current discount rate 5.2 % 5.2 % 5.2 % 5.4 % 5.4 % 5.7 % (1) Weighted average duration (in years) for Businesses Exited includes additional liability. The weighted average interest rates for the additional liability related to businesses exited were 4.2% and 4.3% for the periods ended June 30, 2023 and December 31, 2022, respectively. The following table presents a rollforward of Contract owner account balances for the periods indicated: Wealth Solutions Deferred Group and Individual Annuity Businesses Exited June 30, 2023 December 31, 2022 June 30, 2023 December 31, 2022 Balance at January 1 $ 33,622 $ 33,044 $ 5,146 $ 5,532 Deposits 1,171 2,962 147 310 Fee income (4) (8) (188) (384) Surrenders and withdrawals (2,740) (4,280) (230) (281) Benefit payments (88) (157) (81) (144) Net transfers from (to) separate accounts 70 1,174 (1) — Interest credited 440 874 73 150 Other 5 13 — (37) Ending Balance $ 32,476 $ 33,622 $ 4,866 $ 5,146 Weighted-average crediting rate 2.7 % 2.6 % 2.5 % 2.5 % Net amount at risk (1) $ 135 $ 199 $ 792 $ 900 Cash surrender value $ 31,995 $ 33,125 $ 1,669 $ 1,824 (1) For those guarantees of benefits that are payable in the event of death, the net amount at risk is generally defined as the current guaranteed minimum death benefit in excess of the current account balance at the balance sheet date and is calculated at a contract level. When a contract has both a living benefit and a death benefit, the Company calculates NAR at a contract level and aggregates the higher of the two values together. The following table shows a reconciliation of the Contract owner account balances to the Condensed Consolidated Balance Sheets for the periods indicated: June 30, 2023 December 31, 2022 Wealth Solutions Deferred group and individual annuity $ 32,476 $ 33,622 Businesses exited 4,866 5,146 Other 3,588 3,687 Total $ 40,930 $ 42,455 The following table summarizes detail on the differences between the interest rate being credited to contract holders as of June 30, 2023, and the respective guaranteed minimum interest rates ("GMIRs"): Account Value (1) Excess of crediting rate over GMIR At GMIR Up to .50% Above GMIR 0.51% - 1.00% 1.01% - 1.50% Above GMIR 1.51% - 2.00% Above GMIR More than 2.00% Above GMIR Total Guaranteed minimum interest rate Up to 1.00% $ 162 $ 6,577 $ 2,721 $ 1,872 $ 831 $ 741 $ 12,904 1.01% - 2.00% 575 142 52 4 2 6 781 2.01% - 3.00% 11,930 75 51 112 — 3 12,173 3.01% - 4.00% 9,320 153 1 2 — — 9,475 4.01% and Above 1,601 85 — — — — 1,685 Renewable beyond 12 months (MYGA) (2) 421 — — — 3 — 424 Total discretionary rate setting products $ 24,008 $ 7,032 $ 2,824 $ 1,990 $ 836 $ 751 $ 37,441 (1) Includes only the account values for investment spread products with GMIRs and discretionary crediting rates, net of policy loans. Excludes Stabilizer products, which are fee based. (2) Represents multi year guaranteed annuity ("MYGA") contracts with renewal dates after June 30, 2023 on which we are required to credit interest above the contractual GMIR for at least the next twelve months. The following table summarizes detail on the differences between the interest rate being credited to contract holders as of December 31, 2022 and the respective GMIRs: Account Value (1) Excess of crediting rate over GMIR At GMIR Up to .50% Above GMIR 0.51% - 1.00% 1.01% - 1.50% Above GMIR 1.51% - 2.00% Above GMIR More than 2.00% Above GMIR Total Guaranteed minimum interest rate Up to 1.00% $ 5,848 $ 2,967 $ 1,907 $ 1,112 $ 1,462 $ 102 $ 13,398 1.01% - 2.00% 707 52 35 2 2 7 805 2.01% - 3.00% 12,677 56 46 110 — 3 12,892 3.01% - 4.00% 9,448 153 — — — — 9,601 4.01% and Above 1,643 87 — — — — 1,730 Renewable beyond 12 months (MYGA) (2) 402 — — — 3 — 405 Total discretionary rate setting products $ 30,725 $ 3,315 $ 1,988 $ 1,224 $ 1,467 $ 112 $ 38,831 (1) Includes only the account values for investment spread products with GMIRs and discretionary crediting rates, net of policy loans. Excludes Stabilizer products, which are fee based.

Reinsurance

Reinsurance	6 Months Ended
	Jun. 30, 2023
Insurance [Abstract]
Reinsurance	Reinsurance The Company reinsures its business through a diversified group of reinsurers. However, the Company remains liable to the extent its reinsurers do not meet their obligations under the reinsurance agreements. The Company monitors trends in arbitration and any litigation outcomes with its reinsurers. Collectability of reinsurance balances are evaluated by monitoring ratings and evaluating the financial strength of its reinsurers. Large reinsurance recoverable balances with offshore or other non-accredited reinsurers are secured through various forms of collateral, including secured trusts, funds withheld accounts and irrevocable letters of credit ("LOC"). Information regarding the effect of reinsurance on the Condensed Consolidated Balance Sheets is as follows as of the periods indicated: June 30, 2023 Direct Assumed Ceded Total, Assets Premiums receivable $ 172 $ 10 $ (220) $ (38) Reinsurance recoverable, net of allowance for credit losses — — 12,169 12,169 Total $ 172 $ 10 $ 11,949 $ 12,131 Liabilities Future policy benefits and contract owner account balances $ 49,574 $ 1,009 $ — $ 50,583 Liability for funds withheld under reinsurance agreements 105 — — 105 Total $ 49,679 $ 1,009 $ — $ 50,688 December 31, 2022 Direct Assumed Ceded Total, Assets Premiums receivable $ 172 $ 11 $ (212) $ (29) Reinsurance recoverable, net of allowance for credit losses — — 12,455 12,455 Total $ 172 $ 11 $ 12,243 $ 12,426 Liabilities Future policy benefits and contract owner account balances $ 51,137 $ 1,037 $ — $ 52,174 Liability for funds withheld under reinsurance agreements 104 — — 104 Total $ 51,241 $ 1,037 $ — $ 52,278 Information regarding the effect of reinsurance on the Condensed Consolidated Statements of Operations is as follows for the periods indicated: Three Months Ended June 30, 2023 2022 Premiums: Direct premiums $ 902 $ 816 Reinsurance assumed 5 5 Reinsurance ceded (230) (224) Net premiums $ 677 $ 597 Fee income: Gross fee income $ 571 $ 513 Reinsurance assumed 5 4 Reinsurance ceded (102) (104) Net fee income $ 474 $ 413 Interest credited and other benefits to contract owners / policyholders: Direct interest credited and other benefits to contract owners / policyholders $ 1,014 $ 1,104 Reinsurance assumed 11 14 Reinsurance ceded (343) (464) Net interest credited and other benefits to contract owners / policyholders $ 682 $ 654 Six Months Ended June 30, 2023 2022 Premiums: Direct premiums $ 1,810 $ 1,624 Reinsurance assumed 15 14 Reinsurance ceded (463) (433) Net premiums $ 1,362 $ 1,205 Fee income: Gross fee income $ 1,133 $ 1,045 Reinsurance assumed 9 9 Reinsurance ceded (204) (208) Net fee income $ 938 $ 846 Interest credited and other benefits to contract owners / policyholders: Direct interest credited and other benefits to contract owners / policyholders $ 2,122 $ 2,080 Reinsurance assumed 30 22 Reinsurance ceded (719) (804) Net interest credited and other benefits to contract owners / policyholders $ 1,433 $ 1,298 If the Company determines that a reinsurance agreement does not expose the reinsurer to a reasonable possibility of a significant loss from insurance risk, the Company records the agreement using the deposit method of accounting. As of June 30, 2023 and December 31, 2022, the Company had a deposit asset of $1.4 billion and $1.5 billion, respectively, which is reported in Other assets on the Condensed Consolidated Balance Sheets.

Separate Accounts

Separate Accounts	6 Months Ended
	Jun. 30, 2023
Other Liabilities Disclosure [Abstract]
Separate Accounts	Separate Accounts The following tables present a rollforward of Separate account liabilities for the Wealth Solutions stabilizer and deferred annuity business, including a reconciliation to the Condensed Consolidated Balance Sheets, for the periods indicated: June 30, 2023 December 31, 2022 Wealth Solutions Stabilizer Wealth Solutions Deferred Annuity Total Wealth Solutions Stabilizer Wealth Solutions Deferred Annuity Total Balance at January 1 $ 7,196 $ 69,152 $ 76,348 $ 8,091 $ 86,927 $ 95,018 Policyholder behavior (1) (119) 322 203 (68) (1,309) (1,377) Fee income (17) (206) (223) (34) (423) (457) Investment performance 151 8,314 8,465 (794) (16,044) (16,838) Other — — — 1 1 2 Balance at end of period $ 7,211 $ 77,582 $ 84,793 $ 7,196 $ 69,152 $ 76,348 Reconciliation to Condensed Consolidated Balance Sheets: Other 4,058 3,826 Total Separate Account liabilities $ 88,851 $ 80,174 (1) Policyholder behavior includes premiums and deposits, surrenders and withdrawals, benefit payments, and net transfers to and from the general account. Stabilizer products allow the contract holder to select either the market value of the account or the book value of the account at termination. The book value of the account is equal to deposits plus interest, less any withdrawals. The fair value is estimated using the income approach. Cash surrender value represents the amount of the contract holders' account balances distributable at the balance sheet date, less certain surrender charges. The cash surrender value for Wealth Solutions deferred annuity products was $77,548 and $69,121, as of June 30, 2023 and December 31, 2022, respectively. The aggregate fair value of assets, by major investment asset category, supporting separate accounts was as follows for the periods indicated: June 30, 2023 December 31, 2022 US Treasury securities and obligations of US government corporations and agencies $ 1,157 $ 1,586 Corporate debt securities 1,791 1,647 Foreign debt securities 706 660 Mortgage-backed securities 3,274 3,434 Equity securities (including mutual funds) 81,063 72,309 Cash, cash equivalents and short-term investments 454 311 Receivable for securities and accruals 406 227 Total $ 88,851 $ 80,174

Share-based Incentive Compensat

Share-based Incentive Compensation Plans	6 Months Ended
	Jun. 30, 2023
Share-Based Payment Arrangement [Abstract]
Share-based Incentive Compensation Plans	Share-based Incentive Compensation Plans The Company offers equity-based compensation awards to its employees and non-employee directors under various employee and non-employee incentive plans (together, the "Omnibus Plans"). As of June 30, 2023, common stock reserved and available for issuance under the Omnibus Plans was 8,881,340 shares. Compensation Cost The following table summarizes share-based compensation expense, which includes expenses related to awards granted under the Omnibus Plans for the periods indicated: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Restricted Stock Unit (RSU) awards $ 16 $ 8 $ 53 $ 30 Performance Stock Unit (PSU) awards 10 7 36 31 Total share-based compensation expense 26 15 89 61 Income tax benefit 7 3 22 18 After-tax share-based compensation expense $ 19 $ 12 $ 67 $ 43 Awards Outstanding The following table summarizes RSU and PSU awards activity under the Omnibus Plans for the periods indicated: RSU Awards PSU Awards (awards in millions) Number of Awards Weighted Average Grant Date Fair Value Number of Awards Weighted Average Grant Date Fair Value Outstanding as of January 1, 2023 1.5 $ 60.91 2.1 $ 55.68 Adjustment for PSU performance factor — — (0.1) 61.50 Granted 1.7 70.49 0.8 66.10 Vested (1.0) 63.18 (0.5) 63.08 Forfeited — * 64.54 — * 63.48 Outstanding as of June 30, 2023 2.2 $ 67.06 2.3 $ 61.27 *Less than 0.1 The following table summarizes the number of options under the Omnibus Plans for the periods indicated: Stock Options (awards in millions) Number of Awards Weighted Average Exercise Price Outstanding as of January 1, 2023 1.6 $ 43.05 Granted — — Exercised (0.4) 38.11 Forfeited — — Outstanding as of June 30, 2023 1.2 $ 44.55 Vested, exercisable, as of June 30, 2023 1.2 $ 44.55

Shareholders' Equity

Shareholders' Equity	6 Months Ended
	Jun. 30, 2023
Equity [Abstract]
Shareholder's Equity	Shareholders' Equity Common Shares The following table presents the rollforward of common shares used in calculating the weighted average shares utilized in the basic earnings per common share calculation for the periods indicated: Common Shares (shares in millions) Issued Held in Treasury Outstanding Balance, January 1, 2022 109.0 1.2 107.8 Common shares issued 0.1 — 0.1 Common shares acquired - share repurchase — 11.7 (11.7) Share-based compensation 1.7 0.7 1.0 Treasury Stock retirement (13.0) (13.0) — Balance, December 31, 2022 97.8 0.6 97.2 Common shares issued 9.6 — 9.6 Common shares acquired - share repurchase — 2.3 (2.3) Share-based compensation 1.9 0.7 1.2 Balance, June 30, 2023 109.3 3.6 105.7 Dividends declared per share of Common Stock were as follows for the periods indicated: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Dividends declared per share of Common Stock $ 0.200 $ 0.200 $ 0.400 $ 0.400 On July 27, 2023, the Board of Directors authorized a third-quarter 2023 common stock dividend of $0.40 per share. Share Repurchase Program From time to time, the Company's Board of Directors authorizes the Company to repurchase shares of its common stock. These authorizations permit stock repurchases up to a prescribed dollar amount and generally may be accomplished through various means, including, without limitation, open market transactions, privately negotiated transactions, forward, derivative, or accelerated repurchase, or automatic repurchase transactions, including 10b5-1 plans, or tender offers. Share repurchase authorizations typically expire if unused by a prescribed date. As of June 30, 2023, the Company was authorized to repurchase shares up to an aggregate purchase amount of $109. On July 27, 2023, the Company's Board of Directors provided an additional share repurchase authorization of $500, increasing the aggregate amount of the Company's common stock authorized for repurchase to $609. This share repurchase authorization expires on September 30, 2024 (unless extended) and does not obligate the Company to purchase any shares. The authorization for the share repurchase program may be terminated, increased or decreased by the Company's Board of Directors at any time. During the six months ended June 30, 2023, the Company repurchased 2.3 million shares of common stock for $162. Warrants On May 7, 2013, the Company issued warrants to purchase up to 26,050,846 shares of the Company's common stock equal in the aggregate to 9.99% of the issued and outstanding shares of common stock on that date. On May 10, 2023, the warrants were net share settled in accordance with their terms, resulting in the issuance of 9.6 million common shares. No warrants remain outstanding as of June 30, 2023. For more information related to the warrants, refer to the Shareholders’ equity Note to the Consolidated Financial Statements included in Part II, Item 8. of the Annual Report on Form 10-K . Preferred Stock As of June 30, 2023 and December 31, 2022, there were 100,000,000 shares of preferred stock authorized. Preferred stock issued and outstanding are as follows: June 30, 2023 December 31, 2022 Series Issued Outstanding Issued Outstanding 6.125% Non-cumulative Preferred Stock, Series A 325,000 325,000 325,000 325,000 5.35% Non-cumulative Preferred Stock, Series B 300,000 300,000 300,000 300,000 Total 625,000 625,000 625,000 625,000 The declaration of dividends on preferred stock per share and in the aggregate were as follows for the periods indicated: Series A Series B Three Months Ended June 30, Per Share Aggregate Per Share Aggregate 2023 $ — $ — $ 13.375 $ 4 2022 — — 13.375 4 Six Months Ended June 30, 2023 $ 30.625 $ 10 $ 26.750 $ 8 2022 30.625 10 26.750 8 As of June 30, 2023, there were no preferred stock dividends in arrears.

Earnings per Common Share

Earnings per Common Share	6 Months Ended
	Jun. 30, 2023
Earnings Per Share [Abstract]
Earnings per Common Share	Earnings per Common Share The following table presents a reconciliation of Net income (loss) and shares used in calculating basic and diluted net income (loss) per common share for the periods indicated: Three Months Ended June 30, Six Months Ended June 30, (in millions, except for per share data) 2023 2022 2023 2022 Earnings Net income (loss) available to common shareholders: Net income (loss) $ 235 $ 143 $ 364 $ 254 Less: Preferred stock dividends 4 4 18 18 Less: Net income (loss) attributable to noncontrolling interest and redeemable noncontrolling interest 77 75 123 118 Net income (loss) available to common shareholders $ 154 $ 64 $ 223 $ 118 Weighted average common shares outstanding Basic 103.0 101.7 100.4 103.9 Dilutive Effects (2) : Warrants (3) 4.0 7.1 6.5 7.7 RSU awards 1.1 0.8 1.1 0.9 PSU awards 1.2 0.6 1.2 0.8 Stock Options 0.5 0.6 0.5 0.6 Diluted 109.8 110.8 109.7 113.9 Net income (loss) available to Voya Financial, Inc.'s common shareholders per common share (1) : Basic $ 1.50 $ 0.62 $ 2.22 $ 1.13 Diluted $ 1.41 $ 0.57 $ 2.03 $ 1.03 (1) Basic and diluted earnings per share are calculated using unrounded, actual amounts. Therefore, the components of earnings per share may not sum to its corresponding total. (2) For the six months ended June 30, 2022, weighted average shares used for calculating earnings per share excludes the impact of forward contracts related to the share repurchase agreement entered into on June 21, 2022, as the inclusion of these instruments would be antidilutive to the earnings per share calculation. For more information on the share repurchase agreement, see the Shareholders' Equity Note to these Condensed Consolidated Financial Statements. (3) See the Shareholders' Equity

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income (Loss)	6 Months Ended
	Jun. 30, 2023
Equity [Abstract]
Accumulated Other Comprehensive Income (Loss)	Accumulated Other Comprehensive Income (Loss) Shareholders' equity included the following components of AOCI as of the dates indicated: June 30, 2023 2022 Fixed maturities, net of impairment $ (2,963) $ (1,926) Derivatives (1) 98 129 Change in current discount rate (827) (951) Deferred income tax asset (liability) 898 700 Total (2,794) (2,048) Pension and other postretirement benefits liability, net of tax 3 3 AOCI $ (2,791) $ (2,045) (1) Gains and losses reported in Accumulated Other Comprehensive Income (AOCI) from hedge transactions that resulted in the acquisition of an identified asset are reclassified into earnings in the same period or periods during which the asset acquired affects earnings. As of June 30, 2023, the portion of the AOCI that is expected to be reclassified into earnings within the next 12 months is $17. Changes in AOCI, including the reclassification adjustments recognized in the Condensed Consolidated Statements of Operations, were as follows for the periods indicated: Three Months Ended June 30, 2023 Before-Tax Amount Income Tax (Benefit) After-Tax Amount Available-for-sale securities: Fixed maturities $ (343) $ 72 $ (271) Adjustments for amounts recognized in Net realized capital gains (losses) in the Condensed Consolidated Statements of Operations 15 (3) 12 Change in unrealized gains/losses on available-for-sale securities (328) 69 (259) Derivatives: Derivatives (6) (1) 1 (5) Adjustments related to effective cash flow hedges for amounts recognized in Net investment income in the Condensed Consolidated Statements of Operations (5) 1 (4) Change in unrealized gains/losses on derivatives (11) 2 (9) Change in current discount rate 28 (6) 22 Change in Accumulated other comprehensive income (loss) $ (311) $ 65 $ (246) 1) See the Derivative Financial Instruments Note to these Condensed Consolidated Financial Statements for additional information. Six Months Ended June 30, 2023 Before-Tax Amount Income Tax (Benefit) After-Tax Amount Available-for-sale securities: Fixed maturities $ 318 $ (67) $ 251 Adjustments for amounts recognized in Net gains (losses) in the Condensed Consolidated Statements of Operations 14 (3) 11 Change in unrealized gains (losses) on available-for-sale securities 332 (70) 262 Derivatives: Derivatives (18) (1) 4 (14) Adjustments related to effective cash flow hedges for amounts recognized in Net investment income in the Condensed Consolidated Statements of Operations (10) 2 (8) Change in unrealized gains (losses) on derivatives (28) 6 (22) Change in current discount rate 30 (6) 24 Change in Accumulated other comprehensive income (loss) $ 334 $ (70) $ 264 (1) See the Derivative Financial Instruments Note to these Condensed Consolidated Financial Statements for additional information. Three Months Ended June 30, 2022 Before-Tax Amount Income Tax (Benefit) After-Tax Amount Available-for-sale securities: Fixed maturities $ (2,548) $ 535 $ (2,013) Adjustments for amounts recognized in Net gains (losses) in the Condensed Consolidated Statements of Operations 20 (4) 16 Change in unrealized gains (losses) on available-for-sale securities (2,528) 531 (1,997) Derivatives: Derivatives 54 (1) (11) 43 Adjustments related to effective cash flow hedges for amounts recognized in Net investment income in the Condensed Consolidated Statements of Operations (5) 1 (4) Change in unrealized gains (losses) on derivatives 49 (10) 39 Change in current discount rate 92 (19) 73 Change in Accumulated other comprehensive income (loss) $ (2,387) $ 502 $ (1,885) (1) See the Derivative Financial Instruments Note to these Condensed Consolidated Financial Statements for additional information. Six Months Ended June 30, 2022 Before-Tax Amount Income Tax (Benefit) After-Tax Amount Available-for-sale securities: Fixed maturities $ (5,211) $ 1,094 $ (4,117) Adjustments for amounts recognized in Net gains (losses) in the Condensed Consolidated Statements of Operations 90 (19) 71 Change in unrealized gains (losses) on available-for-sale securities (5,121) 1,075 (4,046) Derivatives: Derivatives 59 (1) (12) 47 Adjustments related to effective cash flow hedges for amounts recognized in Net investment income in the Condensed Consolidated Statements of Operations (10) 2 (8) Change in unrealized gains (losses) on derivatives 49 (10) 39 Change in current discount rate 196 (41) 155 Change in Accumulated other comprehensive income (loss) $ (4,876) $ 1,024 $ (3,852) (1) See the Derivative Financial Instruments Note to these Condensed Consolidated Financial Statements for additional information.

Income Taxes

Income Taxes	3 Months Ended
	Jun. 30, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company uses the estimated annual effective tax rate method in computing its interim tax provision. Certain items, including changes in the realizability of deferred tax assets and changes in liabilities for uncertain tax positions, are excluded from the estimated annual effective tax rate and the actual tax expense or benefit is reported in the period the related item is incurred. The Company's effective tax rates for the three and six months ended June 30, 2023 were 10.6% and 9.9%, respectively, and the Company's effective tax rates for the three and six months ended June 30, 2022 were 5.9% and 7.3%, respectively. The effective tax rate differed from the statutory rate of 21% primarily due to noncontrolling interest, the effect of the dividends received deduction and tax credits. In August 2022, President Biden signed into law the Inflation Reduction Act of 2022, which imposes a 15% corporate alternative minimum tax ("CAMT") on the adjusted financial statement income of large corporations. The CAMT is effective in taxable years beginning after December 31, 2022. The Internal Revenue Service has only issued limited guidance on the CAMT, and uncertainty remains regarding the application of and potential adjustments to the CAMT. If the CAMT applies, the Company will be required to pay tax at the 15% CAMT rate despite our U.S. Federal net operating loss carryforwards. Valuation allowances are provided when it is considered more likely than not that some portion or all of the deferred tax assets ("DTAs") will not be realized. The Company reviews all available positive and negative evidence to determine if a valuation allowance is recorded, including historical and projected pre-tax book income, tax planning strategies and reversals of temporary differences. As of June 30, 2023, the Company had year-to-date gains on securities of $334 in Other comprehensive income, which reduced the related DTA. Additionally, operating income remained positive for the period and was largely consistent with the 2022 year-end valuation allowance analysis. After evaluating the positive and negative evidence, the Company did not change its judgement regarding the realization of DTAs. For more information related to the valuation allowance, refer to the Income Taxes Note to the Consolidated Financial Statements included in Part II, Item 8. of the Annual Report on Form 10-K . Tax Regulatory Matters For the tax years 2021 through 2023, the Company participated in the Internal Revenue Service ("IRS") Compliance Assurance Process ("CAP"), which is a continuous audit program provided by the IRS. For the 2023 tax year, the Company was in the Compliance Maintenance Bridge ("Bridge") phase of CAP. In the Bridge phase, the IRS did not conduct any review or provide any letters of assurance for that tax year.

Financing Agreements

Financing Agreements	6 Months Ended
	Jun. 30, 2023
Debt Disclosure [Abstract]
Financing Agreements	Financing Agreements Short-term and Long-term Debt The following table summarizes the carrying value of the Company’s debt securities issued and outstanding as of the periods indicated: Issuer Maturity June 30, 2023 December 31, 2022 3.976% Senior Notes, due 2025 (2)(3) Voya Financial, Inc. 02/15/2025 $ 389 $ — 3.65% Senior Notes, due 2026 (2)(3) Voya Financial, Inc. 06/15/2026 445 445 5.7% Senior Notes, due 2043 (2)(3) Voya Financial, Inc. 07/15/2043 396 396 4.8% Senior Notes, due 2046 (2)(3) Voya Financial, Inc. 06/15/2046 297 297 4.7% Fixed-to-Floating Rate Junior Subordinated Notes, due 2048 (1) Voya Financial, Inc. 01/23/2048 336 336 5.65% Fixed-to-Floating Rate Junior Subordinated Notes, due 2053 (4) Voya Financial, Inc. 05/15/2053 — 388 7.25% Voya Holdings Inc. debentures, due 2023 (1) Voya Holdings, Inc. 08/15/2023 140 140 7.63% Voya Holdings Inc. debentures, due 2026 (1) Voya Holdings, Inc. 08/15/2026 139 139 6.97% Voya Holdings Inc. debentures, due 2036 (1) Voya Holdings, Inc. 08/15/2036 79 79 8.42% Equitable of Iowa Companies Capital Trust II Notes, due 2027 Equitable of Iowa Capital Trust II 04/01/2027 13 13 1.00% Windsor Property Loan Voya Retirement Insurance and Annuity Company 06/14/2027 2 2 1.25% Notes, due 2023 Benefitfocus, Inc. 12/15/2023 2 — Subtotal 2,238 2,235 Less: Current portion of long-term debt 143 141 Total $ 2,095 $ 2,094 (1) Guaranteed by ING Group. (2) Interest is paid semi-annually in arrears. (3) Guaranteed by Voya Holdings. (4) See the Junior Subordinated Notes section below. As of June 30, 2023, the Company was in compliance with its debt covenants. Aetna Notes As of June 30, 2023, the outstanding principal amount of the Aetna Notes was $358, which is guaranteed by ING Group. As of June 30, 2023, the Company provided $372 of collateral benefiting ING Group, comprised of a deposit of $209 to a control account with a third-party collateral agent and $163 of letter of credit. The collateral may be exchanged at any time upon the posting of any other form of acceptable collateral to the account. Credit Facilities The Company uses credit facilities as part of its capital management practices. Total fees associated with credit facilities for the six months ended June 30, 2023 and 2022 were immaterial. The following table summarizes the Company's credit facilities as of June 30, 2023: ($ in millions) Obligor / Applicant Business Supported Secured / Unsecured Committed / Uncommitted Expiration Capacity Utilization Unused Commitment Voya Financial, Inc. Other Unsecured Committed 05/01/2028 $ 500 $ — $ 500 Voya Financial, Inc. Other Unsecured Committed 04/07/2025 200 163 (1) 37 Total $ 700 $ 163 $ 537 (1) Amount utilized as collateral for outstanding Aetna Notes. Put Option Agreement for Senior Debt Issuance During 2015, the Company entered into an off-balance sheet 10-year put option agreement with a Delaware trust formed by the Company, in connection with the sale by the trust of pre-capitalized trust securities ("P-Caps"), that provides Voya Financial, Inc. the right, at any time over a 10-year period, to issue up to $500 principal amount of its 3.976% Senior Notes due 2025 ("3.976% Senior Notes") to the trust and receive in exchange a corresponding principal amount of U.S. Treasury securities that are held by the trust. The 3.976% Senior Notes will not be issued unless and until the put option is exercised. In return, the Company pays a semi-annual put premium to the trust at a rate of 1.875% per annum applied to the unexercised portion of the put option and reimburses the trust for its expenses. The put premium and expense reimbursements are recorded in Operating expenses in the Condensed Consolidated Statements of Operations. If and when issued, the 3.976% Senior Notes will be guaranteed by Voya Holdings. Upon an event of default, the put option will be exercised automatically in full. The Company has a one-time right to unwind a prior voluntary exercise of the put option by repurchasing all of the 3.976% Senior Notes then held by the trust for U.S. Treasury securities. If the put option has been fully exercised, the 3.976% Senior Notes issued may be redeemed by the Company prior to their maturity at par or, if greater, at a make-whole redemption price, in each case plus accrued and unpaid interest to the date of redemption. The P-Caps are to be redeemed by the trust on February 15, 2025 or upon any early redemption of the 3.976% Senior Notes. On May 1, 2023, pursuant to the put option agreement, the Company exercised the put option to require the trust to purchase $400 aggregate principal amount of 3.976% Senior Notes in exchange for a corresponding amount of U.S. Treasury securities held by the trust. On May 3, 2023, the Company issued $400 aggregate principal amount of 3.976% Senior Notes to the trust and the Company received approximately $400 of U.S. Treasury securities. The proceeds from the sale of the U.S. Treasury securities were used to redeem the 5.650% Fixed-to-Floating Rate Junior Subordinated Notes due 2053 on May 15, 2023 (the "2053 Notes"). See Junior Subordinated Notes below. Junior Subordinated Notes On April 14, 2023, the Company delivered to the holders of the 2053 Notes a notice of redemption, notifying those note holders that the Company has elected to redeem all of the outstanding $393 aggregate principal amount of the 2053 Notes at par. During the three months ended June 30, 2023, the Company completed the redemption of the 2053 Notes, resulting in loss on debt extinguishment of $5, which is included in Interest expense in the Condensed Consolidated Statements of Operations. Senior Unsecured Credit Facility Agreement As of June 30, 2023, the Company had a $500 senior unsecured credit facility with a syndicate of banks which expires May 1, 2028. The facility provides $500 of committed capacity for revolving loan borrowings and letters of credit issuances, including a sublimit for swingline (short-term) loans in an aggregate amount of up to $25. As of June 30, 2023, there were no amounts outstanding as revolving credit borrowings, no amounts of LOCs outstanding, and no amounts of swingline loans outstanding under the senior unsecured credit facility. Under the terms of the facility, the Company is required to maintain a minimum net worth of $4.998 billion, which may increase upon any future equity issuances by the Company.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Leases During the three and six months ended June 30, 2023, the Company recorded an impairment of $12 and $14, respectively, on its right-of-use asset associated with leased office space, respectively. During the six months ended June 30, 2022, the Company recorded an impairment of $3 on its right-of-use asset associated with leased office space. The impairments are included in Operating expenses in the Condensed Consolidated Statements of Operations. Commitments Through the normal course of investment operations, the Company commits to either purchase or sell securities, mortgage loans, or money market instruments, at a specified future date and at a specified price or yield. The inability of counterparties to honor these commitments may result in either a higher or lower replacement cost. Also, there is likely to be a change in the value of the securities underlying the commitments. As of June 30, 2023, the Company had off-balance sheet commitments to acquire mortgage loans of $145 and purchase limited partnerships and private placement investments of $1,005, of which $352 related to consolidated investment entities. Restricted Assets The Company is required to maintain assets on deposit with various regulatory authorities to support its insurance operations. The Company may also post collateral in connection with certain securities lending, repurchase agreements, funding agreements, credit facilities and derivative transactions. The components of the fair value of the restricted assets were as follows as of the dates indicated: June 30, 2023 December 31, 2022 Fixed maturity collateral pledged to FHLB (1) $ 1,851 $ 1,791 FHLB restricted stock (2) 68 67 Other fixed maturities-state deposits 39 38 Cash and cash equivalents 33 27 Securities pledged (3) 1,148 1,162 Total restricted assets $ 3,139 $ 3,085 (1) Included in Fixed maturities, available for sale, at fair value on the Condensed Consolidated Balance Sheets. (2) Included in Other investments on the Condensed Consolidated Balance Sheets. (3) Includes the fair value of loaned securities of $857 and $907 as of June 30, 2023 and December 31, 2022, respectively. In addition, as of June 30, 2023 and December 31, 2022, the Company delivered securities as collateral of $175 and $142 and repurchase agreements of $116 and $113, respectively. Loaned securities and securities delivered as collateral are included in Securities pledged on the Condensed Consolidated Balance Sheets. Federal Home Loan Bank Funding Agreements The Company is a member of the FHLB of Des Moines and the FHLB of Boston and is required to pledge collateral to back funding agreements issued to the FHLB. As of June 30, 2023 and December 31, 2022, the Company had $1,290 and $1,279, respectively, in non-putable funding agreements, which are included in Contract owner account balances on the Condensed Consolidated Balance Sheets. As of June 30, 2023 and December 31, 2022, assets with a market value of approximately $1,851 and $1,791, respectively, collateralized the FHLB funding agreements. Assets pledged to the FHLB are included in Fixed maturities, available-for-sale, at fair value on the Condensed Consolidated Balance Sheets. Litigation, Regulatory Matters and Contingencies Litigation, regulatory and other loss contingencies arise in connection with the Company's activities as a diversified financial services firm. The Company is a defendant in a number of litigation matters, arising from the conduct of its business, both in the ordinary course and otherwise. In some of these matters, claimants seek to recover very large or indeterminate amounts, including compensatory, punitive, treble and exemplary damages. The variability in pleading requirements and past experience demonstrate that the monetary and other relief that may be requested in a lawsuit or claim often bears little relevance to the merits or potential value of a claim. As with other financial services companies, the Company periodically receives informal and formal requests for information from various state and federal governmental agencies and self-regulatory organizations in connection with inquiries and investigations of the products and practices of the Company or the financial services industry. For example, the Company is cooperating with a publicly reported, industry-wide investigation by the SEC regarding compliance with certain record-keeping requirements for business-related electronic communications on unapproved channels. It is the practice of the Company to cooperate fully in these matters. While it is possible that an adverse outcome in certain cases could have a material adverse effect upon the Company's financial position, based on information currently known, management believes that neither the outcome of pending litigation and regulatory matters nor potential liabilities associated with other loss contingencies, are likely to have such an effect. However, given the large and indeterminate amounts sought in certain litigation and the inherent unpredictability of all such matters, it is possible that an adverse outcome in certain of the Company's litigation or regulatory matters, or liabilities arising from other loss contingencies, could, from time to time, have a material adverse effect upon the Company's results of operations or cash flows in a particular quarterly or annual period. For some matters, the Company is able to estimate a possible range of loss. For such matters in which a loss is probable, an accrual has been made. For matters where the Company, however, believes a loss is reasonably possible, but not probable, no accrual is required. For matters for which an accrual has been made, but there remains a reasonably possible range of loss in excess of the amounts accrued or for matters where no accrual is required, the Company develops an estimate of the unaccrued amounts of the reasonably possible range of losses. As of June 30, 2023, the Company estimates the aggregate range of reasonably possible losses, in excess of any amounts accrued for these matters as of such date, to be up to approximately $25. For other matters, the Company is currently not able to estimate the reasonably possible loss or range of loss. The Company is often unable to estimate the possible loss or range of loss until developments in such matters have provided sufficient information to support an assessment of the range of possible loss, such as quantification of a damage demand from plaintiffs, discovery from plaintiffs and other parties, investigation of factual allegations, rulings by a court on motions or appeals, analysis by experts and the progress of settlement discussions. On a quarterly and annual basis, the Company reviews relevant information with respect to litigation and regulatory contingencies and updates the Company's accruals, disclosures and reasonably possible losses or ranges of loss based on such reviews. Litigation includes Henkel of America v. ReliaStar Life Insurance Company, et al. (USDC District of Connecticut, No. 1:18-cv-00965)(filed June 8, 2018). Plaintiff alleges that ReliaStar breached the terms of a stop loss policy it issued to Plaintiff by refusing to reimburse Plaintiff for more than $47 in claims incurred by participants in prior years and submitted for coverage under the stop loss policy. Plaintiff alleges a breach of contract claim or, in the alternative, that the stop loss policy be declared to cover the submitted claims, and also asserts that ReliaStar engaged in unfair trade practices and unfair insurance practices in violation of state statutes, and did so willfully and intentionally to warrant an award of punitive damages under state law. On February 7, 2023, the district court issued its ruling on various motions for partial judgment in which the court denied in part and granted in part the various motions except for Express Scripts’ motion, which the court denied in whole. The Company denies the allegations, which it believes are without merit, and intends to defend the case vigorously. Litigation also includes Ravarino, et al. v. Voya Financial, Inc., et al. (USDC District of Connecticut, No. 3:21-cv-01658)(filed December 14, 2021). In this putative class action, the plaintiffs allege that the named defendants breached their fiduciary duties of prudence and loyalty in the administration of the Voya 401(k) Savings Plan. The plaintiffs claim that the named defendants did not exercise proper prudence in their management of allegedly poorly performing investment options, including proprietary funds, and passed excessive investment-management and other administrative fees for proprietary and non-proprietary funds onto plan participants. The plaintiffs also allege that the defendants engaged in self-dealing through the inclusion of the Voya Stable Value Option into the plan offerings and by setting the “crediting rate” for participants’ investment in the Stable Value Fund artificially low in relation to Voya’s general account investment returns in order to maximize the spread and Voya’s profits at the participants’ expense. The complaint seeks disgorgement of unjust profits as well as costs incurred. On June 13, 2023, the Court issued a ruling granting in part and denying in part Voya's motion to dismiss. The court largely dismissed the claims for breach of fiduciary duty. The remaining claims concern allegations of breaches of the ERISA prohibited transactions rule and a claim for failure to monitor the Voya Small Cap Growth fund. The Company continues to deny the allegations, which it believes are without merit, and intends to defend the case vigorously. Finally, industry wide, life insurers face class action litigation related to the cost of insurance rates and periodic deductions from cash value. Common allegations include that insurance companies have breached the terms of their universal life insurance policies by establishing or increasing the cost of insurance rates using cost factors not permitted by the contract, thereby unjustly enriching themselves. This litigation is generally known as cost of insurance litigation. Cost of insurance litigation for the Company includes Advance Trust & Life Escrow Services, LTA v. ReliaStar Life Insurance Company (USDC District of Minnesota, No. 1:18-cv-02863)(filed October 5, 2018), a putative class action in which Plaintiff alleges that the Company’s universal life insurance policies only permitted the Company to rely upon the policyholders’ expected future mortality experience to establish the cost of insurance, and that as projected mortality experience improved, the policy language required the Company to decrease the cost of insurance. Plaintiff alleges that the Company did not decrease the cost of insurance as required, thereby breaching its contract with the policyholders, and seeks class certification. On May 31, 2023, the parties participated in a mediation, after which they agreed to settle the litigation. On July 31, 2023, the Court granted plaintiffs’ motion for preliminary approval of the settlement agreement. The settlement, which remains subject to final approval by the court, provides that the Company will deposit $39 in cash consideration into a settlement fund, and the Company has fully accrued the $39 as of June 30, 2023. The settlement agreement also provides for noncash consideration consisting of agreements by the Company (1) not to increase cost of insurance rates on the class policies for a period of seven Consistent with the terms of the settlement agreement, the Company specifically and generally denies any and all liability or wrongdoing of any sort relating to this litigation and makes no concessions or admissions of liability or misconduct of any sort. Contingencies related to Performance-based Capital Allocations on Private Equity Funds Certain performance-based capital allocations related to sponsored private equity funds ("carried interest") are not final until the conclusion of an investment term specified in the relevant asset management contract. As a result, such carried interest, if accrued or paid to the Company during such term, is subject to later adjustment based on subsequent fund performance. If the fund’s cumulative investment return falls below specified investment return hurdles, some or all of the previously accrued carried interest is reversed to the extent that the Company is no longer entitled to the performance-based capital allocation. Should the fund’s cumulative investment return subsequently increase above specified investment return hurdles in future periods, previous reversals could be fully or partially recovered. As of June 30, 2023, approximately $131 of previously accrued carried interest would be subject to full or partial reversal in future periods if cumulative fund performance hurdles are not maintained throughout the remaining life of the affected funds.

Consolidated and Nonconsolidate

Consolidated and Nonconsolidated Investment Entities	6 Months Ended
	Jun. 30, 2023
Consolidated Investment Entities [Abstract]
Consolidated and Nonconsolidated Investment Entities	Consolidated and Nonconsolidated Investment EntitiesThe Company holds variable interests in certain investment entities in the form of debt or equity investments, as well as the right to receive management fees, performance fees, and carried interest. The Company consolidates certain entities under the VIE guidance when it is determined that the Company is the primary beneficiary. Alternatively, certain entities are consolidated under the VOE guidance when control is obtained through voting rights. Refer to the Condensed Consolidated Balance Sheets for the assets and liabilities of the Company's consolidated investment entities. The Company has no right to the benefits from, nor does it bear the risks associated with consolidated investment entities beyond the Company’s direct equity and debt investments in and management fees generated from these entities. Such direct investments amounted to approximately $346 and $288 as of June 30, 2023 and December 31, 2022, respectively. If the Company were to liquidate, the assets held by consolidated investment entities would not be available to the general creditors of the Company as a result of the liquidation. Consolidated VIEs and VOEs Collateral Loan Obligations Entities ("CLOs") The Company is involved in the design, creation, and the ongoing management of CLOs. These entities are created for the purpose of acquiring diversified portfolios of senior secured floating rate leveraged loans, and securitizing these assets by issuing multiple tranches of collateralized debt; thereby providing investors with a broad array of risk and return profiles. Also known as collateralized financing entities under Topic 810, CLOs are variable interest entities by definition. In return for providing collateral management services, the Company earns investment management fees and contingent performance fees. In addition to earning fee income, the Company often invests in the subordinated debt of entities formed to be the issuers of CLO offerings during their warehouse periods. The Company’s investments in these CLOs are repaid when the CLOs’ warehouse periods are closed and the CLO offerings are issued. The Company performs ongoing monitoring of the consolidation assessment for CLOs during and after their warehouse periods to determine if Voya remains the primary beneficiary of the CLOs. The fee income earned and investments held are included in the Company's ongoing consolidation assessment for each CLO. The Company was the primary beneficiary of 7 CLOs as of June 30, 2023 and December 31, 2022. Limited Partnerships ("LPs") The Company invests in and manages various limited partnerships, including private equity funds and hedge funds. The LPs generally have a ten-year life and a specified period during which investors can subscribe for limited partnership interests. Once the investors are admitted as limited partners, the investors are required to contribute capital when called by the general partners. The purpose of the LPs is to obtain subscriptions from limited partners and maximize the return to their partners by assembling a diversified portfolio of investments in private equity funds and other securities or assets with similar risk and return characteristics primarily through secondary market purchases. The majority of the investors in the LPs are unrelated parties to the Company. In return for subscriptions, each partner receives an equity interest in the LPs in proportion to its respective investment. These entities have been evaluated by the Company and are determined to be VIEs due to the equity holders, as a group, lacking the characteristics of a controlling financial interest. In return for serving as the general partner of and providing investment management services to these entities, the Company earns management fees and carried interest in the normal course of business. Additionally, the Company often holds an investment in each limited partnership it manages, generally in the form of general partner and limited partner interests. The fee income, carried interest, and investments held are included in the Company’s ongoing consolidation analysis for each limited partnership. The Company consolidated 10 funds, which were structured as partnerships, as of June 30, 2023 and December 31, 2022. The noncontrolling interest related to partnerships increased from $1,482 at December 31, 2022 to $1,660 at June 30, 2023. Changes in market value, contributions, and distributions related to these investments in the funds directly impact the noncontrolling interest component of Shareholders' equity on the Company's Condensed Consolidated Balance Sheets. The change in noncontrolling interest was primarily driven by an increase in net contributions and favorable market appreciation in limited partnership and equity security investments. The Company records the noncontrolling interest using a lag methodology relying on the most recent financial information available. Fair Value Measurement Upon consolidation, the Company elected to apply the FVO for financial assets and financial liabilities held by CLOs and continued to measure these assets (primarily corporate loans) and liabilities (debt obligations issued by CLOs) at fair value in subsequent periods. The Company has elected the FVO to more closely align its accounting with the economics of its transactions and allows the Company to more effectively align changes in the fair value of CLO assets with a commensurate change in the fair value of CLO liabilities. Investments held by consolidated private equity funds are measured and reported at fair value in the Company's Condensed Consolidated Financial Statements. Changes in the fair value of consolidated investment entities are recorded as a separate line item within Income (loss) related to consolidated investment entities in the Company's Condensed Consolidated Statements of Operations. The methodology for measuring the fair value of financial assets and liabilities of consolidated investment entities, and the classification of these measurements in the fair value hierarchy is consistent with the methodology and classification applied by the Company to its investment portfolio, as discussed within the Fair Value Measurements (excluding Consolidated Investment Entities) Note to these Condensed Consolidated Financial Statements. As discussed in more detail below, the Company utilizes valuations obtained from third-party commercial pricing services, brokers and investment sponsors or third-party administrators that supply NAV (or its equivalent) per share used as a practical expedient. The valuations obtained from brokers and third-party commercial pricing services are non-binding. These valuations are reviewed on a monthly or quarterly basis depending on the entity and its underlying investments. Procedures include, but are not limited to, a review of underlying fund investor reports, review of top and worst performing funds requiring further scrutiny, review of variance from prior periods and review of variance from benchmarks, where applicable. In addition, the Company considers both macro and fund specific events that may impact the latest NAV supplied and determines if further adjustments of value should be made. Such changes, if any, are subject to senior management review. When a price cannot be obtained from a commercial pricing service, independent broker quotes are solicited. Securities priced using independent broker quotes are classified as Level 3. Broker quotes and prices obtained from pricing services are reviewed and validated through an internal valuation committee price variance review, comparisons to internal pricing models, back testing to recent trades or monitoring of trading volumes. Cash and Cash Equivalents The carrying amounts for cash reflect the assets’ fair values. The fair value for cash equivalents is determined based on quoted market prices. These assets are classified as Level 1. CLOs Corporate loans : Corporate loan investments, which comprise the majority of consolidated CLO portfolio collateral, are senior secured corporate loans maturing at various dates between 2024 and 2031, paying interest at LIBOR, SOFR, EURIBOR or PRIME plus a spread of up to 8.5%. As of June 30, 2023 and December 31, 2022, the unpaid principal balance exceeded the fair value of the corporate loans by approximately $72 and $85, respectively. Less than 1.0% of the collateral loans were in default as of June 30, 2023 and December 31, 2022. The fair values for corporate loans are determined using independent commercial pricing services. Fair value measurement based on pricing services may be classified in Level 2 or Level 3 depending on the type, complexity, observability and liquidity of the asset being measured. The inputs used by independent commercial pricing services, such as benchmark yields and credit risk adjustments, are those that are derived principally from or corroborated by observable market data. Hence, the fair value measurement of corporate loans priced by independent pricing service providers is classified within Level 2 of the fair value hierarchy. In addition, there are assets held with CLO portfolios that represent senior level debt of other third party CLOs. These CLO investments are classified within Level 3 of the fair value hierarchy. See description of fair value process for CLO notes below. CLO notes : The CLO notes are backed by diversified loan portfolios consisting primarily of senior secured floating rate leveraged loans. Repayment risk is segmented into tranches with credit ratings of these tranches reflecting both the credit quality of underlying collateral as well as how much protection a given tranche is afforded by tranches that are subordinate to it. The most subordinated tranche bears the first loss and receives the residual payments, if any. The interest rates are generally variable rates based on LIBOR, SOFR or EURIBOR plus a pre-defined spread, which varies from 1.0% for the more senior tranches to 9.6% for the more subordinated tranches. CLO notes mature in 2034 and 2037, and have a weighted average maturity of 12 years as of June 30, 2023. The investors in this debt are not affiliated with the Company and have no recourse to the general credit of the Company for this debt. The fair values of the CLO notes are measured based on the fair value of the CLO's corporate loans, as the Company uses the measurement alternative available under ASU 2014-13 and determined that the inputs for measuring financial assets are more observable. The CLO notes are classified within Level 2 of the fair value hierarchy, consistent with the classification of the majority of the CLO financial assets. The Company reviews the detailed prices including comparisons to prior periods for reasonableness. The Company utilizes a formal pricing challenge process to request a review of any price during which time the vendor examines its assumptions and relevant market inputs to determine if a price change is warranted. The following narrative indicates the sensitivity of inputs: • Default Rate: An increase (decrease) in the expected default rate would likely increase (decrease) the discount margin (increase risk premium) used to value the CLO investments and CLO notes and, as a result, would potentially decrease the value of the CLO investments and CLO notes. • Recovery Rate: A decrease (increase) in the expected recovery of defaulted assets would potentially decrease (increase) the valuation of CLO investments and CLO notes. • Prepayment Rate: A decrease (increase) in the expected rate of collateral prepayments would potentially decrease (increase) the valuation of CLO investments and CLO notes as the expected weighted average life ("WAL") would increase (decrease). • Discount Margin (spread over LIBOR/SOFR): An increase (decrease) in the discount margin used to value the CLO investments and CLO notes would decrease (increase) the value of the CLO investments and CLO notes. Private Equity Funds As prescribed in ASC Topic 820, the unit of account for these investments is the interest in the investee fund. The Company owns an undivided interest in the fund portfolio and does not have the ability to dispose of individual assets and liabilities in the fund portfolio. Rather, the Company would be required to redeem or dispose of its entire interest in the investee fund. There is no current active market for interests in underlying private equity funds. Valuation is generally based on the valuations provided by the fund's general partner or investment manager. The valuations typically reflect the fair value of the Company's capital account balance of each fund investment, including unrealized capital gains (losses), as reported in the financial statements of the respective investee fund as of the respective year end or the latest available date. In circumstances where fair values are not provided, the Company seeks to determine the fair value of fund investments based upon other information provided by the fund's general partner or investment manager or from other sources. The fair value of securities received in-kind from fund investments is determined based on the restrictions around the securities. • Unrestricted, publicly traded securities are valued at the closing public market price on the reporting date; • Restricted, publicly traded securities may be valued at a discount from the closing public market price on the reporting date, depending on the circumstances; and • Privately held securities are valued by the directors/general partner of the investee fund, based on a variety of factors, including the price of recent transactions in the company's securities and the company's earnings, revenue and book value. In the case of direct investments or co-investments in private equity companies, the Company initially recognizes investments at cost and subsequently adjusts investments to fair value. On a quarterly basis, the Company reviews the general partner or lead investor's valuation of the investee company, taking into account other available information, such as indications of a market value through subsequent issues of capital or transactions between third parties, performance of the investee company during the period and public, comparable companies' analysis, where appropriate. Investments in these funds typically may not be fully redeemed at net asset value ("NAV") within 90 days because of inherent restriction on near term redemptions. As of June 30, 2023 and December 31, 2022, certain private equity funds maintained term loans and revolving lines of credit of $1,354 and $1,366, respectively. The term loans mature in twelve The following table summarizes the fair value hierarchy levels of consolidated investment entities as of June 30, 2023: Level 1 Level 2 Level 3 NAV Total Assets VIEs Cash and cash equivalents $ 154 $ — $ — $ — $ 154 Corporate loans — 1,407 — — 1,407 Limited partnerships/corporations — — — 3,120 3,120 VOE Corporate loans — 25 — — 25 Total assets $ 154 $ 1,432 $ — $ 3,120 $ 4,706 Liabilities VIEs CLO notes $ — $ 1,331 $ — $ — $ 1,331 Total liabilities $ — $ 1,331 $ — $ — $ 1,331 The following table summarizes the fair value hierarchy levels of consolidated investment entities as of December 31, 2022: Level 1 Level 2 Level 3 NAV Total Assets VIEs Cash and cash equivalents $ 88 $ — $ — $ — $ 88 Corporate loans — 1,293 — — 1,293 Limited partnerships/corporations — — — 2,802 2,802 Total assets $ 88 $ 1,293 $ — $ 2,802 $ 4,183 Liabilities VIEs CLO notes $ — $ 1,234 $ — $ — $ 1,234 Total liabilities $ — $ 1,234 $ — $ — $ 1,234 Transfers of investments out of Level 3 and into Level 2 or Level 1, if any, are recorded as of the beginning of the period in which the transfer occurred. For the three and six months ended June 30, 2023 and 2022, there were no transfers in or out of Level 3 or transfers between Level 1 and Level 2. Deconsolidation of Certain Investment Entities Certain investment entities that have historically been consolidated in the financial statements may require deconsolidation as of the reporting period because: (a) such funds have been liquidated or dissolved; or (b) the Company is no longer deemed to be the primary beneficiary of the VIEs/VOEs as it no longer has a controlling financial interest. The change in CLO’s consolidation status due to the close of the warehouse and the launch of the CLO do not meet the criteria described above as this transaction represents normal business operations of the entity. Refer to the CLO life cycle described above. The Company had one deconsolidation during the three and six months ended June 30, 2023 as a result of CLO notes redemption. The Company had no deconsolidation during the three and six months ended June 30, 2022. For deconsolidated investment entities, the Company continues to serve as the general partner and/or investment manager until such entities are fully liquidated. Nonconsolidated VIEs The Company also holds variable interest in certain CLOs and LPs that are not consolidated as it has been determined that the Company is not the primary beneficiary. CLOs As of June 30, 2023 and December 31, 2022, the Company held $371 and $364 ownership interests, respectively, in unconsolidated CLOs, which also represents the Company's maximum exposure to loss. LPs As of June 30, 2023 and December 31, 2022, the Company held $1,800 and $1,781 ownership interests, respectively, in unconsolidated limited partnerships, which also represents the Company's maximum exposure to loss. Securitizations The Company invests in various tranches of securitization entities, including RMBS, CMBS and ABS. Through its investments, the Company is not obligated to provide any financial or other support to these entities. Each of the RMBS, CMBS and ABS entities are thinly capitalized by design and considered VIEs. The Company's involvement with these entities is limited to that of a passive investor. The Company has no unilateral right to appoint or remove the servicer, special servicer or investment manager, which are generally viewed to have the power to direct the activities that most significantly impact the securitization entities' economic performance, in any of these entities, nor does the Company function in any of these roles. The Company, through its investments or other arrangements, does not have the obligation to absorb losses or the right to receive benefits from the entity that could potentially be significant to the entity. Therefore, the Company is not the primary beneficiary and does not consolidate any of the RMBS, CMBS and ABS entities in which it holds investments. These investments are accounted for as investments available-for-sale as described in the Fair Value Measurements (excluding Consolidated Investment Entities) Note to these Condensed Consolidated Financial Statements and unrealized capital gains (losses) on these securities are recorded directly in AOCI, except for certain RMBS which are accounted for under the FVO whose change in fair value is reflected in Net gains (losses) in the Condensed Consolidated Statements of Operations. The Company’s maximum exposure to loss on these structured investments is limited to the amount of its investment. Refer to the Investments (excluding Consolidated Investment Entities) Note to these Condensed Consolidated Financial Statements for details regarding the carrying amounts and classifications of these assets.

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets	6 Months Ended
	Jun. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Other Intangible Assets	Goodwill and Other Intangible Assets Goodwill The changes in the carrying amount of goodwill reported in the Company's operating segments were as follows: Wealth Solutions Health Solutions Investment Management Consolidated Balance as of January 1, 2022 $ 17 $ 24 $ 31 $ 72 Additions from business combinations — — 255 255 Balance as of December 31, 2022 $ 17 $ 24 $ 286 $ 327 Additions from business combinations — 319 — 319 Balance as of June 30, 2023 $ 17 $ 343 $ 286 $ 646 Other Intangible Assets The following table presents other intangible assets as of the dates indicated: Weighted June 30, 2023 December 31, 2022 Gross Accumulated Net Gross Accumulated Net Indefinite-life intangibles: Right to manage client assets N/A $ 345 $ — $ 345 $ 345 $ — $ 345 Management contract rights N/A 5 — 5 5 — 5 Total indefinite-life intangibles $ 350 $ — $ 350 $ 350 $ — $ 350 Finite-life intangibles: Management contract rights 17 years $ 190 $ 10 $ 180 $ 741 $ 554 $ 187 Customer relationship lists 8 years 325 119 206 135 111 24 Trademarks 8 years 15 1 14 — — — Computer software 4 years 483 325 158 502 432 70 Total intangible assets $ 1,363 $ 455 $ 908 $ 1,728 $ 1,097 $ 631 Amortization expense related to intangible assets were $42 and $22 for the six months ended June 30, 2023 and 2022, respectively. Fully amortized management contract rights of $550 were written off during the quarter.

Segments

Segments	6 Months Ended
	Jun. 30, 2023
Segment Reporting [Abstract]
Segments	Segments The Company provides its principal products and services through three segments: Wealth Solutions, Health Solutions and Investment Management. The Company's chief operating decision maker views and manages the business through these three segments. The Wealth Solutions segment provides tax-deferred, employer-sponsored retirement savings plans and administrative services to corporate, education, healthcare, other non-profit and government entities, and stable value products to institutional clients where the Company may or may not be providing defined contribution products and services, as well as individual retirement accounts ("IRAs"), other retail financial products and comprehensive financial services to individual customers. The Health Solutions segment provides stop loss, group life, voluntary employee-paid and disability products to mid-sized and large businesses as well as benefit administration software solutions to employers and health plans. On January 24, 2023, the Company completed its acquisition of Benefitfocus. The financial results of Benefitfocus are reported in the Health Solutions segment for periods after the acquisition. The Investment Management segment provides investment products and retirement solutions across a broad range of geographies, market sectors, investment styles and capitalization spectrums. Products and services are offered to institutional clients, including public, corporate and union retirement plans, endowments and foundations and insurance companies, as well as individual investors and general accounts of the Company's insurance subsidiaries and are distributed through the Company's direct sales force, consultant channel and intermediary partners (such as banks, broker-dealers and independent financial advisers). The Company includes in Corporate the following corporate and business activities: • corporate operations, corporate level assets and financial obligations, financing and interest expenses, dividend payments made to preferred shareholders, and other items not allocated or directly related to the Company's segments, including items such as expenses related to organizational restructurings, certain expenses and liabilities of employee benefit plans, certain adjustments to short-term and long-term incentive accruals and intercompany eliminations; and • investment income on assets backing surplus in excess of amounts held at the segment level. Measurement Effective the first quarter of 2023, the Company excludes from Adjusted operating earnings before income taxes the amortization of acquisition-related intangible assets. In addition, the Company excludes the expected return on plan assets net of interest costs associated with our qualified defined benefit pension plan, which are influenced by economic and market conditions and not indicative of normal operations. Adjusted operating earnings before income taxes in Corporate still includes the service costs related to the Company's qualified defined benefit pension plan and service and interest costs related to non-qualified defined benefit pension plans. Historical periods have been recast to conform with this change. Adjusted operating earnings before income taxes is a meaningful measure used by management to evaluate its business and segment performance. This measure enhances the understanding of the Company’s financial results by focusing on the operating performance and trends of the underlying core business segments by excluding items that tend to be highly variable from period to period based on capital market conditions and/or other factors. The Company uses the same accounting policies and procedures to measure segment Adjusted operating earnings before income taxes as it does for the directly comparable U.S. GAAP measure Income (loss) before income taxes. Adjusted operating earnings before income taxes does not replace Income (loss) before income taxes as the U.S. GAAP measure of the Company’s consolidated results of operations. Therefore, the Company believes that it is useful to evaluate both measures when reviewing the Company’s financial and operating performance. Each segment’s Adjusted operating earnings before income taxes is calculated by adjusting Income (loss) before income taxes for the following items: • Net investment gains (losses), which are significantly influenced by economic and market conditions, including interest rates and credit spreads, and are not indicative of normal operations. Net investment gains (losses) include gains (losses) on the sale of securities, impairments, changes in the fair value of investments using the FVO unrelated to the implied loan-backed security income recognition for certain mortgage-backed obligations, and changes in the fair value of derivative instruments, excluding gains (losses) associated with swap settlements and accrued interest. It also includes changes in the fair value of derivatives related to managed custody guarantees, net of related reserve increases (decreases), less the estimated cost of these benefits, changes in nonperformance spread, and changes in market risk benefits; • Income (loss) related to businesses exited or to be exited through reinsurance or divestment, which includes gains and (losses) associated with transactions to exit blocks of business, amortization of intangible assets and residual run-off activity. Excluding this activity better reveals trends in the Company's core business and more closely aligns Adjusted operating earnings before income taxes with how the Company manages its segments; • Income (loss) attributable to noncontrolling interests to which the Company is not economically entitled, such as Allianz's stake in the results of VIM Holdings LLC (referred to as redeemable noncontrolling interest or Allianz noncontrolling interest) or the attribution of results from consolidated VIEs or VOEs; • Dividend payments made to preferred shareholders are included as reductions to reflect the Adjusted operating earnings before income taxes that are available to common shareholders; • Other adjustments may include the following items: • Income (loss) related to early extinguishment of debt since the outcome of decisions to restructure debt are not indicative of normal operations; • Impairment of goodwill and intangible assets as these represent losses related to infrequent events and do not reflect normal, cash-settled expenses; • Amortization of acquisition-related intangible assets as well as contingent consideration fair value adjustments incurred in connection with certain acquisitions which are not indicative of current Operating expense fundamentals; • Expected return on plan assets net of interest costs associated with the Company's qualified defined benefit pension plan and immediate recognition of net actuarial gains (losses) related to all of the Company's pension and other postretirement benefit obligations and gains (losses) from plan amendments and curtailments. These amounts do not reflect cash-settled expenses, and are not indicative of current Operating expense fundamentals; and • Other items not indicative of normal operations or performance of the Company's segments or related to events such as capital or organizational restructurings, including certain costs related to debt and equity offerings, acquisition / merger integration expenses, severance and other third-party expenses associated with such activities, and expenses attributable to vacant real estate. These items vary widely in timing, scope and frequency between periods as well as between companies to which the Company is compared. Accordingly, the Company adjusts for these items as management believes that these items distort the ability to make a meaningful evaluation of the current and future performance of the Company's segments. The summary below reconciles Adjusted operating earnings before income taxes for the segments to Income (loss) before income taxes for the periods indicated: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Adjusted operating earnings before income taxes by segment: Wealth Solutions $ 174 $ 197 $ 306 $ 425 Health Solutions 124 50 218 72 Investment Management 63 40 105 79 Corporate (54) (60) (123) (128) Total including Allianz noncontrolling interest 307 228 507 448 Less: Earning (loss) attributable to Allianz noncontrolling interest 13 — 21 — Total $ 294 $ 228 $ 486 $ 448 Adjustments: Net investment gains (losses) (38) (59) (47) (171) Income (loss) related to businesses exited or to be exited through reinsurance or divestment (21) (55) (54) (91) Income (loss) attributable to noncontrolling interests 77 75 123 118 Dividend payments made to preferred shareholders 4 4 18 18 Other adjustments (52) (40) (122) (48) Total adjustments to income (loss) before income taxes (31) (75) (82) (174) Income (loss) before income taxes $ 263 $ 152 $ 404 $ 274 Adjusted operating revenues is a measure of the Company's segment revenues. Each segment's Operating revenues are calculated by adjusting Total revenues to exclude the following items: • Net investment gains (losses); • Revenues related to businesses exited or to be exited through reinsurance or divestment; • Revenues attributable to noncontrolling interests, which represents the attribution of results from consolidated VIEs or VOEs; and • Other adjustments primarily reflect fee income earned by the Company's broker-dealers for sales of non-proprietary products, which are reflected net of commission expense in the Company's segments’ operating revenues, other items where the income is passed on to third parties and the elimination of intercompany investment expenses included in Adjusted operating revenues. The summary below reconciles Adjusted operating revenues for the segments to Total revenues for the periods indicated: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Adjusted operating revenues by segment: Wealth Solutions $ 705 $ 709 $ 1,389 $ 1,465 Health Solutions 775 641 1,549 1,288 Investment Management 226 171 455 349 Corporate 15 17 26 39 Total $ 1,721 $ 1,537 $ 3,419 $ 3,140 Adjustments: Net investment gains (losses) $ (46) $ (60) $ (60) $ (180) Revenues related to businesses exited or to be exited through reinsurance or divestment 2 (55) 32 (109) Revenues attributable to noncontrolling interests 128 93 188 142 Other adjustments 67 8 127 36 Total adjustments to revenues 151 (14) 288 (111) Total revenues $ 1,871 $ 1,524 $ 3,706 $ 3,030 Other Segment Information The Investment Management segment revenues include the following intersegment revenues, primarily consisting of asset-based management and administration fees for the periods indicated: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Investment Management intersegment revenues $ 22 $ 23 $ 44 $ 45 The summary below presents Total assets for the Company’s segments as of the dates indicated: June 30, 2023 December 31, 2022 Wealth Solutions $ 118,943 $ 111,701 Health Solutions 3,378 2,668 Investment Management 1,648 1,611 Corporate 26,241 26,712 Total assets, before consolidation (1) 150,210 142,692 Consolidation of investment entities 4,406 3,914 Total assets $ 154,616 $ 146,606 (1) Total assets, before consolidation include the Company's direct investments in CIEs prior to consolidation, which are accounted for using the equity method or fair value option.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Pay vs Performance Disclosure
Net Income (Loss)	$ 158	$ 68	$ 241	$ 136

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended	6 Months Ended
	Jun. 30, 2023 shares	Jun. 30, 2023 shares
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		During the three months ended June 30, 2023, the following trading plans were adopted or terminated by directors and officers of the Company (as defined in Rule 16a-1(f)) that are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c): Name and title of director or officer Date of adoption of trading arrangement Duration of trading arrangement Aggregate number of securities to be sold or purchased under trading arrangement Nan A Ferrara, EVP Organizational Health and Enterprise Capability Building May 12, 2023 August 11, 2023 to August 8, 2024 12,820
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Nan A Ferrara [Member]
Trading Arrangements, by Individual
Name	Nan A Ferrara
Title	EVP Organizational Health and Enterprise Capability Building
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	May 12, 2023
Arrangement Duration	363 days
Aggregate Available	12,820	12,820

Business, Basis of Presentati_2

Business, Basis of Presentation and Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2023
Accounting Policies [Abstract]
Adoption of New Pronouncements	The following table provides a description of future adoptions of new accounting standards that may have an impact on the Company's financial statements when adopted: Standard Description of Requirements Effective Date and Transition Provisions Effect on the Financial Statements or Other Significant Matters ASU 2022-03, Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions This standard, issued in June 2022, clarifies that contractual restrictions on equity security sales are not considered part of the security unit of account and, therefore, are not considered in measuring fair value. In addition, the restrictions cannot be recognized and measured as separate units of account. Disclosures on such restrictions are also required. The amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, and are required to be applied prospectively, with any adjustments from the adoption recognized in earnings and disclosed. The Company is currently in the process of determining the impact of adoption of the provisions of ASU 2022-03.
Derivatives	The Company primarily enters into the following types of derivatives: Interest rate swaps: Interest rate swaps are used by the Company primarily to reduce market risks from changes in interest rates and to alter interest rate exposure arising from mismatches between assets and/or liabilities. Interest rate swaps are also used to hedge the interest rate risk associated with the value of assets it owns or in an anticipation of acquiring them. Using interest rate swaps, the Company agrees with another party to exchange, at specified intervals, the difference between fixed rate and floating rate interest payments, calculated by reference to an agreed upon notional principal amount. These transactions are entered into pursuant to master agreements that provide for a single net payment to be made to/from the counterparty at each due date. The Company utilizes these contracts in qualifying hedging relationships as well as non-qualifying hedging relationships. Foreign exchange swaps: The Company uses foreign exchange or currency swaps to reduce the risk of change in the value, yield or cash flows associated with certain foreign denominated invested assets. Foreign exchange swaps represent contracts that require the exchange of foreign currency cash flows against U.S. dollar cash flows at regular periods, typically quarterly or semi-annually. The Company utilizes these contracts in qualifying hedging relationships as well as non-qualifying hedging relationships. Total return swaps: The Company uses total return swaps as a hedge of interest related risks within various Legacy Annuity and Retirement products. Total return swaps are also used as a hedge of other corporate liabilities. Using total return swaps, the Company agrees with another party to exchange, at specified intervals, the difference between the economic performance of assets or a market index and a fixed or variable funding multiplied by reference to an agreed upon notional amount. No cash is exchanged at the onset of the contracts. Cash is paid and received over the life of the contract based upon the terms of the swaps. The Company utilized these contracts in non-qualifying hedging relationships. Futures: Futures contracts are used to hedge against a decrease in certain equity indices. Such decreases may correlate to a decrease in variable annuity account values which would increase the possibility of the Company incurring an expense for guaranteed benefits in excess of account values. The Company also uses interest rate futures contracts to hedge its exposure to market risks due to changes in interest rates. The Company enters into exchange traded futures with regulated futures commissions that are members of the exchange. The Company also posts initial and variation margins, with the exchange, on a daily basis. The Company utilizes exchange-traded futures in non-qualifying hedging relationships. The Company may also use futures contracts as a hedge against an increase in certain equity indices.
Income Tax	The Company uses the estimated annual effective tax rate method in computing its interim tax provision. Certain items, including changes in the realizability of deferred tax assets and changes in liabilities for uncertain tax positions, are excluded from the estimated annual effective tax rate and the actual tax expense or benefit is reported in the period the related item is incurred.

Business, Basis of Presentati_3

Business, Basis of Presentation and Significant Accounting Policies (Tables)	6 Months Ended
	Jun. 30, 2023
Accounting Policies [Abstract]
Adoption of New Accounting Pronouncements and Future Adoption of Accounting Pronouncements	The following tables provide additional information related to the transition adjustments: DAC VOBA Wealth Solutions Deferred and Individual Annuities Businesses Exited (1) Balance, December 31, 2020 $ 119 $ 1,186 $ 70 Adjustment for removal of related balances in AOCI 571 104 635 Balance, January 1, 2021 $ 690 $ 1,290 $ 705 Liability for Future Policy Benefits Health Solutions Group (2) Health Solutions Voluntary (3) Businesses Exited (1) Balance, December 31, 2020 $ 822 $ 188 $ 5,448 Adjustment for reversal of related balances in AOCI — — (386) Adjustment for loss contracts under the modified retrospective approach 7 3 3 Effect of remeasurement of liability at current discount rate 118 83 1,362 Balance, January 1, 2021 $ 947 $ 274 $ 6,427 (1) Includes long duration retail individual life and annuity business exited via reinsurance (2) Includes long duration employee-sponsored group life and health products (3) Includes long duration employee-paid whole life products The following table presents information on transition adjustments, net of tax, related to the adoption of ASU 2018-12 for retained earnings and AOCI to arrive at the opening balances as of January 1, 2021: Total Shareholders' equity December 31, 2020 $ 11,178 AOCI Reversal of AOCI adjustments 1,328 Effect of remeasurement of liability at current discount rate (1,065) Total AOCI adjustments $ 263 Retained Earnings Establishment of MRBs $ (132) Other adjustments 27 Total Retained earnings $ (105) Total adjustment for the adoption of ASU 2018-12 $ 158 Total Shareholders' equity January 1, 2021 $ 11,336 The following table provides a description of the Company’s adoption of other new ASUs issued by the FASB and the impact of adoption on the Company’s financial statements: Standard Description of Requirements Effective Date and Transition Provisions Effect on the Financial Statements or Other Significant Matters ASU 2022-02, Troubled Debt Restructurings ("TDRs") and Vintage Disclosures This standard, issued in March 2022, eliminates the accounting guidance on troubled debt restructurings for creditors, requires enhanced disclosures for creditors about loan modifications when a borrower is experiencing financial difficulty, and requires public business entities to include current-period gross write-offs in the vintage disclosure tables. January 1, 2023 on a prospective basis. Adoption of the ASU did not have an impact on the Company's financial condition, results of operations, or cash flows. Required disclosure changes have been included in the Investments (excluding Consolidated Investment Entities) Note to these Condensed Consolidated Financial Statements . ASU 2020-04, Reference Rate Reform This standard, issued in March 2020, provides temporary optional expedients and exceptions for applying U.S. GAAP principles to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments were effective as of March 12, 2020, the issuance date of the ASU. An entity may elect to apply the amendments prospectively through December 31, 2024. The Company has elected to apply the expedient provided in ASU 2020-04 for qualifying contract modifications. To date, adoption of the guidance has not had a material impact on the Company’s financial condition and results of operations. The Company will continue to evaluate the impacts of reference rate reform on contract modifications and hedging relationships as transition progresses. Future Adoption of Accounting Pronouncements The following table provides a description of future adoptions of new accounting standards that may have an impact on the Company's financial statements when adopted: Standard Description of Requirements Effective Date and Transition Provisions Effect on the Financial Statements or Other Significant Matters ASU 2022-03, Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions This standard, issued in June 2022, clarifies that contractual restrictions on equity security sales are not considered part of the security unit of account and, therefore, are not considered in measuring fair value. In addition, the restrictions cannot be recognized and measured as separate units of account. Disclosures on such restrictions are also required. The amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, and are required to be applied prospectively, with any adjustments from the adoption recognized in earnings and disclosed. The Company is currently in the process of determining the impact of adoption of the provisions of ASU 2022-03.

Investments (excluding Consol_2

Investments (excluding Consolidated Investment Entities) (Tables)	6 Months Ended
	Jun. 30, 2023
Investments, Debt and Equity Securities [Abstract]
Marketable Securities	Available-for-sale and fair value option ("FVO") fixed maturities were as follows as of June 30, 2023: Amortized Cost Gross Unrealized Capital Gains Gross Unrealized Capital Losses Embedded Derivatives (2) Fair Value Allowance for credit losses Fixed maturities: U.S. Treasuries $ 434 $ 9 $ 18 $ — $ 425 $ — U.S. Government agencies and authorities 54 3 1 — 56 — State, municipalities and political subdivisions 931 1 110 — 822 — U.S. corporate public securities 8,845 116 1,082 — 7,878 1 U.S. corporate private securities 5,113 27 405 — 4,735 — Foreign corporate public securities and foreign governments (1) 3,081 28 336 — 2,767 6 Foreign corporate private securities (1) 3,092 18 193 — 2,915 2 Residential mortgage-backed securities 3,870 33 277 2 3,628 — Commercial mortgage-backed securities 4,326 1 644 — 3,676 7 Other asset-backed securities 2,422 6 137 — 2,291 — Total fixed maturities, including securities pledged 32,168 242 3,203 2 29,193 16 Less: Securities pledged 1,266 — 118 — 1,148 — Total fixed maturities $ 30,902 $ 242 $ 3,085 $ 2 $ 28,045 $ 16 (1) Primarily U.S. dollar denominated. (2) Embedded derivatives within fixed maturity securities are reported with the host investment. The changes in fair value of embedded derivatives are reported in Net gains (losses) in the Condensed Consolidated Statements of Operations. Available-for-sale and FVO fixed maturities were as follows as of December 31, 2022: Amortized Cost Gross Unrealized Capital Gains Gross Unrealized Capital Losses Embedded Derivatives (2) Fair Value Allowance for credit losses Fixed maturities: U.S. Treasuries $ 590 $ 12 $ 21 $ — $ 581 $ — U.S. Government agencies and authorities 58 3 2 — 59 — State, municipalities and political subdivisions 978 1 134 — 845 — U.S. corporate public securities 9,343 97 1,239 — 8,201 — U.S. corporate private securities 5,087 14 409 — 4,692 — Foreign corporate public securities and foreign governments (1) 3,343 18 403 — 2,949 9 Foreign corporate private securities (1) 3,254 7 225 — 3,034 2 Residential mortgage-backed securities 4,230 34 290 3 3,977 — Commercial mortgage-backed securities 4,466 2 585 — 3,883 — Other asset-backed securities 2,307 3 173 — 2,136 1 Total fixed maturities, including securities pledged 33,656 191 3,481 3 30,357 12 Less: Securities pledged 1,303 3 144 — 1,162 — Total fixed maturities $ 32,353 $ 188 $ 3,337 $ 3 $ 29,195 $ 12 (1) Primarily U.S. dollar denominated. (2) Embedded derivatives within fixed maturity securities are reported with the host investment. The changes in fair value of embedded derivatives are reported in Net gains (losses) in the Condensed Consolidated Statements of Operations.
Investments Classified by Contractual Maturity Date	The amortized cost and fair value of fixed maturities, including securities pledged, as of June 30, 2023, are shown below by contractual maturity. Actual maturities may differ from contractual maturities as securities may be restructured, called or prepaid. Mortgage-backed securities ("MBS") and Other asset-backed securities ("ABS") are shown separately because they are not due at a single maturity date. Amortized Fair Due to mature: One year or less $ 650 $ 643 After one year through five years 4,054 3,844 After five years through ten years 4,126 3,887 After ten years 12,720 11,224 Mortgage-backed securities 8,196 7,304 Other asset-backed securities 2,422 2,291 Fixed maturities, including securities pledged $ 32,168 $ 29,193
U.S. and Foreign Corporate Securities by Industry	The following tables present the composition of the U.S. and foreign corporate securities within the fixed maturity portfolio by industry category as of the dates indicated: Amortized Gross Gross Fair June 30, 2023 Communications $ 1,202 $ 26 $ 114 $ 1,114 Financial 3,982 42 452 3,572 Industrial and other companies 7,824 44 824 7,044 Energy 1,987 43 139 1,891 Utilities 3,547 24 332 3,239 Transportation 1,101 7 105 1,003 Total $ 19,643 $ 186 $ 1,966 $ 17,863 December 31, 2022 Communications $ 1,156 $ 16 $ 130 $ 1,042 Financial 4,153 31 491 3,693 Industrial and other companies 8,379 26 953 7,452 Energy 1,979 39 160 1,858 Utilities 3,664 21 355 3,330 Transportation 1,165 2 128 1,039 Total $ 20,496 $ 135 $ 2,217 $ 18,414
Schedule of Securities Borrowed Under Securities Lending Transactions	The following table presents borrowings under securities lending transactions by asset class from cash collateral invested and non-cash collateral as of the dates indicated: June 30, 2023 December 31, 2022 U.S. Treasuries $ 41 $ 53 U.S. corporate public securities 576 604 Short-term investments 1 — Foreign corporate public securities and foreign governments 266 285 Total $ 884 $ 942
Financing Receivable, Allowance for Credit Loss	The following table presents a rollforward of the allowance for credit losses on available-for-sale fixed maturity securities for the periods presented: Six Months Ended June 30, 2023 U.S. corporate public securities Commercial mortgage-backed securities Foreign corporate public securities and foreign governments Foreign corporate private securities Other asset-backed securities Total Balance as of January 1 $ — $ — $ 9 $ 2 $ 1 $ 12 Credit losses on securities for which credit losses were not previously recorded 1 7 — — — 8 Reductions for securities sold during the period — — (2) — — (2) Increase (decrease) on securities with allowance recorded in previous period — — (1) — (1) (2) Balance as of June 30 $ 1 $ 7 $ 6 $ 2 $ — $ 16 Year Ended December 31, 2022 Residential mortgage-backed securities Foreign Foreign corporate private securities Other asset-backed securities Total Balance as of January 1 $ 1 $ — $ 56 $ 1 $ 58 Credit losses on securities for which credit losses were not previously recorded — 9 — — 9 Reductions for securities sold during the period — — (57) — (57) Increase (decrease) on securities with allowance recorded in previous period (1) — 3 — 2 Balance as of December 31 $ — $ 9 $ 2 $ 1 $ 12
Schedule of Unrealized Loss on Investments	The following table presents available-for-sale fixed maturities, including securities pledged, for which an allowance for credit losses has not been recorded by market sector and duration as of June 30, 2023: Twelve Months or Less More Than Twelve Total Fair Value Unrealized Capital Losses Number of securities Fair Value Unrealized Capital Losses Number of securities Fair Value Unrealized Capital Losses Number of securities U.S. Treasuries $ 202 $ 5 24 $ 63 $ 13 14 $ 265 $ 18 38 U.S. Government agencies and authorities 14 — * 1 3 1 1 17 1 2 State, municipalities and political subdivisions 191 10 80 587 100 216 778 110 296 U.S. corporate public securities 1,723 89 305 4,266 993 1,011 5,989 1,082 1,316 U.S. corporate private securities 1,272 55 127 2,597 350 276 3,869 405 403 Foreign corporate public securities and foreign governments 552 19 97 1,588 317 334 2,140 336 431 Foreign corporate private securities 1,051 33 74 1,497 160 133 2,548 193 207 Residential mortgage-backed 585 31 236 1,146 246 545 1,731 277 781 Commercial mortgage-backed 492 46 79 3,046 598 550 3,538 644 629 Other asset-backed 192 7 44 1,745 130 467 1,937 137 511 Total $ 6,274 $ 295 1,067 $ 16,538 $ 2,908 3,547 $ 22,812 $ 3,203 4,614 *Less than $1 The Company concluded that an allowance for credit losses was unnecessary for these securities because the unrealized losses are interest rate related. The following table presents available-for-sale fixed maturities, including securities pledged, for which an allowance for credit losses has not been recorded by market sector and duration as of December 31, 2022: Twelve Months or Less More Than Twelve Total Fair Value Unrealized Capital Losses Number of securities Fair Value Unrealized Capital Losses Number of securities Fair Value Unrealized Capital Losses Number of securities U.S. Treasuries $ 197 $ 19 19 $ 9 $ 2 7 $ 206 $ 21 26 U.S. Government agencies and authorities 21 2 2 — — — 21 2 2 State, municipalities and political subdivisions 751 121 284 30 13 17 781 134 301 U.S. corporate public securities 5,479 792 1,054 1,137 447 347 6,616 1,239 1,401 U.S. corporate private securities 3,569 322 375 458 87 32 4,027 409 407 Foreign corporate public securities and foreign governments 2,050 260 371 391 143 97 2,441 403 468 Foreign corporate private securities 2,728 211 217 65 14 6 2,793 225 223 Residential mortgage-backed 1,538 128 536 562 162 283 2,100 290 819 Commercial mortgage-backed 2,628 390 441 1,133 195 207 3,761 585 648 Other asset-backed 1,430 104 334 578 69 191 2,008 173 525 Total $ 20,391 $ 2,349 3,633 $ 4,363 $ 1,132 1,187 $ 24,754 $ 3,481 4,820
Other than Temporary Impairment, Credit Losses Recognized in Earnings	The following table identifies the Company's intent impairments included in the Condensed Consolidated Statements of Operations, excluding impairments included in Other comprehensive income (loss) by type for the periods indicated: Three Months Ended June 30, 2023 2022 Impairment No. of Impairment No. of Residential mortgage-backed $ 2 34 $ 2 17 Commercial mortgage-backed 5 3 — * 1 Total $ 7 37 $ 2 18 *Less than $1 Six Months Ended June 30, 2023 2022 Impairment No. of Impairment No. of Residential mortgage-backed $ 2 36 $ 9 27 Commercial mortgage-backed 5 3 — * 1 Total $ 7 39 $ 9 28 *Less than $1
Mortgage Loans by Loan to Value Ratio	The following tables present commercial mortgage loans by year of origination and LTV ratio as of the dates indicated. The information is updated as of June 30, 2023 and December 31, 2022, respectively. As of June 30, 2023 Loan-to-Value Ratios Year of Origination 0% - 50% >50% - 60% >60% - 70% >70% - 80% >80% and above Total 2023 $ 78 $ 168 $ — $ — $ — $ 246 2022 250 330 69 — — 649 2021 242 248 212 — — 702 2020 158 161 9 10 — 338 2019 229 82 28 — — 339 2018 159 38 5 — — 202 2017 and prior 2,489 396 5 — — 2,890 Total $ 3,605 $ 1,423 $ 328 $ 10 $ — $ 5,366 As of December 31, 2022 Loan-to-Value Ratios Year of Origination 0% - 50% >50% - 60% >60% - 70% >70% - 80% >80% and above Total 2022 $ 250 $ 320 $ 65 $ — $ — $ 635 2021 240 272 255 10 — 777 2020 119 209 25 10 — 363 2019 227 94 29 — — 350 2018 163 41 2 — — 206 2017 and prior 2,606 482 26 — — 3,114 Total $ 3,605 $ 1,418 $ 402 $ 20 $ — $ 5,445
Mortgage Loans by Debt Service Coverage Ratio	The following tables present commercial mortgage loans by year of origination and DSC ratio as of the dates indicated. The information is updated as of June 30, 2023 and December 31, 2022, respectively. As of June 30, 2023 Debt Service Coverage Ratios Year of Origination >1.5x >1.25x - 1.5x >1.0x - 1.25x <1.0x Total* 2023 $ 70 $ 93 $ 83 $ — $ 246 2022 245 82 210 112 649 2021 256 21 62 363 702 2020 242 27 5 64 338 2019 186 39 107 7 339 2018 123 24 55 — 202 2017 and prior 2,078 362 211 239 2,890 Total $ 3,200 $ 648 $ 733 $ 785 $ 5,366 *No commercial mortgage loans were secured by land or construction loans As of December 31, 2022 Debt Service Coverage Ratios Year of Origination >1.5x >1.25x - 1.5x >1.0x - 1.25x <1.0x Total* 2022 $ 331 $ 100 $ 181 $ 23 $ 635 2021 273 33 269 202 777 2020 259 11 11 82 363 2019 222 54 67 7 350 2018 128 27 51 — 206 2017 and prior 2,172 454 226 262 3,114 Total $ 3,385 $ 679 $ 805 $ 576 $ 5,445 *No commercial mortgage loans were secured by land or construction loans
Mortgage Loans by Geographic Location of Collateral	The following tables present the commercial mortgage loans by year of origination and U.S. region as of the dates indicated. The information is updated as of June 30, 2023 and December 31, 2022, respectively. As of June 30, 2023 U.S. Region Year of Origination Pacific South Atlantic Middle Atlantic West South Central Mountain East North Central New England West North Central East South Central Total 2023 $ 21 $ 48 $ 5 $ 97 $ 11 $ 32 $ 3 $ 26 $ 3 $ 246 2022 140 130 48 99 113 93 5 1 20 649 2021 99 63 128 146 112 95 9 49 1 702 2020 74 160 18 10 12 40 — 7 17 338 2019 53 102 10 75 46 5 14 13 21 339 2018 49 60 53 10 14 10 — 6 — 202 2017 and prior 743 593 736 195 207 201 48 142 25 2,890 Total $ 1,179 $ 1,156 $ 998 $ 632 $ 515 $ 476 $ 79 $ 244 $ 87 $ 5,366 As of December 31, 2022 U.S. Region Year of Origination Pacific South Atlantic Middle Atlantic West South Central Mountain East North Central New England West North Central East South Central Total 2022 $ 140 $ 129 $ 48 $ 98 $ 114 $ 82 $ 4 $ 1 $ 19 $ 635 2021 99 72 134 143 112 138 9 48 22 777 2020 74 170 18 16 12 39 — 7 27 363 2019 58 106 10 77 46 5 14 13 21 350 2018 50 62 55 10 14 10 — 5 — 206 2017 and prior 777 623 759 248 227 257 49 149 25 3,114 Total $ 1,198 $ 1,162 $ 1,024 $ 592 $ 525 $ 531 $ 76 $ 223 $ 114 $ 5,445
Mortgage Loans by Property Type of Collateral	The following tables present the commercial mortgage loans by year of origination and property type as of the dates indicated. The information is updated as of June 30, 2023 and December 31, 2022, respectively. As of June 30, 2023 Property Type Year of Origination Retail Industrial Apartments Office Hotel/Motel Other Mixed Use Total 2023 $ 93 $ 108 $ 26 $ 19 $ — $ — $ — $ 246 2022 79 265 251 34 10 10 — 649 2021 37 153 360 125 — 18 9 702 2020 58 60 77 143 — — — 338 2019 45 83 163 36 12 — — 339 2018 36 82 55 12 — 17 — 202 2017 and prior 806 700 632 485 67 150 50 2,890 Total $ 1,154 $ 1,451 $ 1,564 $ 854 $ 89 $ 195 $ 59 $ 5,366 As of December 31, 2022 Property Type Year of Origination Retail Industrial Apartments Office Hotel/Motel Other Mixed Use Total 2022 $ 79 $ 255 $ 247 $ 34 $ 10 $ 10 $ — $ 635 2021 37 168 420 125 — 18 9 777 2020 58 61 93 151 — — — 363 2019 46 85 165 40 14 — — 350 2018 37 84 56 12 — 17 — 206 2017 and prior 888 757 679 513 69 156 52 3,114 Total $ 1,145 $ 1,410 $ 1,660 $ 875 $ 93 $ 201 $ 61 $ 5,445
Allowance for Credit Losses on Financing Receivables	The following table summarizes the activity in the allowance for losses for commercial mortgage loans for the periods indicated: June 30, 2023 December 31, 2022 Allowance for credit losses, beginning of period $ 18 $ 15 Credit losses on mortgage loans for which credit losses were not previously recorded 1 3 Increase (decrease) on mortgage loans with allowance recorded in previous period 8 — Provision for expected credit losses 27 18 Write-offs — — Recoveries of amounts previously written-off — — Allowance for credit losses, end of period $ 27 $ 18
Financing Receivable, Past Due	The following table presents past due commercial mortgage loans as of the dates indicated: June 30, 2023 December 31, 2022 Delinquency: Current $ 5,366 $ 5,445 30-59 days past due — — 60-89 days past due — — Greater than 90 days past due — — Total $ 5,366 $ 5,445
Net Investment Income	The following table summarizes Net investment income for the periods indicated: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Fixed maturities $ 440 $ 495 $ 898 $ 974 Equity securities 7 5 14 9 Mortgage loans on real estate 62 60 123 119 Policy loans 5 5 11 11 Short-term investments and cash equivalents 9 2 18 3 Limited partnerships and other 40 29 62 125 Gross investment income 563 596 1,126 1,241 Less: Investment expenses 18 15 36 30 Net investment income $ 545 $ 581 $ 1,090 $ 1,211
Realized Gain (Loss) on Investments	Net gains (losses) were as follows for the periods indicated: Three Months Ended June 30, 2023 2022 Fixed maturities, available-for-sale, including securities pledged $ (18) $ (6) Fixed maturities, at fair value option (144) (245) Equity securities, at fair value (1) (24) Derivatives 119 32 Embedded derivatives - fixed maturities (2) (2) Other derivatives, net — 12 Standalone derivatives — — Managed custody guarantees — 1 Mortgage loans (10) 1 Other investments — 5 Net gains (losses) $ (56) $ (226) Six Months Ended June 30, 2023 2022 Fixed maturities, available-for-sale, including securities pledged $ (17) $ (79) Fixed maturities, at fair value option (108) (550) Equity securities, at fair value (3) (32) Derivatives 65 126 Embedded derivatives - fixed maturities (1) (6) Other derivatives, net — 17 Standalone derivatives — 1 Managed custody guarantees 3 (2) Mortgage Loans (10) 5 Other investments (1) 6 Net gains (losses) $ (72) $ (514)
Gain (Loss) on Investments	Proceeds from the sale of fixed maturities, available-for-sale and equity securities and the related gross realized gains and losses, before tax, were as follows for the periods indicated: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Proceeds on sales $ 2,331 $ 971 $ 3,637 $ 2,220 Gross gains 23 15 43 30 Gross losses 30 12 55 44

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	6 Months Ended
	Jun. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Notional Amounts of Outstanding Derivative Positions	The notional amounts and fair values of derivatives were as follows as of the dates indicated: June 30, 2023 December 31, 2022 Notional Asset Liability Notional Asset Liability Derivatives: Qualifying for hedge accounting (1) Fair value hedges: Foreign exchange contracts $ 103 $ 1 $ — $ 81 $ — $ 6 Cash flow hedges: Interest rate contracts 44 — — 22 — — Foreign exchange contracts 745 54 3 718 71 2 Derivatives: Non-qualifying for hedge accounting (1) Interest rate contracts 27,506 374 390 18,304 341 376 Foreign exchange contracts 249 4 1 160 9 2 Equity contracts 255 11 2 248 1 1 Credit contracts 177 — 4 174 — 2 Embedded derivatives and Managed custody guarantees: Within fixed maturity investments (2) N/A 2 — N/A 3 — Within reinsurance agreements (4) N/A 78 47 N/A 95 46 Managed custody guarantees (3) N/A — 3 N/A — 6 Total $ 524 $ 450 $ 520 $ 441 (1) Open derivative contracts are reported as Derivatives assets or liabilities on the Condensed Consolidated Balance Sheets at fair value. (2) Included in Fixed maturities, available-for-sale, at fair value on the Condensed Consolidated Balance Sheets. (3) Included in Contract owner account balances on the Condensed Consolidated Balance Sheets. (4) Included in Other liabilities, Other assets and Premium receivable and reinsurance recoverable on the Condensed Consolidated Balance Sheets. N/A - Not applicable
Offsetting Assets and Liabilities	Although the Company has not elected to net its derivative exposures, the notional amounts and fair values of Over-The-Counter ("OTC") and cleared derivatives excluding exchange traded contracts are presented in the tables below as of the dates indicated: June 30, 2023 Notional Amount Asset Fair Value Liability Fair Value Credit contracts $ 177 $ — $ 4 Equity contracts 225 11 2 Foreign exchange contracts 1,097 59 4 Interest rate contracts 24,444 374 389 444 399 Counterparty netting (1) (341) (341) Cash collateral netting (1) (96) (52) Securities collateral netting (1) (5) (5) Net receivables/payables $ 2 $ 1 (1) Represents the netting of receivable balances with payable balances, net of collateral, for the same counterparty under eligible netting agreements. December 31, 2022 Notional Amount Asset Fair Value Liability Fair Value Credit contracts $ 174 $ — $ 2 Equity contracts 201 1 1 Foreign exchange contracts 959 80 10 Interest rate contracts 13,328 339 376 420 389 Counterparty netting (1) (295) (295) Cash collateral netting (1) (64) (88) Securities collateral netting (1) (6) (1) Net receivables/payables $ 55 $ 5 (1) Represents the netting of receivable balances with payable balances, net of collateral, for the same counterparty under eligible netting agreements.
Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance	The location and effect of derivatives qualifying for hedge accounting on the Condensed Consolidated Statements of Operations and Condensed Consolidated Statements of Comprehensive Income are as follows for the periods indicated: Three Months Ended June 30, 2023 2022 Interest Rate Contracts Foreign Exchange Contracts Interest Rate Contracts Foreign Exchange Contracts Derivatives: Qualifying for hedge accounting Location of Gain (Loss) Reclassified from Accumulated Other Comprehensive Income into Income Net investment income Net investment income and Net gains/(losses) Net investment income Net investment income and Net gains/(losses) Amount of Gain (Loss) Recognized in Other Comprehensive Income $ — $ (6) $ (1) $ 55 Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Income — 2 — 2 Six Months Ended June 30, 2023 2022 Interest Rate Contracts Foreign Exchange Contracts Interest Rate Contracts Foreign Exchange Contracts Derivatives: Qualifying for hedge accounting Location of Gain (Loss) Reclassified from Accumulated Other Comprehensive Income into Income Net investment income Net investment income and Net gains/(losses) Net investment income Net investment income and Net gains/(losses) Amount of Gain (Loss) Recognized in Other Comprehensive Income $ — $ (18) $ (2) $ 62 Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Income — 5 — 5 The location and amount of gain (loss) recognized in the Condensed Consolidated Statements of Operations for derivatives qualifying for hedge accounting are as follows for the periods indicated: Three Months Ended June 30, 2023 2022 Net investment income Net gains/(losses) Net investment income Net gains/(losses) Total amounts of line items presented in the statements of operations in which the effects of fair value or cash flow hedges are recorded $ 545 $ (56) $ 581 $ (226) Derivatives: Qualifying for hedge accounting Fair value hedges: Foreign exchange contracts: Hedged items — — — (5) Derivatives designated as hedging instruments (1) — — — 6 Cash flow hedges: Foreign exchange contracts: Gain (loss) reclassified from accumulated other comprehensive income into income 2 — 2 — Six Months Ended June 30, 2023 2022 Net investment income Net gains/(losses) Net investment income Net gains/(losses) Total amounts of line items presented in the statements of operations in which the effects of fair value or cash flow hedges are recorded $ 1,090 $ (72) $ 1,211 $ (514) Derivatives: Qualifying for hedge accounting Fair value hedges: Foreign exchange contracts: Hedged items — 2 — (7) Derivatives designated as hedging instruments (1) — (1) — 8 Cash flow hedges: Foreign exchange contracts: Gain (loss) reclassified from accumulated other comprehensive income into income 5 — 5 — (1) For the three months ended June 30, 2023, an immaterial amount of the change in derivative instruments designated and qualifying as fair value hedges was excluded from the assessment of hedge effectiveness and recognized currently in earning. For the six months ended June 30, 2023, $1 of the change in derivative instruments designated and qualifying as fair value hedges was excluded from the assessment of hedge effectiveness and recognized currently in earning. For the three and six months ended June 30, 2022, $1 of the change in derivative instruments designated and qualifying as fair value hedges was excluded from the assessment of hedge effectiveness and recognized currently in earning. The location and effect of derivatives not designated as hedging instruments on the Condensed Consolidated Statements of Operations are as follows for the periods indicated: Location of Gain (Loss) on Derivative Three Months Ended June 30, 2023 2022 Derivatives: Non-qualifying for hedge accounting Interest rate contracts Net gains (losses) $ 114 $ 52 Foreign exchange contracts Net gains (losses) — (1) Equity contracts Net gains (losses) 5 (20) Credit contracts Net gains (losses) — (4) Embedded derivatives and Managed custody guarantees: Within fixed maturity investments Net gains (losses) (2) (2) Within reinsurance agreements (1) Policyholder benefits 8 84 Managed custody guarantees Net gains (losses) — 1 Total $ 125 $ 110 Location of Gain (Loss) on Derivative Six Months Ended June 30, 2023 2022 Derivatives: Non-qualifying for hedge accounting Interest rate contracts Net gains (losses) $ 58 $ 152 Foreign exchange contracts Net gains (losses) 1 (2) Equity contracts Net gains (losses) 8 (28) Credit contracts Net gains (losses) (1) (4) Embedded derivatives and Managed custody guarantees: Within fixed maturity investments Net gains (losses) (1) (6) Within reinsurance agreements (1) Policyholder benefits (18) 176 Managed custody guarantees Net gains (losses) 3 (2) Total $ 50 $ 286 (1) For the three and six months ended June 30, 2023, the amount excludes immaterial gains (losses) from standalone derivatives that were recognized in Net gains (losses). For the three months ended June 30, 2022, no gains (losses) from standalone derivatives were recognized. For the six months ended June 30, 2022, the amount excluded gains (losses) of $1 from standalone derivatives recognized in Net gains (losses).

Fair Value Measurements (excl_2

Fair Value Measurements (excluding Consolidated Investment Entities) (Tables)	6 Months Ended
	Jun. 30, 2023
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	The following table presents the Company's hierarchy for its assets and liabilities measured at fair value on a recurring basis as of June 30, 2023: Level 1 Level 2 Level 3 Total Assets: Fixed maturities, including securities pledged: U.S. Treasuries $ 367 $ 58 $ — $ 425 U.S. Government agencies and authorities — 55 1 56 State, municipalities and political subdivisions — 822 — 822 U.S. corporate public securities — 7,858 20 7,878 U.S. corporate private securities — 3,003 1,732 4,735 Foreign corporate public securities and foreign governments (1) — 2,767 — 2,767 Foreign corporate private securities (1) — 2,502 413 2,915 Residential mortgage-backed securities — 3,571 57 3,628 Commercial mortgage-backed securities — 3,676 — 3,676 Other asset-backed securities — 2,246 45 2,291 Total fixed maturities, including securities pledged 367 26,558 2,268 29,193 Equity securities 117 — 192 309 Derivatives: Interest rate contracts — 374 — 374 Foreign exchange contracts — 59 — 59 Equity contracts — 11 — 11 Embedded derivative on reinsurance — 78 — 78 Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements 2,297 36 — 2,333 Assets held in separate accounts 83,005 5,502 344 88,851 Total assets $ 85,786 $ 32,618 $ 2,804 $ 121,208 Percentage of Level to total 71 % 27 % 2 % 100 % Liabilities: Contingent consideration $ — $ — $ 112 $ 112 Stabilizer and MCGs — — 3 3 Derivatives: Interest rate contracts 4 386 — 390 Foreign exchange contracts — 4 — 4 Equity contracts — 2 — 2 Credit contracts — 4 — 4 Embedded derivative on reinsurance — (11) (2) 58 (3) 47 Total liabilities $ 4 $ 385 $ 173 $ 562 (1) Primarily U.S. dollar denominated. (2) The Company classifies the embedded derivative within liabilities given the underlying nature of the balance and the right-of-offset. (3) Represents the standalone derivative. The following table presents the Company's hierarchy for its assets and liabilities measured at fair value on a recurring basis as of December 31, 2022: Level 1 Level 2 Level 3 Total Assets: Fixed maturities, including securities pledged: U.S. Treasuries $ 433 $ 148 $ — $ 581 U.S. Government agencies and authorities — 58 1 59 State, municipalities and political subdivisions — 845 — 845 U.S. corporate public securities — 8,181 20 8,201 U.S. corporate private securities — 2,891 1,801 4,692 Foreign corporate public securities and foreign governments (1) — 2,946 3 2,949 Foreign corporate private securities (1) — 2,602 432 3,034 Residential mortgage-backed securities — 3,949 28 3,977 Commercial mortgage-backed securities — 3,883 — 3,883 Other asset-backed securities — 2,072 64 2,136 Total fixed maturities, including securities pledged 433 27,575 2,349 30,357 Equity securities 140 — 196 336 Derivatives: Interest rate contracts 2 339 — 341 Foreign exchange contracts — 80 — 80 Equity contracts — 1 — 1 Embedded derivative on reinsurance — 95 — 95 Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements 2,430 24 — 2,454 Assets held in separate accounts 74,600 5,227 347 80,174 Total assets $ 77,605 $ 33,341 $ 2,892 $ 113,838 Percentage of Level to total 68 % 29 % 3 % 100 % Liabilities: Contingent consideration $ — $ — $ 112 $ 112 Stabilizer and MCGs — — 6 6 Derivatives: Interest rate contracts 3 373 — 376 Foreign exchange contracts — 10 — 10 Equity contracts — 1 — 1 Credit contracts — 2 — 2 Embedded derivative on reinsurance — (12) (2) 58 (3) 46 Total liabilities $ 3 $ 374 $ 176 $ 553 (1) Primarily U.S. dollar denominated. (2) The Company classifies the embedded derivative within liabilities given the underlying nature of the balance and the right-of-offset. (3) Represents the standalone derivative.
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation	The following tables summarize the change in fair value of the Company's Level 3 assets and liabilities and transfers in and out of Level 3 for the periods indicated: Three Months Ended June 30, 2023 Fair Value as of April 1 Realized/Unrealized Purchases Issuances Sales Settlements Transfers Transfers Fair Value as of June 30 Change In (3) Change In Unrealized Gains (Losses) Included in OCI (3) Net OCI Fixed maturities, including securities pledged: U.S. Government agencies and authorities $ 1 $ — $ — $ — $ — $ — $ — $ — $ — $ 1 $ — $ — U.S. corporate public securities 21 — (1) — — — — — — 20 — — U.S. corporate private securities 1,800 — (29) 20 — (3) (56) — — 1,732 — (29) Foreign corporate private securities (1) 441 1 — 19 — — (93) 45 — 413 1 — Residential mortgage-backed securities 56 (3) — 4 — — — — — 57 (3) — Other asset-backed securities 77 — — 4 — — (1) — (35) 45 — — Total fixed maturities, including securities pledged 2,396 (2) (30) 47 — (3) (150) 45 (35) 2,268 (2) (29) Equity securities, at fair value 192 — — — — — — — — 192 — — Contingent consideration (112) — — — — — — — — (112) — — Stabilizer and MCGs (2) (3) — — — — — — — — (3) — — Embedded derivatives on reinsurance (58) — — — — — — — — (58) — — Assets held in separate accounts (4) 349 (8) — 7 — (7) — 3 — 344 — — (1) Primarily U.S. dollar denominated. (2) All gains and losses on Level 3 liabilities are classified as realized gains (losses) for the purpose of this disclosure because it is impracticable to track realized and unrealized gains (losses) separately on a contract by contract basis. These amounts are included in Net gains (losses) in the Condensed Consolidated Statements of Operations. (3) For financial instruments still held as of June 30 amounts are included in Net investment income and Net gains (losses) in the Condensed Consolidated Statements of Operations or Unrealized gains (losses) on securities in the Condensed Consolidated Statements of Comprehensive Income. (4) The investment income and realized gains (losses) and change in unrealized gains (losses) included in net income for separate account assets are offset by an equal amount for separate account liabilities, which results in a net zero impact on Net income (loss) for the Company. Six Months Ended June 30, 2023 Fair Value as of January 1 Realized/Unrealized Purchases Issuances Sales Settlements Transfers Transfers Fair Value as of June 30 Change In (3) Change In Unrealized Gains (Losses) Included in OCI (3) Net OCI Fixed maturities, including securities pledged: U.S. Government agencies and authorities $ 1 $ — $ — $ — $ — $ — $ — $ — $ — $ 1 $ — $ — U.S. corporate public securities 20 — — — — — — — — 20 — — U.S. corporate private securities 1,801 — 6 61 — (3) (133) — — 1,732 1 5 Foreign corporate public securities and foreign governments (1) 3 — — — — — — — (3) — — — Foreign corporate private securities (1) 432 3 7 75 — — (181) 77 — 413 3 6 Residential mortgage-backed securities 28 (3) — 32 — — — — — 57 (3) — Other asset-backed securities 64 — — 4 — — (1) — (22) 45 — — Total fixed maturities, including securities pledged 2,349 — 13 172 — (3) (315) 77 (25) 2,268 1 11 Equity securities, at fair value 196 (4) — — — — — — — 192 (3) — Contingent consideration (112) — — — — — — — — (112) — — Stabilizer and MCGs (2) (6) 4 — — (1) — — — — (3) — — Embedded derivatives on reinsurance (58) — — — — — — — — (58) — — Assets held in separate accounts (4) 347 (4) — 7 — (9) — 3 — 344 — — (1) Primarily U.S. dollar denominated. (2) All gains and losses on Level 3 liabilities are classified as realized gains (losses) for the purpose of this disclosure because it is impracticable to track realized and unrealized gains (losses) separately on a contract by contract basis. These amounts are included in Net gains (losses) in the Condensed Consolidated Statements of Operations. (3) For financial instruments still held as of June 30 amounts are included in Net investment income and Net gains (losses) in the Condensed Consolidated Statements of Operations or Unrealized gains (losses) on securities in the Condensed Consolidated Statements of Comprehensive Income. (4) The investment income and realized gains (losses) and change in unrealized gains (losses) included in net income for separate account assets are offset by an equal amount for separate account liabilities, which results in a net zero impact on Net income (loss) for the Company. Three Months Ended June 30, 2022 Fair Value as of April 1 Realized/Unrealized Purchases Issuances Sales Settlements Transfers Transfers Fair Value as of June 30 Change In (3) Change In Unrealized Gains (Losses) Included in OCI (3) Net OCI Fixed maturities, including securities pledged: U.S. corporate public securities $ 71 $ — $ (1) $ 1 $ — $ — $ — $ — $ (52) $ 19 $ — $ 1 U.S. corporate private securities 1,925 (1) (134) 89 — — (58) — (41) 1,780 (1) (133) Foreign corporate public securities and foreign governments (1) 11 — — 4 — — — — (11) 4 — — Foreign corporate private securities (1) 496 (3) (7) 51 — — (15) — (119) 403 (4) (7) Residential mortgage-backed securities 45 (6) — 2 — — (9) 1 (2) 31 (6) — Other asset-backed securities 49 — (2) 35 — — (5) — (14) 63 — (2) Total fixed maturities, including securities pledged 2,597 (10) (144) 182 — — (87) 1 (239) 2,300 (11) (143) Equity securities, at fair value 203 (17) — 26 — — — — (9) 203 (17) — Contingent consideration (11) — — — — — — — — (11) — — Stabilizer and MCGs (2) (15) 11 — — — — — — — (4) — — Embedded derivatives on (86) — — — — — — — — (86) — — Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements 8 — — — — — (8) — — — — — Assets held in separate accounts (4) 334 (12) — 67 — (3) — — (37) 349 — — (1) Primarily U.S. dollar denominated. (2) All gains and losses on Level 3 liabilities are classified as realized gains (losses) for the purpose of this disclosure because it is impracticable to track realized and unrealized gains (losses) separately on a contract by contract basis. These amounts are included in Net gains (losses) in the Condensed Consolidated Statements of Operations. (3) For financial instruments still held as of June 30, amounts are included in Net investment income and Net gains (losses) in the Condensed Consolidated Statements of Operations or Unrealized gains (losses) on securities in the Condensed Consolidated Statements of Comprehensive Income. (4) The investment income and realized gains (losses) and change in unrealized gains (losses) included in net income for separate account assets are offset by an equal amount for separate account liabilities, which results in a net zero impact on Net income (loss) for the Company. Six Months Ended June 30, 2022 Fair Value as of January 1 Realized/Unrealized Purchases Issuances Sales Settlements Transfers Transfers Fair Value as of June 30 Change In (3) Change In Unrealized Gains (Losses) Included in OCI (3) Net OCI Fixed maturities, including securities pledged: U.S. corporate public securities $ 16 $ — $ (1) $ 5 $ — $ — $ — $ — $ (1) $ 19 $ — $ (1) U.S. corporate private securities 1,910 (2) (277) 158 — — (120) 121 (10) 1,780 (2) (276) Foreign corporate public securities and foreign governments (1) — — — 4 — — — — — 4 — — Foreign corporate private securities (1) 353 (22) (31) 97 — — (28) 148 (114) 403 (4) (31) Residential mortgage-backed securities 43 (15) — 4 — — — 1 (2) 31 (15) — Other asset-backed securities 44 — (4) 39 — (10) (6) — — 63 — (4) Total fixed maturities, including securities pledged 2,366 (39) (313) 307 — (10) (154) 270 (127) 2,300 (21) (312) Equity securities, at fair value 203 (26) — 26 — — — — — 203 (26) — Contingent consideration (11) — — — — — — — — (11) — — Stabilizer and MCGs (2) (20) 17 — — (1) — — — — (4) — — Embedded derivatives on reinsurance (87) 1 — — — — — — — (86) — — Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements — — — 8 — — (8) — — — — — Assets held in separate accounts (4) 316 (26) — 132 — (4) — 6 (75) 349 — — (1) Primarily U.S. dollar denominated. (2) All gains and losses on Level 3 liabilities are classified as realized gains (losses) for the purpose of this disclosure because it is impracticable to track realized and unrealized gains (losses) separately on a contract by contract basis. These amounts are included in Net gains (losses) in the Condensed Consolidated Statements of Operations. (3) For financial instruments still held as of June 30 amounts are included in Net investment income and Net gains (losses) in the Condensed Consolidated Statements of Operations or Unrealized gains (losses) on securities in the Condensed Consolidated Statements of Comprehensive Income. (4) The investment income and realized gains (losses) and change in unrealized gains (losses) included in net income for separate account assets are offset by an equal amount for separate account liabilities, which results in a net zero impact on Net income (loss) for the Company.
Fair Value, by Balance Sheet Grouping	The carrying values and estimated fair values of the Company's financial instruments as of the dates indicated: June 30, 2023 December 31, 2022 Carrying Fair Carrying Fair Assets: Fixed maturities, including securities pledged $ 29,193 $ 29,193 $ 30,357 $ 30,357 Equity securities 309 309 336 336 Mortgage loans on real estate 5,366 4,998 5,445 5,149 Policy loans 358 358 363 363 Cash, cash equivalents, short-term investments and short-term investments under securities loan agreements 2,333 2,333 2,454 2,454 Derivatives 444 444 422 422 Embedded derivatives on reinsurance 78 78 95 95 Other investments 69 69 68 68 Assets held in separate accounts 88,851 88,851 80,174 80,174 Liabilities: Investment contract liabilities: Funding agreements without fixed maturities and deferred annuities (1) $ 34,335 $ 35,615 $ 35,707 $ 36,385 Funding agreements with fixed maturities 1,290 1,298 1,285 1,281 Supplementary contracts, immediate annuities and other 673 614 727 636 Stabilizer and MCGs 3 3 6 6 Derivatives 400 400 389 389 Embedded derivative on reinsurance 47 47 46 46 Short-term debt 143 143 141 142 Long-term debt 2,095 1,941 2,094 1,935 (1) Certain amounts included in Funding agreements without fixed maturities and deferred annuities are also reflected within the Stabilizer and MCGs section of the table above. The following table summarizes the fair value hierarchy levels of consolidated investment entities as of June 30, 2023: Level 1 Level 2 Level 3 NAV Total Assets VIEs Cash and cash equivalents $ 154 $ — $ — $ — $ 154 Corporate loans — 1,407 — — 1,407 Limited partnerships/corporations — — — 3,120 3,120 VOE Corporate loans — 25 — — 25 Total assets $ 154 $ 1,432 $ — $ 3,120 $ 4,706 Liabilities VIEs CLO notes $ — $ 1,331 $ — $ — $ 1,331 Total liabilities $ — $ 1,331 $ — $ — $ 1,331 The following table summarizes the fair value hierarchy levels of consolidated investment entities as of December 31, 2022: Level 1 Level 2 Level 3 NAV Total Assets VIEs Cash and cash equivalents $ 88 $ — $ — $ — $ 88 Corporate loans — 1,293 — — 1,293 Limited partnerships/corporations — — — 2,802 2,802 Total assets $ 88 $ 1,293 $ — $ 2,802 $ 4,183 Liabilities VIEs CLO notes $ — $ 1,234 $ — $ — $ 1,234 Total liabilities $ — $ 1,234 $ — $ — $ 1,234
Financial Instruments Not Carried at Fair Value	The following table presents the classifications of financial instruments which are not carried at fair value on the Condensed Consolidated Balance Sheets: Financial Instrument Classification Mortgage loans on real estate Level 3 Policy loans Level 2 Other investments Level 2 Funding agreements without fixed maturities and deferred annuities Level 3 Funding agreements with fixed maturities Level 2 Supplementary contracts and immediate annuities Level 3 Short-term debt and Long-term debt Level 2

Deferred Policy Acquisition C_2

Deferred Policy Acquisition Costs and Value of Business Acquired (Tables)	6 Months Ended
	Jun. 30, 2023
Deferred Policy Acquisition Costs and Present Value of Future Insurance Profits, Net [Abstract]
Deferred Policy Acquisition Costs and Value of Business Acquired	The following tables present a rollforward of DAC and VOBA for the periods indicated: DAC VOBA Wealth Solutions Deferred and Individual Annuities Businesses exited Balance as of January 1, 2022 $ 691 $ 1,158 $ 473 Deferrals of commissions and expenses 59 — 5 Amortization expense (59) (115) (39) Balance as of December 31, 2022 $ 691 $ 1,043 $ 439 Deferrals of commissions and expenses 29 — 2 Amortization expense (28) (53) (19) Balance as of June 30, 2023 $ 692 $ 990 $ 422 The following table shows a reconciliation of DAC and VOBA balances to the Condensed Consolidated Balance Sheets for the periods indicated: June 30, 2023 December 31, 2022 DAC: Wealth Solutions Deferred and Individual Annuities $ 692 $ 691 Businesses exited 990 1,043 Other 200 190 VOBA 422 439 Total $ 2,304 $ 2,363

Financial Services, Insurance_2

Financial Services, Insurance, ASU 2018-12 Transition (Tables)	6 Months Ended
	Jun. 30, 2023
Reserves for Future Policy Benefits and Contract Owner Balances [Abstract]
Liability for Future Policy Benefit, Activity	The balances and changes in the liability for future policy benefits for Health Solutions Group, Health Solutions Voluntary and Businesses Exited are presented in the tables below for the periods indicated: Health Solutions Group Health Solutions Voluntary Businesses Exited June 30, 2023 December 31, 2022 June 30, 2023 December 31, 2022 June 30, 2023 December 31, 2022 Present Value of Expected Net Premiums: Balance at January 1 $ 77 $ 93 $ 97 $ 105 $ 4,244 $ 5,634 Beginning balance at original discount rate 84 85 100 92 4,128 4,226 Effect of change in cash flow assumptions — (7) — — — (69) Effect of actual variances from expected experience 12 23 5 20 (37) 86 Adjusted balance at January 1 96 101 105 112 4,091 4,243 Interest accrual 1 2 2 4 112 230 Net premiums collected (1) (11) (19) (8) (16) (161) (345) Ending balance at original discount rate 86 84 99 100 4,042 4,128 Effects of changes in discount rate assumptions (6) (7) (3) (3) 153 116 Balance at end of period $ 80 $ 77 $ 96 $ 97 $ 4,195 $ 4,244 Present Value of Expected Future Policy Benefits: Balance at January 1 $ 881 $ 1,048 $ 285 $ 359 $ 8,639 $ 11,444 Beginning balance at original discount rate 913 952 294 290 8,644 9,079 Effect of change in cash flow assumptions 4 (43) (1) (2) — (77) Effect of actual variances from expected experience (2) (27) 5 11 (41) (52) Adjusted balance at January 1 915 882 298 299 8,603 8,950 Issuances 68 139 — — 9 13 Interest accrual 12 25 7 14 220 458 Benefit payments (64) (133) (11) (19) (388) (777) Ending balance at original discount rate 931 913 294 294 8,444 8,644 Effects of changes in discount rate assumptions (34) (32) (5) (9) 51 (5) Balance at end of period $ 897 $ 881 $ 289 $ 285 $ 8,495 $ 8,639 Net liability for future policy benefits $ 816 $ 804 $ 193 $ 188 $ 4,300 $ 4,395 Less: Reinsurance recoverable 299 283 — — 4,412 4,411 Net liability for future policy benefits, after reinsurance recoverable $ 517 $ 521 $ 193 $ 188 $ (112) $ (16) (1) Net Premiums collected represent the portion of gross premiums collected from policyholders that is used to fund expected benefit payments. The reconciliation of the net liability for future policy benefits to the liability for future policy benefits in the Condensed Consolidated Balance Sheets is presented below: June 30, 2023 December 31, 2022 Health Solutions Group $ 816 $ 804 Health Solutions Voluntary 193 188 Businesses Exited - Future policy benefits 4,300 4,395 Businesses Exited – Additional liability 2,074 2,107 Other 2,270 2,225 Total $ 9,653 $ 9,719 The amount of undiscounted expected gross premiums and future benefit payments is presented in the table below: June 30, 2023 December 31, 2022 Undiscounted Discounted Undiscounted Discounted Health Solutions Group Expected future benefit payments $ 1,160 $ 931 $ 1,141 $ 913 Expected future gross premiums 288 231 286 231 Health Solutions Voluntary Expected future benefit payments 589 294 588 294 Expected future gross premiums 308 205 307 205 The following table presents a rollforward of the additional reserve liability for Businesses exited for the periods indicated: Businesses exited June 30, 2023 December 31, 2022 Balance at beginning of period $ 2,107 $ 1,715 Effect of change in cash flow assumptions — 540 Effect of actual variances from expected experience (58) 15 Adjusted balance at January 1 2,049 2,270 Interest accrual 43 80 Excess Benefits (209) (427) Assessments 191 184 Balance at end of period 2,074 2,107 Less: Reinsurance recoverable 2,021 2,054 Net additional liability, after reinsurance recoverable $ 53 $ 53 The following table presents the weighted average duration of the liability for future policy benefits and the weighted average interest rates for the periods indicated: Health Solutions Group Health Solutions Voluntary Businesses Exited June 30, 2023 December 31, 2022 June 30, 2023 December 31, 2022 June 30, 2023 December 31, 2022 Weighted average duration (in years) (1) 7 7 14 14 8 8 Interest accretion rate 4.0 % 4.1 % 5.3 % 5.3 % 4.9 % 5.0 % Current discount rate 5.2 % 5.2 % 5.2 % 5.4 % 5.4 % 5.7 %
Policyholder Account Balance	The following table presents a rollforward of Contract owner account balances for the periods indicated: Wealth Solutions Deferred Group and Individual Annuity Businesses Exited June 30, 2023 December 31, 2022 June 30, 2023 December 31, 2022 Balance at January 1 $ 33,622 $ 33,044 $ 5,146 $ 5,532 Deposits 1,171 2,962 147 310 Fee income (4) (8) (188) (384) Surrenders and withdrawals (2,740) (4,280) (230) (281) Benefit payments (88) (157) (81) (144) Net transfers from (to) separate accounts 70 1,174 (1) — Interest credited 440 874 73 150 Other 5 13 — (37) Ending Balance $ 32,476 $ 33,622 $ 4,866 $ 5,146 Weighted-average crediting rate 2.7 % 2.6 % 2.5 % 2.5 % Net amount at risk (1) $ 135 $ 199 $ 792 $ 900 Cash surrender value $ 31,995 $ 33,125 $ 1,669 $ 1,824 (1) For those guarantees of benefits that are payable in the event of death, the net amount at risk is generally defined as the current guaranteed minimum death benefit in excess of the current account balance at the balance sheet date and is calculated at a contract level. When a contract has both a living benefit and a death benefit, the Company calculates NAR at a contract level and aggregates the higher of the two values together. The following table shows a reconciliation of the Contract owner account balances to the Condensed Consolidated Balance Sheets for the periods indicated: June 30, 2023 December 31, 2022 Wealth Solutions Deferred group and individual annuity $ 32,476 $ 33,622 Businesses exited 4,866 5,146 Other 3,588 3,687 Total $ 40,930 $ 42,455 The following table summarizes detail on the differences between the interest rate being credited to contract holders as of June 30, 2023, and the respective guaranteed minimum interest rates ("GMIRs"): Account Value (1) Excess of crediting rate over GMIR At GMIR Up to .50% Above GMIR 0.51% - 1.00% 1.01% - 1.50% Above GMIR 1.51% - 2.00% Above GMIR More than 2.00% Above GMIR Total Guaranteed minimum interest rate Up to 1.00% $ 162 $ 6,577 $ 2,721 $ 1,872 $ 831 $ 741 $ 12,904 1.01% - 2.00% 575 142 52 4 2 6 781 2.01% - 3.00% 11,930 75 51 112 — 3 12,173 3.01% - 4.00% 9,320 153 1 2 — — 9,475 4.01% and Above 1,601 85 — — — — 1,685 Renewable beyond 12 months (MYGA) (2) 421 — — — 3 — 424 Total discretionary rate setting products $ 24,008 $ 7,032 $ 2,824 $ 1,990 $ 836 $ 751 $ 37,441 (1) Includes only the account values for investment spread products with GMIRs and discretionary crediting rates, net of policy loans. Excludes Stabilizer products, which are fee based. (2) Represents multi year guaranteed annuity ("MYGA") contracts with renewal dates after June 30, 2023 on which we are required to credit interest above the contractual GMIR for at least the next twelve months. The following table summarizes detail on the differences between the interest rate being credited to contract holders as of December 31, 2022 and the respective GMIRs: Account Value (1) Excess of crediting rate over GMIR At GMIR Up to .50% Above GMIR 0.51% - 1.00% 1.01% - 1.50% Above GMIR 1.51% - 2.00% Above GMIR More than 2.00% Above GMIR Total Guaranteed minimum interest rate Up to 1.00% $ 5,848 $ 2,967 $ 1,907 $ 1,112 $ 1,462 $ 102 $ 13,398 1.01% - 2.00% 707 52 35 2 2 7 805 2.01% - 3.00% 12,677 56 46 110 — 3 12,892 3.01% - 4.00% 9,448 153 — — — — 9,601 4.01% and Above 1,643 87 — — — — 1,730 Renewable beyond 12 months (MYGA) (2) 402 — — — 3 — 405 Total discretionary rate setting products $ 30,725 $ 3,315 $ 1,988 $ 1,224 $ 1,467 $ 112 $ 38,831 (1) Includes only the account values for investment spread products with GMIRs and discretionary crediting rates, net of policy loans. Excludes Stabilizer products, which are fee based.

Reinsurance (Tables)

Reinsurance (Tables)	6 Months Ended
	Jun. 30, 2023
Insurance [Abstract]
Effects of Reinsurance	Information regarding the effect of reinsurance on the Condensed Consolidated Balance Sheets is as follows as of the periods indicated: June 30, 2023 Direct Assumed Ceded Total, Assets Premiums receivable $ 172 $ 10 $ (220) $ (38) Reinsurance recoverable, net of allowance for credit losses — — 12,169 12,169 Total $ 172 $ 10 $ 11,949 $ 12,131 Liabilities Future policy benefits and contract owner account balances $ 49,574 $ 1,009 $ — $ 50,583 Liability for funds withheld under reinsurance agreements 105 — — 105 Total $ 49,679 $ 1,009 $ — $ 50,688 December 31, 2022 Direct Assumed Ceded Total, Assets Premiums receivable $ 172 $ 11 $ (212) $ (29) Reinsurance recoverable, net of allowance for credit losses — — 12,455 12,455 Total $ 172 $ 11 $ 12,243 $ 12,426 Liabilities Future policy benefits and contract owner account balances $ 51,137 $ 1,037 $ — $ 52,174 Liability for funds withheld under reinsurance agreements 104 — — 104 Total $ 51,241 $ 1,037 $ — $ 52,278 Information regarding the effect of reinsurance on the Condensed Consolidated Statements of Operations is as follows for the periods indicated: Three Months Ended June 30, 2023 2022 Premiums: Direct premiums $ 902 $ 816 Reinsurance assumed 5 5 Reinsurance ceded (230) (224) Net premiums $ 677 $ 597 Fee income: Gross fee income $ 571 $ 513 Reinsurance assumed 5 4 Reinsurance ceded (102) (104) Net fee income $ 474 $ 413 Interest credited and other benefits to contract owners / policyholders: Direct interest credited and other benefits to contract owners / policyholders $ 1,014 $ 1,104 Reinsurance assumed 11 14 Reinsurance ceded (343) (464) Net interest credited and other benefits to contract owners / policyholders $ 682 $ 654 Six Months Ended June 30, 2023 2022 Premiums: Direct premiums $ 1,810 $ 1,624 Reinsurance assumed 15 14 Reinsurance ceded (463) (433) Net premiums $ 1,362 $ 1,205 Fee income: Gross fee income $ 1,133 $ 1,045 Reinsurance assumed 9 9 Reinsurance ceded (204) (208) Net fee income $ 938 $ 846 Interest credited and other benefits to contract owners / policyholders: Direct interest credited and other benefits to contract owners / policyholders $ 2,122 $ 2,080 Reinsurance assumed 30 22 Reinsurance ceded (719) (804) Net interest credited and other benefits to contract owners / policyholders $ 1,433 $ 1,298

Separate Accounts (Tables)

Separate Accounts (Tables)	6 Months Ended
	Jun. 30, 2023
Other Liabilities Disclosure [Abstract]
Separate Account, Liability	The following tables present a rollforward of Separate account liabilities for the Wealth Solutions stabilizer and deferred annuity business, including a reconciliation to the Condensed Consolidated Balance Sheets, for the periods indicated: June 30, 2023 December 31, 2022 Wealth Solutions Stabilizer Wealth Solutions Deferred Annuity Total Wealth Solutions Stabilizer Wealth Solutions Deferred Annuity Total Balance at January 1 $ 7,196 $ 69,152 $ 76,348 $ 8,091 $ 86,927 $ 95,018 Policyholder behavior (1) (119) 322 203 (68) (1,309) (1,377) Fee income (17) (206) (223) (34) (423) (457) Investment performance 151 8,314 8,465 (794) (16,044) (16,838) Other — — — 1 1 2 Balance at end of period $ 7,211 $ 77,582 $ 84,793 $ 7,196 $ 69,152 $ 76,348 Reconciliation to Condensed Consolidated Balance Sheets: Other 4,058 3,826 Total Separate Account liabilities $ 88,851 $ 80,174 (1) Policyholder behavior includes premiums and deposits, surrenders and withdrawals, benefit payments, and net transfers to and from the general account.
Fair Value, Separate Account Investment	The aggregate fair value of assets, by major investment asset category, supporting separate accounts was as follows for the periods indicated: June 30, 2023 December 31, 2022 US Treasury securities and obligations of US government corporations and agencies $ 1,157 $ 1,586 Corporate debt securities 1,791 1,647 Foreign debt securities 706 660 Mortgage-backed securities 3,274 3,434 Equity securities (including mutual funds) 81,063 72,309 Cash, cash equivalents and short-term investments 454 311 Receivable for securities and accruals 406 227 Total $ 88,851 $ 80,174

Share-based Incentive Compens_2

Share-based Incentive Compensation Plans (Tables)	6 Months Ended
	Jun. 30, 2023
Share-Based Payment Arrangement [Abstract]
Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan	The following table summarizes share-based compensation expense, which includes expenses related to awards granted under the Omnibus Plans for the periods indicated: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Restricted Stock Unit (RSU) awards $ 16 $ 8 $ 53 $ 30 Performance Stock Unit (PSU) awards 10 7 36 31 Total share-based compensation expense 26 15 89 61 Income tax benefit 7 3 22 18 After-tax share-based compensation expense $ 19 $ 12 $ 67 $ 43
Schedule of Share-based Compensation, Activity	The following table summarizes RSU and PSU awards activity under the Omnibus Plans for the periods indicated: RSU Awards PSU Awards (awards in millions) Number of Awards Weighted Average Grant Date Fair Value Number of Awards Weighted Average Grant Date Fair Value Outstanding as of January 1, 2023 1.5 $ 60.91 2.1 $ 55.68 Adjustment for PSU performance factor — — (0.1) 61.50 Granted 1.7 70.49 0.8 66.10 Vested (1.0) 63.18 (0.5) 63.08 Forfeited — * 64.54 — * 63.48 Outstanding as of June 30, 2023 2.2 $ 67.06 2.3 $ 61.27 *Less than 0.1
Schedule of Share-based Compensation, Stock Options, Activity	The following table summarizes the number of options under the Omnibus Plans for the periods indicated: Stock Options (awards in millions) Number of Awards Weighted Average Exercise Price Outstanding as of January 1, 2023 1.6 $ 43.05 Granted — — Exercised (0.4) 38.11 Forfeited — — Outstanding as of June 30, 2023 1.2 $ 44.55 Vested, exercisable, as of June 30, 2023 1.2 $ 44.55

Shareholders' Equity (Tables)

Shareholders' Equity (Tables)	6 Months Ended
	Jun. 30, 2023
Equity [Abstract]
Schedule of Common Stock Outstanding Roll Forward	The following table presents the rollforward of common shares used in calculating the weighted average shares utilized in the basic earnings per common share calculation for the periods indicated: Common Shares (shares in millions) Issued Held in Treasury Outstanding Balance, January 1, 2022 109.0 1.2 107.8 Common shares issued 0.1 — 0.1 Common shares acquired - share repurchase — 11.7 (11.7) Share-based compensation 1.7 0.7 1.0 Treasury Stock retirement (13.0) (13.0) — Balance, December 31, 2022 97.8 0.6 97.2 Common shares issued 9.6 — 9.6 Common shares acquired - share repurchase — 2.3 (2.3) Share-based compensation 1.9 0.7 1.2 Balance, June 30, 2023 109.3 3.6 105.7
Schedule of Dividends Declared	Dividends declared per share of Common Stock were as follows for the periods indicated: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Dividends declared per share of Common Stock $ 0.200 $ 0.200 $ 0.400 $ 0.400 The declaration of dividends on preferred stock per share and in the aggregate were as follows for the periods indicated: Series A Series B Three Months Ended June 30, Per Share Aggregate Per Share Aggregate 2023 $ — $ — $ 13.375 $ 4 2022 — — 13.375 4 Six Months Ended June 30, 2023 $ 30.625 $ 10 $ 26.750 $ 8 2022 30.625 10 26.750 8
Schedule of Share Repurchase Agreements
Schedule of Preferred Stock Issued and Outstanding	As of June 30, 2023 and December 31, 2022, there were 100,000,000 shares of preferred stock authorized. Preferred stock issued and outstanding are as follows: June 30, 2023 December 31, 2022 Series Issued Outstanding Issued Outstanding 6.125% Non-cumulative Preferred Stock, Series A 325,000 325,000 325,000 325,000 5.35% Non-cumulative Preferred Stock, Series B 300,000 300,000 300,000 300,000 Total 625,000 625,000 625,000 625,000

Earnings per Common Share (Tabl

Earnings per Common Share (Tables)	6 Months Ended
	Jun. 30, 2023
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	The following table presents a reconciliation of Net income (loss) and shares used in calculating basic and diluted net income (loss) per common share for the periods indicated: Three Months Ended June 30, Six Months Ended June 30, (in millions, except for per share data) 2023 2022 2023 2022 Earnings Net income (loss) available to common shareholders: Net income (loss) $ 235 $ 143 $ 364 $ 254 Less: Preferred stock dividends 4 4 18 18 Less: Net income (loss) attributable to noncontrolling interest and redeemable noncontrolling interest 77 75 123 118 Net income (loss) available to common shareholders $ 154 $ 64 $ 223 $ 118 Weighted average common shares outstanding Basic 103.0 101.7 100.4 103.9 Dilutive Effects (2) : Warrants (3) 4.0 7.1 6.5 7.7 RSU awards 1.1 0.8 1.1 0.9 PSU awards 1.2 0.6 1.2 0.8 Stock Options 0.5 0.6 0.5 0.6 Diluted 109.8 110.8 109.7 113.9 Net income (loss) available to Voya Financial, Inc.'s common shareholders per common share (1) : Basic $ 1.50 $ 0.62 $ 2.22 $ 1.13 Diluted $ 1.41 $ 0.57 $ 2.03 $ 1.03 (1) Basic and diluted earnings per share are calculated using unrounded, actual amounts. Therefore, the components of earnings per share may not sum to its corresponding total. (2) For the six months ended June 30, 2022, weighted average shares used for calculating earnings per share excludes the impact of forward contracts related to the share repurchase agreement entered into on June 21, 2022, as the inclusion of these instruments would be antidilutive to the earnings per share calculation. For more information on the share repurchase agreement, see the Shareholders' Equity Note to these Condensed Consolidated Financial Statements. (3) See the Shareholders' Equity

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Income (Loss) (Tables)	6 Months Ended
	Jun. 30, 2023
Equity [Abstract]
Schedule of Accumulated Other Comprehensive Income	Shareholders' equity included the following components of AOCI as of the dates indicated: June 30, 2023 2022 Fixed maturities, net of impairment $ (2,963) $ (1,926) Derivatives (1) 98 129 Change in current discount rate (827) (951) Deferred income tax asset (liability) 898 700 Total (2,794) (2,048) Pension and other postretirement benefits liability, net of tax 3 3 AOCI $ (2,791) $ (2,045)
Schedule of Amounts Recognized in Other Comprehensive Income (Loss)	Changes in AOCI, including the reclassification adjustments recognized in the Condensed Consolidated Statements of Operations, were as follows for the periods indicated: Three Months Ended June 30, 2023 Before-Tax Amount Income Tax (Benefit) After-Tax Amount Available-for-sale securities: Fixed maturities $ (343) $ 72 $ (271) Adjustments for amounts recognized in Net realized capital gains (losses) in the Condensed Consolidated Statements of Operations 15 (3) 12 Change in unrealized gains/losses on available-for-sale securities (328) 69 (259) Derivatives: Derivatives (6) (1) 1 (5) Adjustments related to effective cash flow hedges for amounts recognized in Net investment income in the Condensed Consolidated Statements of Operations (5) 1 (4) Change in unrealized gains/losses on derivatives (11) 2 (9) Change in current discount rate 28 (6) 22 Change in Accumulated other comprehensive income (loss) $ (311) $ 65 $ (246) 1) See the Derivative Financial Instruments Note to these Condensed Consolidated Financial Statements for additional information. Six Months Ended June 30, 2023 Before-Tax Amount Income Tax (Benefit) After-Tax Amount Available-for-sale securities: Fixed maturities $ 318 $ (67) $ 251 Adjustments for amounts recognized in Net gains (losses) in the Condensed Consolidated Statements of Operations 14 (3) 11 Change in unrealized gains (losses) on available-for-sale securities 332 (70) 262 Derivatives: Derivatives (18) (1) 4 (14) Adjustments related to effective cash flow hedges for amounts recognized in Net investment income in the Condensed Consolidated Statements of Operations (10) 2 (8) Change in unrealized gains (losses) on derivatives (28) 6 (22) Change in current discount rate 30 (6) 24 Change in Accumulated other comprehensive income (loss) $ 334 $ (70) $ 264 (1) See the Derivative Financial Instruments Note to these Condensed Consolidated Financial Statements for additional information. Three Months Ended June 30, 2022 Before-Tax Amount Income Tax (Benefit) After-Tax Amount Available-for-sale securities: Fixed maturities $ (2,548) $ 535 $ (2,013) Adjustments for amounts recognized in Net gains (losses) in the Condensed Consolidated Statements of Operations 20 (4) 16 Change in unrealized gains (losses) on available-for-sale securities (2,528) 531 (1,997) Derivatives: Derivatives 54 (1) (11) 43 Adjustments related to effective cash flow hedges for amounts recognized in Net investment income in the Condensed Consolidated Statements of Operations (5) 1 (4) Change in unrealized gains (losses) on derivatives 49 (10) 39 Change in current discount rate 92 (19) 73 Change in Accumulated other comprehensive income (loss) $ (2,387) $ 502 $ (1,885) (1) See the Derivative Financial Instruments Note to these Condensed Consolidated Financial Statements for additional information. Six Months Ended June 30, 2022 Before-Tax Amount Income Tax (Benefit) After-Tax Amount Available-for-sale securities: Fixed maturities $ (5,211) $ 1,094 $ (4,117) Adjustments for amounts recognized in Net gains (losses) in the Condensed Consolidated Statements of Operations 90 (19) 71 Change in unrealized gains (losses) on available-for-sale securities (5,121) 1,075 (4,046) Derivatives: Derivatives 59 (1) (12) 47 Adjustments related to effective cash flow hedges for amounts recognized in Net investment income in the Condensed Consolidated Statements of Operations (10) 2 (8) Change in unrealized gains (losses) on derivatives 49 (10) 39 Change in current discount rate 196 (41) 155 Change in Accumulated other comprehensive income (loss) $ (4,876) $ 1,024 $ (3,852) (1) See the Derivative Financial Instruments Note to these Condensed Consolidated Financial Statements for additional information.

Revenue from Contracts with Cus

Revenue from Contracts with Customers (Tables)	6 Months Ended
	Jun. 30, 2023
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	Financial services and software subscriptions and services revenue is disaggregated by type of service in the following table: Three months ended June 30, Six months ended June 30, 2023 2022 2023 2022 Wealth Solutions Advisory and R&A $ 124 $ 127 $ 244 $ 260 Distribution and shareholder servicing 30 31 59 64 Investment Management Advisory, asset management and R&A 232 159 462 329 Distribution and shareholder servicing 32 38 64 80 Health Solutions R&A 4 5 11 9 Software subscriptions and services 54 — 114 — Corporate R&A 5 17 17 38 Total financial services and software subscriptions and services revenue 481 377 971 780 Revenue from other sources (1) 79 80 131 150 Total Fee income and Other revenue $ 560 $ 457 $ 1,102 $ 930 (1) Primarily consists of revenue from insurance contracts and financial instruments.

Financing Agreements (Tables)

Financing Agreements (Tables)	6 Months Ended
	Jun. 30, 2023
Debt Disclosure [Abstract]
Schedule of Long-term Debt Instruments	The following table summarizes the carrying value of the Company’s debt securities issued and outstanding as of the periods indicated: Issuer Maturity June 30, 2023 December 31, 2022 3.976% Senior Notes, due 2025 (2)(3) Voya Financial, Inc. 02/15/2025 $ 389 $ — 3.65% Senior Notes, due 2026 (2)(3) Voya Financial, Inc. 06/15/2026 445 445 5.7% Senior Notes, due 2043 (2)(3) Voya Financial, Inc. 07/15/2043 396 396 4.8% Senior Notes, due 2046 (2)(3) Voya Financial, Inc. 06/15/2046 297 297 4.7% Fixed-to-Floating Rate Junior Subordinated Notes, due 2048 (1) Voya Financial, Inc. 01/23/2048 336 336 5.65% Fixed-to-Floating Rate Junior Subordinated Notes, due 2053 (4) Voya Financial, Inc. 05/15/2053 — 388 7.25% Voya Holdings Inc. debentures, due 2023 (1) Voya Holdings, Inc. 08/15/2023 140 140 7.63% Voya Holdings Inc. debentures, due 2026 (1) Voya Holdings, Inc. 08/15/2026 139 139 6.97% Voya Holdings Inc. debentures, due 2036 (1) Voya Holdings, Inc. 08/15/2036 79 79 8.42% Equitable of Iowa Companies Capital Trust II Notes, due 2027 Equitable of Iowa Capital Trust II 04/01/2027 13 13 1.00% Windsor Property Loan Voya Retirement Insurance and Annuity Company 06/14/2027 2 2 1.25% Notes, due 2023 Benefitfocus, Inc. 12/15/2023 2 — Subtotal 2,238 2,235 Less: Current portion of long-term debt 143 141 Total $ 2,095 $ 2,094 (1) Guaranteed by ING Group. (2) Interest is paid semi-annually in arrears. (3) Guaranteed by Voya Holdings. (4) See the Junior Subordinated Notes section below.
Schedule of Line of Credit Facilities	The following table summarizes the Company's credit facilities as of June 30, 2023: ($ in millions) Obligor / Applicant Business Supported Secured / Unsecured Committed / Uncommitted Expiration Capacity Utilization Unused Commitment Voya Financial, Inc. Other Unsecured Committed 05/01/2028 $ 500 $ — $ 500 Voya Financial, Inc. Other Unsecured Committed 04/07/2025 200 163 (1) 37 Total $ 700 $ 163 $ 537 (1) Amount utilized as collateral for outstanding Aetna Notes.

Commitments and Contingencies (

Commitments and Contingencies (Tables)	6 Months Ended
	Jun. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Schedule of Restricted Assets	Restricted Assets The Company is required to maintain assets on deposit with various regulatory authorities to support its insurance operations. The Company may also post collateral in connection with certain securities lending, repurchase agreements, funding agreements, credit facilities and derivative transactions. The components of the fair value of the restricted assets were as follows as of the dates indicated: June 30, 2023 December 31, 2022 Fixed maturity collateral pledged to FHLB (1) $ 1,851 $ 1,791 FHLB restricted stock (2) 68 67 Other fixed maturities-state deposits 39 38 Cash and cash equivalents 33 27 Securities pledged (3) 1,148 1,162 Total restricted assets $ 3,139 $ 3,085 (1) Included in Fixed maturities, available for sale, at fair value on the Condensed Consolidated Balance Sheets. (2) Included in Other investments on the Condensed Consolidated Balance Sheets. (3) Includes the fair value of loaned securities of $857 and $907 as of June 30, 2023 and December 31, 2022, respectively. In addition, as of June 30, 2023 and December 31, 2022, the Company delivered securities as collateral of $175 and $142 and repurchase agreements of $116 and $113, respectively. Loaned securities and securities delivered as collateral are included in Securities pledged on the Condensed Consolidated Balance Sheets.

Consolidated and Nonconsolida_2

Consolidated and Nonconsolidated Investment Entities (Tables)	6 Months Ended
	Jun. 30, 2023
Consolidated Investment Entities [Abstract]
Fair Value, by Balance Sheet Grouping	The carrying values and estimated fair values of the Company's financial instruments as of the dates indicated: June 30, 2023 December 31, 2022 Carrying Fair Carrying Fair Assets: Fixed maturities, including securities pledged $ 29,193 $ 29,193 $ 30,357 $ 30,357 Equity securities 309 309 336 336 Mortgage loans on real estate 5,366 4,998 5,445 5,149 Policy loans 358 358 363 363 Cash, cash equivalents, short-term investments and short-term investments under securities loan agreements 2,333 2,333 2,454 2,454 Derivatives 444 444 422 422 Embedded derivatives on reinsurance 78 78 95 95 Other investments 69 69 68 68 Assets held in separate accounts 88,851 88,851 80,174 80,174 Liabilities: Investment contract liabilities: Funding agreements without fixed maturities and deferred annuities (1) $ 34,335 $ 35,615 $ 35,707 $ 36,385 Funding agreements with fixed maturities 1,290 1,298 1,285 1,281 Supplementary contracts, immediate annuities and other 673 614 727 636 Stabilizer and MCGs 3 3 6 6 Derivatives 400 400 389 389 Embedded derivative on reinsurance 47 47 46 46 Short-term debt 143 143 141 142 Long-term debt 2,095 1,941 2,094 1,935 (1) Certain amounts included in Funding agreements without fixed maturities and deferred annuities are also reflected within the Stabilizer and MCGs section of the table above. The following table summarizes the fair value hierarchy levels of consolidated investment entities as of June 30, 2023: Level 1 Level 2 Level 3 NAV Total Assets VIEs Cash and cash equivalents $ 154 $ — $ — $ — $ 154 Corporate loans — 1,407 — — 1,407 Limited partnerships/corporations — — — 3,120 3,120 VOE Corporate loans — 25 — — 25 Total assets $ 154 $ 1,432 $ — $ 3,120 $ 4,706 Liabilities VIEs CLO notes $ — $ 1,331 $ — $ — $ 1,331 Total liabilities $ — $ 1,331 $ — $ — $ 1,331 The following table summarizes the fair value hierarchy levels of consolidated investment entities as of December 31, 2022: Level 1 Level 2 Level 3 NAV Total Assets VIEs Cash and cash equivalents $ 88 $ — $ — $ — $ 88 Corporate loans — 1,293 — — 1,293 Limited partnerships/corporations — — — 2,802 2,802 Total assets $ 88 $ 1,293 $ — $ 2,802 $ 4,183 Liabilities VIEs CLO notes $ — $ 1,234 $ — $ — $ 1,234 Total liabilities $ — $ 1,234 $ — $ — $ 1,234

Intangible Assets, Goodwill and

Intangible Assets, Goodwill and Other (Tables)	6 Months Ended
	Jun. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The changes in the carrying amount of goodwill reported in the Company's operating segments were as follows: Wealth Solutions Health Solutions Investment Management Consolidated Balance as of January 1, 2022 $ 17 $ 24 $ 31 $ 72 Additions from business combinations — — 255 255 Balance as of December 31, 2022 $ 17 $ 24 $ 286 $ 327 Additions from business combinations — 319 — 319 Balance as of June 30, 2023 $ 17 $ 343 $ 286 $ 646
Schedule of Indefinite-Lived Intangible Assets	The following table presents other intangible assets as of the dates indicated: Weighted June 30, 2023 December 31, 2022 Gross Accumulated Net Gross Accumulated Net Indefinite-life intangibles: Right to manage client assets N/A $ 345 $ — $ 345 $ 345 $ — $ 345 Management contract rights N/A 5 — 5 5 — 5 Total indefinite-life intangibles $ 350 $ — $ 350 $ 350 $ — $ 350 Finite-life intangibles: Management contract rights 17 years $ 190 $ 10 $ 180 $ 741 $ 554 $ 187 Customer relationship lists 8 years 325 119 206 135 111 24 Trademarks 8 years 15 1 14 — — — Computer software 4 years 483 325 158 502 432 70 Total intangible assets $ 1,363 $ 455 $ 908 $ 1,728 $ 1,097 $ 631
Schedule of Finite-Lived Intangible Assets	The following table presents other intangible assets as of the dates indicated: Weighted June 30, 2023 December 31, 2022 Gross Accumulated Net Gross Accumulated Net Indefinite-life intangibles: Right to manage client assets N/A $ 345 $ — $ 345 $ 345 $ — $ 345 Management contract rights N/A 5 — 5 5 — 5 Total indefinite-life intangibles $ 350 $ — $ 350 $ 350 $ — $ 350 Finite-life intangibles: Management contract rights 17 years $ 190 $ 10 $ 180 $ 741 $ 554 $ 187 Customer relationship lists 8 years 325 119 206 135 111 24 Trademarks 8 years 15 1 14 — — — Computer software 4 years 483 325 158 502 432 70 Total intangible assets $ 1,363 $ 455 $ 908 $ 1,728 $ 1,097 $ 631

Segments (Tables)

Segments (Tables)	6 Months Ended
	Jun. 30, 2023
Segment Reporting [Abstract]
Reconciliation of Operating Earnings Before Income Taxes from Segments to Consolidated	The summary below reconciles Adjusted operating earnings before income taxes for the segments to Income (loss) before income taxes for the periods indicated: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Adjusted operating earnings before income taxes by segment: Wealth Solutions $ 174 $ 197 $ 306 $ 425 Health Solutions 124 50 218 72 Investment Management 63 40 105 79 Corporate (54) (60) (123) (128) Total including Allianz noncontrolling interest 307 228 507 448 Less: Earning (loss) attributable to Allianz noncontrolling interest 13 — 21 — Total $ 294 $ 228 $ 486 $ 448 Adjustments: Net investment gains (losses) (38) (59) (47) (171) Income (loss) related to businesses exited or to be exited through reinsurance or divestment (21) (55) (54) (91) Income (loss) attributable to noncontrolling interests 77 75 123 118 Dividend payments made to preferred shareholders 4 4 18 18 Other adjustments (52) (40) (122) (48) Total adjustments to income (loss) before income taxes (31) (75) (82) (174) Income (loss) before income taxes $ 263 $ 152 $ 404 $ 274
Reconciliation of Revenue from Segments to Total Revenues	The summary below reconciles Adjusted operating revenues for the segments to Total revenues for the periods indicated: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Adjusted operating revenues by segment: Wealth Solutions $ 705 $ 709 $ 1,389 $ 1,465 Health Solutions 775 641 1,549 1,288 Investment Management 226 171 455 349 Corporate 15 17 26 39 Total $ 1,721 $ 1,537 $ 3,419 $ 3,140 Adjustments: Net investment gains (losses) $ (46) $ (60) $ (60) $ (180) Revenues related to businesses exited or to be exited through reinsurance or divestment 2 (55) 32 (109) Revenues attributable to noncontrolling interests 128 93 188 142 Other adjustments 67 8 127 36 Total adjustments to revenues 151 (14) 288 (111) Total revenues $ 1,871 $ 1,524 $ 3,706 $ 3,030
Schedule of Intersegment Revenues Included in Investment Management Segment	The Investment Management segment revenues include the following intersegment revenues, primarily consisting of asset-based management and administration fees for the periods indicated: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Investment Management intersegment revenues $ 22 $ 23 $ 44 $ 45
Summary of Financial Information for Segments	The summary below presents Total assets for the Company’s segments as of the dates indicated: June 30, 2023 December 31, 2022 Wealth Solutions $ 118,943 $ 111,701 Health Solutions 3,378 2,668 Investment Management 1,648 1,611 Corporate 26,241 26,712 Total assets, before consolidation (1) 150,210 142,692 Consolidation of investment entities 4,406 3,914 Total assets $ 154,616 $ 146,606 (1) Total assets, before consolidation include the Company's direct investments in CIEs prior to consolidation, which are accounted for using the equity method or fair value option.

Business, Basis of Presentati_4

Business, Basis of Presentation and Significant Accounting Policies - Narrative (Details) $ in Millions	6 Months Ended
	Jun. 30, 2023 USD ($) segment	Jun. 30, 2022 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)
Number of operating segments | segment	3
Cash purchase consideration	$ 558
Goodwill	646		$ 327	$ 72
Intangible assets acquired	1,363		1,728
Amortization of intangible assets	42	$ 22
Benefitfocus
Intangible assets acquired	70
Amortization of intangible assets	29
Customer Relationships
Intangible assets acquired	325		$ 135
Customer relationships acquired	$ 190
Useful life of intangible assets acquired	8 years
Intangible Assets, Amortization Period
Useful life of intangible assets acquired	15 years
Intangible Assets, Amortization Period | Benefitfocus
Useful life of intangible assets acquired	5 years
Benefitfocus
Cash purchase consideration	$ 583
VFI SLK
Cash purchase consideration	50
Benefitfocus
Total purchase consideration	595
Other cash payments for acquisition	25
Cash acquired from acquisition	49
Goodwill	319
Intangible assets acquired	275
Deferred tax assets acquired	45
Lease liabilities assumed	$ 91
VIM Holdings
Noncontrolling interest, ownership percentage by parent	76%
Noncontrolling interest, ownership percentage by noncontrolling owners	24%

Business, Basis of Presentati_5

Business, Basis of Presentation and Significant Accounting Policies - Adoption of New Pronouncements (Details) - USD ($) $ in Millions	Dec. 31, 2020	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Jan. 01, 2021
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
DAC		$ 2,304		$ 2,363
VOBA		422		439			$ 473
Total Shareholders' equity		5,357		4,831	$ 5,298
Accumulated Other Comprehensive Income (Loss)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total Shareholders' equity		(2,791)			(2,045)
Retained Earnings
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total Shareholders' equity		40	$ (118)	(201)	$ (1,034)	$ (1,102)	(1,170)
Wealth Solutions
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
DAC		692		691			691
business exited
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
DAC		990		1,043			1,158
Liability for Future Policy Benefits		8,495		8,639			11,444
Employee Benefits, Group
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Liability for Future Policy Benefits		897		881			1,048
Employee Benefits, Voluntary
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Liability for Future Policy Benefits		$ 289		285			359
Previously Reported
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
VOBA	$ 70
Total Shareholders' equity	11,178		5,521	4,831		7,184	9,668
Previously Reported | Accumulated Other Comprehensive Income (Loss)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total Shareholders' equity			$ (2,545)	$ (3,055)		$ (160)	$ 1,807
Previously Reported | Wealth Solutions
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
DAC	119
Previously Reported | business exited
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
DAC	1,186
Liability for Future Policy Benefits	5,448
Previously Reported | Employee Benefits, Group
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Liability for Future Policy Benefits	822
Previously Reported | Employee Benefits, Voluntary
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Liability for Future Policy Benefits	188
Revision of Prior Period, Adjustment
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
VOBA								$ 705
Total Shareholders' equity								11,336
Revision of Prior Period, Adjustment | Accumulated Other Comprehensive Income (Loss)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
VOBA, Adjustment for removal of related balances in AOCI	635
Effect of remeasurement of liability at current discount rate	(1,065)
Total Shareholders' equity	1,328
Revision of Prior Period, Adjustment | Retained Earnings
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Establishment of MRBs	(132)
Other Adjustments	27
Revision of Prior Period, Adjustment | Wealth Solutions
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
DAC								690
Revision of Prior Period, Adjustment | Wealth Solutions | Accumulated Other Comprehensive Income (Loss)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
DAC	571
Revision of Prior Period, Adjustment | business exited
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
DAC								1,290
Liability for Future Policy Benefits								6,427
Effect of remeasurement of liability at current discount rate	1,362
Revision of Prior Period, Adjustment | business exited | Accumulated Other Comprehensive Income (Loss)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
DAC	104
Liability for Future Policy Benefits	(386)
Revision of Prior Period, Adjustment | Employee Benefits, Group
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Liability for Future Policy Benefits								947
Effect of remeasurement of liability at current discount rate	118
Revision of Prior Period, Adjustment | Employee Benefits, Group | Accumulated Other Comprehensive Income (Loss)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Liability for Future Policy Benefits	0
Revision of Prior Period, Adjustment | Employee Benefits, Voluntary
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Liability for Future Policy Benefits								274
Effect of remeasurement of liability at current discount rate	83
Revision of Prior Period, Adjustment | Employee Benefits, Voluntary | Accumulated Other Comprehensive Income (Loss)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Liability for Future Policy Benefits	0
Effect of Modified Retrospective Application Accounting Standards Update 2018-12
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total Shareholders' equity								$ 158
Effect of Modified Retrospective Application Accounting Standards Update 2018-12 | Accumulated Other Comprehensive Income (Loss)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total Shareholders' equity	263
Effect of Modified Retrospective Application Accounting Standards Update 2018-12 | Retained Earnings
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total Shareholders' equity	(105)
Effect of Modified Retrospective Application Accounting Standards Update 2018-12 | business exited
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Liability for Future Policy Benefits	3
Effect of Modified Retrospective Application Accounting Standards Update 2018-12 | Employee Benefits, Group
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Liability for Future Policy Benefits	7
Effect of Modified Retrospective Application Accounting Standards Update 2018-12 | Employee Benefits, Voluntary
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Liability for Future Policy Benefits	$ 3

Investments (excluding Consol_3

Investments (excluding Consolidated Investment Entities) - Fixed Maturities (Details) - USD ($) $ in Millions	Jun. 30, 2023	Dec. 31, 2022
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, amortized cost	$ 28,812	$ 30,202
Securities pledged, amortized costs	1,266	1,303
Fixed maturities, allowance for credit losses	16	12
U.S. Treasuries
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, amortized cost	434	590
Gross Unrealized Capital Gains	9	12
Gross Unrealized Capital Losses	18	21
Embedded Derivatives	0	0
Fixed maturities, available-for-sale, at fair value	425	581
Fixed maturities, allowance for credit losses	0	0
U.S. Government agencies and authorities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, amortized cost	54	58
Gross Unrealized Capital Gains	3	3
Gross Unrealized Capital Losses	1	2
Embedded Derivatives	0	0
Fixed maturities, available-for-sale, at fair value	56	59
Fixed maturities, allowance for credit losses	0	0
State, municipalities and political subdivisions
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, amortized cost	931	978
Gross Unrealized Capital Gains	1	1
Gross Unrealized Capital Losses	110	134
Embedded Derivatives	0	0
Fixed maturities, available-for-sale, at fair value	822	845
Fixed maturities, allowance for credit losses	0	0
U.S. corporate public securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, amortized cost	8,845	9,343
Gross Unrealized Capital Gains	116	97
Gross Unrealized Capital Losses	1,082	1,239
Embedded Derivatives	0	0
Fixed maturities, available-for-sale, at fair value	7,878	8,201
Fixed maturities, allowance for credit losses	1	0
U.S. corporate private securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, amortized cost	5,113	5,087
Gross Unrealized Capital Gains	27	14
Gross Unrealized Capital Losses	405	409
Embedded Derivatives	0	0
Fixed maturities, available-for-sale, at fair value	4,735	4,692
Fixed maturities, allowance for credit losses	0	0
Foreign corporate public securities and foreign governments
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, amortized cost	3,081	3,343
Gross Unrealized Capital Gains	28	18
Gross Unrealized Capital Losses	336	403
Embedded Derivatives	0	0
Fixed maturities, available-for-sale, at fair value	2,767	2,949
Fixed maturities, allowance for credit losses	6	9
Foreign corporate private securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, amortized cost	3,092	3,254
Gross Unrealized Capital Gains	18	7
Gross Unrealized Capital Losses	193	225
Embedded Derivatives	0	0
Fixed maturities, available-for-sale, at fair value	2,915	3,034
Fixed maturities, allowance for credit losses	2	2
Residential mortgage-backed
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, amortized cost	3,870	4,230
Gross Unrealized Capital Gains	33	34
Gross Unrealized Capital Losses	277	290
Embedded Derivatives	2	3
Fixed maturities, available-for-sale, at fair value	3,628	3,977
Fixed maturities, allowance for credit losses	0	0
Commercial mortgage-backed securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, amortized cost	4,326	4,466
Gross Unrealized Capital Gains	1	2
Gross Unrealized Capital Losses	644	585
Embedded Derivatives	0	0
Fixed maturities, available-for-sale, at fair value	3,676	3,883
Fixed maturities, allowance for credit losses	7	0
Other asset-backed securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, amortized cost	2,422	2,307
Gross Unrealized Capital Gains	6	3
Gross Unrealized Capital Losses	137	173
Embedded Derivatives	0	0
Fixed maturities, available-for-sale, at fair value	2,291	2,136
Fixed maturities, allowance for credit losses	0	1
Fixed maturities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, amortized cost	32,168	33,656
Total fixed maturities, less securities pledged, Amortized Cost	30,902	32,353
Gross Unrealized Capital Gains	242	191
Total fixed maturities, less securities pledged, Gross Unrealized Capital Gains	242	188
Gross Unrealized Capital Losses	3,203	3,481
Total fixed maturities, less securities pledged, Gross Unrealized Capital Losses	3,085	3,337
Embedded Derivatives	2	3
Fixed maturities, available-for-sale, at fair value	29,193	30,357
Total fixed maturities, less securities pledged, Fair Value	28,045	29,195
Fixed maturities, allowance for credit losses	16	12
Collateral Pledged
Available-for-sale Securities, Including Securities Pledged [Line Items]
Securities pledged	1,148	1,162
Collateral Pledged | Fixed maturities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Securities pledged, amortized costs	1,266	1,303
Securities pledged, Gross Unrealized Capital Gains	0	3
Securities pledged, Gross Unrealized Capital Losses	118	144
Embedded Derivatives	0	0
Securities pledged	1,148	1,162
Fixed maturities, allowance for credit losses	$ 0	$ 0

Investments (excluding Consol_4

Investments (excluding Consolidated Investment Entities) - Debt Maturities (Details) - USD ($) $ in Millions	Jun. 30, 2023	Dec. 31, 2022
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, amortized cost	$ 28,812	$ 30,202
Fixed maturities
Available-for-sale Securities, Including Securities Pledged [Line Items]
One year or less, Amortized Cost	650
One year or less, Fair Value	643
After one year through five years, Amortized Cost	4,054
After one year through five years, Fair Value	3,844
After five years through ten years, Amortized Cost	4,126
After five years through ten years, Fair Value	3,887
After ten years, Amortized Cost	12,720
After ten years, Fair Value	11,224
Fixed maturities, amortized cost	32,168	33,656
Fixed maturities, available-for-sale, at fair value	29,193	30,357
Mortgage-backed securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Without single maturity date, Amortized Cost	8,196
Without single maturity date, Fair Value	7,304
Other asset-backed securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Without single maturity date, Amortized Cost	2,422
Without single maturity date, Fair Value	2,291
Fixed maturities, amortized cost	2,422	2,307
Fixed maturities, available-for-sale, at fair value	$ 2,291	$ 2,136

Investments (excluding Consol_5

Investments (excluding Consolidated Investment Entities) - Fixed Maturities and Equity Securities, Repurchase Agreements and Securities Lending (Narrative) (Details) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Available-for-sale Securities, Including Securities Pledged [Line Items]
Single issuer in excess of total equity	no
Initial collateral required, percent of market value of loaned securities	102%
Securities received as collateral	$ 180	$ 135
Payables under securities loan and repurchase agreements, including collateral held	1,301	1,302
Securities pledged as collateral
Available-for-sale Securities, Including Securities Pledged [Line Items]
Securities pledged under repurchase agreements, carrying value	116	113
Fair value of loaned securities	857	907
Short-term Investments
Available-for-sale Securities, Including Securities Pledged [Line Items]
Securities received as collateral	704	807
Cash collateral, included in Payables
Available-for-sale Securities, Including Securities Pledged [Line Items]
Payables under securities loan and repurchase agreements, including collateral held	704	$ 807
Collateral Pledged
Available-for-sale Securities, Including Securities Pledged [Line Items]
Securities sold under agreements to repurchase, asset	$ 0
Mortgage-backed securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Percent collateralized mortgage backed securities including interest-only strip or principal-only strip	47.50%	41.60%
U.S. Treasuries
Available-for-sale Securities, Including Securities Pledged [Line Items]
Payables under securities loan and repurchase agreements, including collateral held	$ 41	$ 53
U.S. corporate public securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Payables under securities loan and repurchase agreements, including collateral held	576	604
Foreign corporate public securities and foreign governments
Available-for-sale Securities, Including Securities Pledged [Line Items]
Payables under securities loan and repurchase agreements, including collateral held	266	285
Total
Available-for-sale Securities, Including Securities Pledged [Line Items]
Payables under securities loan and repurchase agreements, including collateral held	884	942
Short-term Investments
Available-for-sale Securities, Including Securities Pledged [Line Items]
Payables under securities loan and repurchase agreements, including collateral held	$ 1	$ 0

Investments (excluding Consol_6

Investments (excluding Consolidated Investment Entities) - Composition of US and Foreign Corporate Securities (Details) - USD ($) $ in Millions	Jun. 30, 2023	Dec. 31, 2022
Schedule of Available for Sale, including Securities Pledged [Line Items]
Amortized Cost	$ 28,812	$ 30,202
Communications
Schedule of Available for Sale, including Securities Pledged [Line Items]
Amortized Cost	1,202	1,156
Gross Unrealized Capital Gains	26	16
Gross Unrealized Capital Losses	114	130
Fixed maturities, available-for-sale, at fair value	1,114	1,042
Financial
Schedule of Available for Sale, including Securities Pledged [Line Items]
Amortized Cost	3,982	4,153
Gross Unrealized Capital Gains	42	31
Gross Unrealized Capital Losses	452	491
Fixed maturities, available-for-sale, at fair value	3,572	3,693
Industrial and other companies
Schedule of Available for Sale, including Securities Pledged [Line Items]
Amortized Cost	7,824	8,379
Gross Unrealized Capital Gains	44	26
Gross Unrealized Capital Losses	824	953
Fixed maturities, available-for-sale, at fair value	7,044	7,452
Energy
Schedule of Available for Sale, including Securities Pledged [Line Items]
Amortized Cost	1,987	1,979
Gross Unrealized Capital Gains	43	39
Gross Unrealized Capital Losses	139	160
Fixed maturities, available-for-sale, at fair value	1,891	1,858
Utilities
Schedule of Available for Sale, including Securities Pledged [Line Items]
Amortized Cost	3,547	3,664
Gross Unrealized Capital Gains	24	21
Gross Unrealized Capital Losses	332	355
Fixed maturities, available-for-sale, at fair value	3,239	3,330
Transportation
Schedule of Available for Sale, including Securities Pledged [Line Items]
Amortized Cost	1,101	1,165
Gross Unrealized Capital Gains	7	2
Gross Unrealized Capital Losses	105	128
Fixed maturities, available-for-sale, at fair value	1,003	1,039
Total
Schedule of Available for Sale, including Securities Pledged [Line Items]
Amortized Cost	19,643	20,496
Gross Unrealized Capital Gains	186	135
Gross Unrealized Capital Losses	1,966	2,217
Fixed maturities, available-for-sale, at fair value	$ 17,863	$ 18,414

Investments (excluding Consol_7

Investments (excluding Consolidated Investment Entities) - Borrowings under securities lending transactions (Details) - USD ($) $ in Millions	Jun. 30, 2023	Dec. 31, 2022
Summary of Investment Holdings [Line Items]
Payables under securities loan and repurchase agreements, including collateral held	$ 1,301	$ 1,302
U.S. Treasuries
Summary of Investment Holdings [Line Items]
Payables under securities loan and repurchase agreements, including collateral held	41	53
U.S. corporate public securities
Summary of Investment Holdings [Line Items]
Payables under securities loan and repurchase agreements, including collateral held	576	604
Short-term Investments
Summary of Investment Holdings [Line Items]
Payables under securities loan and repurchase agreements, including collateral held	1	0
Foreign corporate public securities and foreign governments
Summary of Investment Holdings [Line Items]
Payables under securities loan and repurchase agreements, including collateral held	266	285
Total
Summary of Investment Holdings [Line Items]
Payables under securities loan and repurchase agreements, including collateral held	$ 884	$ 942

Investments (excluding Consol_8

Investments (excluding Consolidated Investment Entities) - Allowance for Credit Losses on Available-for-sale Fixed Maturity Securities (Details) - USD ($) $ in Millions	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	$ 12	$ 58
Credit losses on securities for which credit losses were not previously recorded	8
Credit losses on securities for which credit losses were not previously recorded		9
Reductions for securities sold during the period	(2)	(57)
Increase (decrease) on securities with allowance recorded in previous period	(2)	2
Ending Balance	16	12
U.S. corporate public securities
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	0
Credit losses on securities for which credit losses were not previously recorded	1
Reductions for securities sold during the period	0
Increase (decrease) on securities with allowance recorded in previous period	0
Ending Balance	1	0
Residential mortgage-backed
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	0	1
Credit losses on securities for which credit losses were not previously recorded		0
Reductions for securities sold during the period		0
Increase (decrease) on securities with allowance recorded in previous period		(1)
Ending Balance		0
Commercial mortgage-backed securities
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	0
Credit losses on securities for which credit losses were not previously recorded	7
Reductions for securities sold during the period	0
Increase (decrease) on securities with allowance recorded in previous period	0
Ending Balance	7	0
Foreign corporate public securities and foreign governments
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	9	0
Credit losses on securities for which credit losses were not previously recorded	0
Credit losses on securities for which credit losses were not previously recorded		9
Reductions for securities sold during the period	2	0
Increase (decrease) on securities with allowance recorded in previous period	(1)	0
Ending Balance	6	9
Foreign corporate private securities
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	2	56
Credit losses on securities for which credit losses were not previously recorded	0
Credit losses on securities for which credit losses were not previously recorded		0
Reductions for securities sold during the period	0	(57)
Increase (decrease) on securities with allowance recorded in previous period	0	3
Ending Balance	2	2
Other asset-backed securities
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	1	1
Credit losses on securities for which credit losses were not previously recorded	0
Credit losses on securities for which credit losses were not previously recorded		0
Reductions for securities sold during the period	0	0
Increase (decrease) on securities with allowance recorded in previous period	(1)	0
Ending Balance	$ 0	$ 1

Investments (excluding Consol_9

Investments (excluding Consolidated Investment Entities) - Unrealized Capital Losses (Details) $ in Millions	Jun. 30, 2023 USD ($) security	Dec. 31, 2022 USD ($) security
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	$ 6,274	$ 20,391
Twelve months or less below amortized cost, Unrealized Capital Loss	$ 295	$ 2,349
Twelve months or less below amortized cost, total number of securities in an unrealized loss position | security	1,067	3,633
More than twelve months below amortized cost, Fair Value	$ 16,538	$ 4,363
More than twelve months below amortized cost, Unrealized Capital Loss	$ 2,908	$ 1,132
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	3,547	1,187
Total, Fair Value	$ 22,812	$ 24,754
Total Unrealized Capital Losses	$ 3,203	$ 3,481
Total, Number of securities | security	4,614	4,820
U.S. Treasuries
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	$ 202	$ 197
Twelve months or less below amortized cost, Unrealized Capital Loss	$ 5	$ 19
Twelve months or less below amortized cost, total number of securities in an unrealized loss position | security	24	19
More than twelve months below amortized cost, Fair Value	$ 63	$ 9
More than twelve months below amortized cost, Unrealized Capital Loss	$ 13	$ 2
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	14	7
Total, Fair Value	$ 265	$ 206
Total Unrealized Capital Losses	$ 18	$ 21
Total, Number of securities | security	38	26
U.S. Government agencies and authorities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	$ 14	$ 21
Twelve months or less below amortized cost, Unrealized Capital Loss	$ 0	$ 2
Twelve months or less below amortized cost, total number of securities in an unrealized loss position | security	1	2
More than twelve months below amortized cost, Fair Value	$ 3	$ 0
More than twelve months below amortized cost, Unrealized Capital Loss	$ 1	$ 0
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	1	0
Total, Fair Value	$ 17	$ 21
Total Unrealized Capital Losses	$ 1	$ 2
Total, Number of securities | security	2	2
State, municipalities and political subdivisions
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	$ 191	$ 751
Twelve months or less below amortized cost, Unrealized Capital Loss	$ 10	$ 121
Twelve months or less below amortized cost, total number of securities in an unrealized loss position | security	80	284
More than twelve months below amortized cost, Fair Value	$ 587	$ 30
More than twelve months below amortized cost, Unrealized Capital Loss	$ 100	$ 13
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	216	17
Total, Fair Value	$ 778	$ 781
Total Unrealized Capital Losses	$ 110	$ 134
Total, Number of securities | security	296	301
U.S. corporate public securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	$ 1,723	$ 5,479
Twelve months or less below amortized cost, Unrealized Capital Loss	$ 89	$ 792
Twelve months or less below amortized cost, total number of securities in an unrealized loss position | security	305	1,054
More than twelve months below amortized cost, Fair Value	$ 4,266	$ 1,137
More than twelve months below amortized cost, Unrealized Capital Loss	$ 993	$ 447
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	1,011	347
Total, Fair Value	$ 5,989	$ 6,616
Total Unrealized Capital Losses	$ 1,082	$ 1,239
Total, Number of securities | security	1,316	1,401
U.S. corporate private securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	$ 1,272	$ 3,569
Twelve months or less below amortized cost, Unrealized Capital Loss	$ 55	$ 322
Twelve months or less below amortized cost, total number of securities in an unrealized loss position | security	127	375
More than twelve months below amortized cost, Fair Value	$ 2,597	$ 458
More than twelve months below amortized cost, Unrealized Capital Loss	$ 350	$ 87
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	276	32
Total, Fair Value	$ 3,869	$ 4,027
Total Unrealized Capital Losses	$ 405	$ 409
Total, Number of securities | security	403	407
Foreign corporate public securities and foreign governments
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	$ 552	$ 2,050
Twelve months or less below amortized cost, Unrealized Capital Loss	$ 19	$ 260
Twelve months or less below amortized cost, total number of securities in an unrealized loss position | security	97	371
More than twelve months below amortized cost, Fair Value	$ 1,588	$ 391
More than twelve months below amortized cost, Unrealized Capital Loss	$ 317	$ 143
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	334	97
Total, Fair Value	$ 2,140	$ 2,441
Total Unrealized Capital Losses	$ 336	$ 403
Total, Number of securities | security	431	468
Foreign corporate private securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	$ 1,051	$ 2,728
Twelve months or less below amortized cost, Unrealized Capital Loss	$ 33	$ 211
Twelve months or less below amortized cost, total number of securities in an unrealized loss position | security	74	217
More than twelve months below amortized cost, Fair Value	$ 1,497	$ 65
More than twelve months below amortized cost, Unrealized Capital Loss	$ 160	$ 14
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	133	6
Total, Fair Value	$ 2,548	$ 2,793
Total Unrealized Capital Losses	$ 193	$ 225
Total, Number of securities | security	207	223
Residential mortgage-backed
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	$ 585	$ 1,538
Twelve months or less below amortized cost, Unrealized Capital Loss	$ 31	$ 128
Twelve months or less below amortized cost, total number of securities in an unrealized loss position | security	236	536
More than twelve months below amortized cost, Fair Value	$ 1,146	$ 562
More than twelve months below amortized cost, Unrealized Capital Loss	$ 246	$ 162
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	545	283
Total, Fair Value	$ 1,731	$ 2,100
Total Unrealized Capital Losses	$ 277	$ 290
Total, Number of securities | security	781	819
Commercial mortgage-backed securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	$ 492	$ 2,628
Twelve months or less below amortized cost, Unrealized Capital Loss	$ 46	$ 390
Twelve months or less below amortized cost, total number of securities in an unrealized loss position | security	79	441
More than twelve months below amortized cost, Fair Value	$ 3,046	$ 1,133
More than twelve months below amortized cost, Unrealized Capital Loss	$ 598	$ 195
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	550	207
Total, Fair Value	$ 3,538	$ 3,761
Total Unrealized Capital Losses	$ 644	$ 585
Total, Number of securities | security	629	648
Other asset-backed securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	$ 192	$ 1,430
Twelve months or less below amortized cost, Unrealized Capital Loss	$ 7	$ 104
Twelve months or less below amortized cost, total number of securities in an unrealized loss position | security	44	334
More than twelve months below amortized cost, Fair Value	$ 1,745	$ 578
More than twelve months below amortized cost, Unrealized Capital Loss	$ 130	$ 69
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	467	191
Total, Fair Value	$ 1,937	$ 2,008
Total Unrealized Capital Losses	$ 137	$ 173
Total, Number of securities | security	511	525

Investments (excluding Conso_10

Investments (excluding Consolidated Investment Entities) - Unrealized Capital Losses 1 (Details) $ in Millions	6 Months Ended
	Jun. 30, 2023 USD ($) security	Dec. 31, 2022 USD ($) security
Available-for-sale Securities, Including Securities Pledged [Line Items]
Available-for-sale Securities, change in loss position	$ 278
Total Unrealized Capital Losses	3,203	$ 3,481
More than twelve months below amortized cost, Unrealized Capital Loss	$ 2,908	$ 1,132
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	3,547	1,187
Commercial mortgage-backed securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Total Unrealized Capital Losses	$ 644	$ 585
More than twelve months below amortized cost, Unrealized Capital Loss	$ 598	$ 195
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	550	207
Fair value decline below amortized cost greater than 20%
Available-for-sale Securities, Including Securities Pledged [Line Items]
More than twelve months below amortized cost, Unrealized Capital Loss	$ 834
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	603

Investments (excluding Conso_11

Investments (excluding Consolidated Investment Entities) - Impairments (Details) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2023 USD ($) security	Jun. 30, 2022 USD ($) security	Jun. 30, 2023 USD ($) security	Jun. 30, 2022 USD ($) security
Available-for-sale Securities, Including Securities Pledged [Line Items]
Impairment | $	$ 7	$ 2	$ 7	$ 9
No. of Securities | security	37	18	39	28
Residential mortgage-backed
Available-for-sale Securities, Including Securities Pledged [Line Items]
Impairment | $	$ 2	$ 2	$ 2	$ 9
No. of Securities | security	34	17	36	27
Commercial mortgage-backed securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Impairment | $	$ 5	$ 0	$ 5	$ 0
No. of Securities | security	3	1	3	1

Investments (excluding Conso_12

Investments (excluding Consolidated Investment Entities) - Debt Restructuring (Narrative) (Details)	6 Months Ended
	Jun. 30, 2023 loan
Commercial mortgage loans
Financing Receivable, Troubled Debt Restructuring [Line Items]
Troubled debt restructuring, number of contracts	0

Investments (excluding Conso_13

Investments (excluding Consolidated Investment Entities) - Loans by Loan to Value (Details) - USD ($) $ in Millions	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Schedule of Loans by Loan to Value Ratio [Line Items]
Targeted maximum amount of mortgage loans lended, percent of estimated fair value of underlying real estate	75%
Benchmark loan to value ratio, greater than indicates unpaid loan amount exceeds underlying collateral	100%
Benchmark ratio	100%
Commercial mortgage loans	$ 5,366	$ 5,445
0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Loan to value ratio, minimum	0%	0%
Loan to value ratio, maximum	50%	50%
Commercial mortgage loans	$ 3,605	$ 3,605
50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Loan to value ratio, minimum	50%	50%
Loan to value ratio, maximum	60%	60%
Commercial mortgage loans	$ 1,423	$ 1,418
60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Loan to value ratio, minimum	60%	60%
Loan to value ratio, maximum	70%	70%
Commercial mortgage loans	$ 328	$ 402
70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Loan to value ratio, minimum	70%	70%
Loan to value ratio, maximum	80%	80%
Commercial mortgage loans	$ 10	$ 20
80% and above
Schedule of Loans by Loan to Value Ratio [Line Items]
Loan to value ratio, minimum	80%	80%
Commercial mortgage loans	$ 0	$ 0
Year of Origination 2023
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	246
Year of Origination 2023 | 0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	78
Year of Origination 2023 | 50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	168
Year of Origination 2023 | 60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	0
Year of Origination 2023 | 70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	0
Year of Origination 2023 | 80% and above
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	0
Year of Origination 2022
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	649	635
Year of Origination 2022 | 0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	250	250
Year of Origination 2022 | 50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	330	320
Year of Origination 2022 | 60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	69	65
Year of Origination 2022 | 70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2022 | 80% and above
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2021
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	702	777
Year of Origination 2021 | 0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	242	240
Year of Origination 2021 | 50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	248	272
Year of Origination 2021 | 60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	212	255
Year of Origination 2021 | 70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	0	10
Year of Origination 2021 | 80% and above
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2020
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	338	363
Year of Origination 2020 | 0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	158	119
Year of Origination 2020 | 50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	161	209
Year of Origination 2020 | 60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	9	25
Year of Origination 2020 | 70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	10	10
Year of Origination 2020 | 80% and above
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2019
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	339	350
Year of Origination 2019 | 0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	229	227
Year of Origination 2019 | 50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	82	94
Year of Origination 2019 | 60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	28	29
Year of Origination 2019 | 70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2019 | 80% and above
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2018
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	202	206
Year of Origination 2018 | 0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	159	163
Year of Origination 2018 | 50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	38	41
Year of Origination 2018 | 60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	5	2
Year of Origination 2018 | 70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2018 | 80% and above
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2017 and prior
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	2,890	3,114
Year of Origination 2017 and prior | 0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	2,489	2,606
Year of Origination 2017 and prior | 50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	396	482
Year of Origination 2017 and prior | 60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	5	26
Year of Origination 2017 and prior | 70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2017 and prior | 80% and above
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	$ 0	$ 0

Investments (excluding Conso_14

Investments (excluding Consolidated Investment Entities) - Loans by Debt Service Coverage Ratio (Details) - USD ($) $ in Millions	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	$ 5,366	$ 5,445
>1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Debt Service Coverage Ratio, minimum	150%	150%
>1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Debt Service Coverage Ratio, minimum	125%	125%
Debt Service Coverage Ratio, maximum	150%	150%
>1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Debt Service Coverage Ratio, minimum	100%	100%
Debt Service Coverage Ratio, maximum	125%	125%
Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Debt Service Coverage Ratio, maximum	100%	100%
Year of Origination 2023
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	$ 246
Year of Origination 2023 | >1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	70
Year of Origination 2023 | >1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	93
Year of Origination 2023 | >1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	83
Year of Origination 2023 | Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	0
Year of Origination 2023 | Total
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	246
Year of Origination 2022
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	649	$ 635
Year of Origination 2022 | >1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	245	331
Year of Origination 2022 | >1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	82	100
Year of Origination 2022 | >1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	210	181
Year of Origination 2022 | Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	112	23
Year of Origination 2022 | Total
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	649	635
Year of Origination 2021
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	702	777
Year of Origination 2021 | >1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	256	273
Year of Origination 2021 | >1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	21	33
Year of Origination 2021 | >1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	62	269
Year of Origination 2021 | Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	363	202
Year of Origination 2021 | Total
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	702	777
Year of Origination 2020
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	338	363
Year of Origination 2020 | >1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	242	259
Year of Origination 2020 | >1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	27	11
Year of Origination 2020 | >1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	5	11
Year of Origination 2020 | Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	64	82
Year of Origination 2020 | Total
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	338	363
Year of Origination 2019
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	339	350
Year of Origination 2019 | >1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	186	222
Year of Origination 2019 | >1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	39	54
Year of Origination 2019 | >1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	107	67
Year of Origination 2019 | Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	7	7
Year of Origination 2019 | Total
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	339	350
Year of Origination 2018
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	202	206
Year of Origination 2018 | >1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	123	128
Year of Origination 2018 | >1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	24	27
Year of Origination 2018 | >1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	55	51
Year of Origination 2018 | Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2018 | Total
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	202	206
Year of Origination 2017 and prior
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	2,890	3,114
Year of Origination 2017 and prior | >1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	2,078	2,172
Year of Origination 2017 and prior | >1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	362	454
Year of Origination 2017 and prior | >1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	211	226
Year of Origination 2017 and prior | Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	239	262
Year of Origination 2017 and prior | Total
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	2,890	3,114
Total | >1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	3,200	3,385
Total | >1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	648	679
Total | >1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	733	805
Total | Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	785	576
Total | Total
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	$ 5,366	$ 5,445

Investments (excluding Conso_15

Investments (excluding Consolidated Investment Entities) - Loans by U.S. Region (Details) - USD ($) $ in Millions	Jun. 30, 2023	Dec. 31, 2022
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	$ 5,366	$ 5,445
Year of Origination 2023
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	246
Year of Origination 2023 | Pacific
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	21
Year of Origination 2023 | South Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	48
Year of Origination 2023 | Middle Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	5
Year of Origination 2023 | West South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	97
Year of Origination 2023 | Mountain
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	11
Year of Origination 2023 | East North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	32
Year of Origination 2023 | New England
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	3
Year of Origination 2023 | West North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	26
Year of Origination 2023 | East South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	3
Year of Origination 2023 | Total
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	246
Year of Origination 2022
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	649	635
Year of Origination 2022 | Pacific
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	140	140
Year of Origination 2022 | South Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	130	129
Year of Origination 2022 | Middle Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	48	48
Year of Origination 2022 | West South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	99	98
Year of Origination 2022 | Mountain
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	113	114
Year of Origination 2022 | East North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	93	82
Year of Origination 2022 | New England
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	5	4
Year of Origination 2022 | West North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	1	1
Year of Origination 2022 | East South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	20	19
Year of Origination 2022 | Total
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	649	635
Year of Origination 2021
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	702	777
Year of Origination 2021 | Pacific
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	99	99
Year of Origination 2021 | South Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	63	72
Year of Origination 2021 | Middle Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	128	134
Year of Origination 2021 | West South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	146	143
Year of Origination 2021 | Mountain
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	112	112
Year of Origination 2021 | East North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	95	138
Year of Origination 2021 | New England
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	9	9
Year of Origination 2021 | West North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	49	48
Year of Origination 2021 | East South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	1	22
Year of Origination 2021 | Total
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	702	777
Year of Origination 2020
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	338	363
Year of Origination 2020 | Pacific
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	74	74
Year of Origination 2020 | South Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	160	170
Year of Origination 2020 | Middle Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	18	18
Year of Origination 2020 | West South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	10	16
Year of Origination 2020 | Mountain
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	12	12
Year of Origination 2020 | East North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	40	39
Year of Origination 2020 | New England
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2020 | West North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	7	7
Year of Origination 2020 | East South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	17	27
Year of Origination 2020 | Total
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	338	363
Year of Origination 2019
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	339	350
Year of Origination 2019 | Pacific
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	53	58
Year of Origination 2019 | South Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	102	106
Year of Origination 2019 | Middle Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	10	10
Year of Origination 2019 | West South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	75	77
Year of Origination 2019 | Mountain
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	46	46
Year of Origination 2019 | East North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	5	5
Year of Origination 2019 | New England
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	14	14
Year of Origination 2019 | West North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	13	13
Year of Origination 2019 | East South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	21	21
Year of Origination 2019 | Total
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	339	350
Year of Origination 2018
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	202	206
Year of Origination 2018 | Pacific
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	49	50
Year of Origination 2018 | South Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	60	62
Year of Origination 2018 | Middle Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	53	55
Year of Origination 2018 | West South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	10	10
Year of Origination 2018 | Mountain
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	14	14
Year of Origination 2018 | East North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	10	10
Year of Origination 2018 | New England
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2018 | West North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	6	5
Year of Origination 2018 | East South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2018 | Total
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	202	206
Year of Origination 2017 and prior
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	2,890	3,114
Year of Origination 2017 and prior | Pacific
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	743	777
Year of Origination 2017 and prior | South Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	593	623
Year of Origination 2017 and prior | Middle Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	736	759
Year of Origination 2017 and prior | West South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	195	248
Year of Origination 2017 and prior | Mountain
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	207	227
Year of Origination 2017 and prior | East North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	201	257
Year of Origination 2017 and prior | New England
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	48	49
Year of Origination 2017 and prior | West North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	142	149
Year of Origination 2017 and prior | East South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	25	25
Year of Origination 2017 and prior | Total
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	2,890	3,114
Total | Pacific
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	1,179	1,198
Total | South Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	1,156	1,162
Total | Middle Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	998	1,024
Total | West South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	632	592
Total | Mountain
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	515	525
Total | East North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	476	531
Total | New England
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	79	76
Total | West North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	244	223
Total | East South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	87	114
Total | Total
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	$ 5,366	$ 5,445

Investments (excluding Conso_16

Investments (excluding Consolidated Investment Entities) - Loans by Property Type (Details) - USD ($) $ in Millions	Jun. 30, 2023	Dec. 31, 2022
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	$ 5,366	$ 5,445
Year of Origination 2023
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	246
Year of Origination 2023 | Retail
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	93
Year of Origination 2023 | Industrial
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	108
Year of Origination 2023 | Apartments
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	26
Year of Origination 2023 | Office
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	19
Year of Origination 2023 | Hotel/Motel
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	0
Year of Origination 2023 | Other
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	0
Year of Origination 2023 | Mixed Use
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	0
Year of Origination 2023 | Total
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	246
Year of Origination 2022
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	649	635
Year of Origination 2022 | Retail
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	79	79
Year of Origination 2022 | Industrial
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	265	255
Year of Origination 2022 | Apartments
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	251	247
Year of Origination 2022 | Office
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	34	34
Year of Origination 2022 | Hotel/Motel
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	10	10
Year of Origination 2022 | Other
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	10	10
Year of Origination 2022 | Mixed Use
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2022 | Total
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	649	635
Year of Origination 2021
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	702	777
Year of Origination 2021 | Retail
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	37	37
Year of Origination 2021 | Industrial
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	153	168
Year of Origination 2021 | Apartments
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	360	420
Year of Origination 2021 | Office
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	125	125
Year of Origination 2021 | Hotel/Motel
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2021 | Other
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	18	18
Year of Origination 2021 | Mixed Use
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	9	9
Year of Origination 2021 | Total
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	702	777
Year of Origination 2020
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	338	363
Year of Origination 2020 | Retail
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	58	58
Year of Origination 2020 | Industrial
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	60	61
Year of Origination 2020 | Apartments
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	77	93
Year of Origination 2020 | Office
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	143	151
Year of Origination 2020 | Hotel/Motel
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2020 | Other
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2020 | Mixed Use
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2020 | Total
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	338	363
Year of Origination 2019
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	339	350
Year of Origination 2019 | Retail
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	45	46
Year of Origination 2019 | Industrial
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	83	85
Year of Origination 2019 | Apartments
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	163	165
Year of Origination 2019 | Office
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	36	40
Year of Origination 2019 | Hotel/Motel
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	12	14
Year of Origination 2019 | Other
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2019 | Mixed Use
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2019 | Total
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	339	350
Year of Origination 2018
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	202	206
Year of Origination 2018 | Retail
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	36	37
Year of Origination 2018 | Industrial
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	82	84
Year of Origination 2018 | Apartments
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	55	56
Year of Origination 2018 | Office
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	12	12
Year of Origination 2018 | Hotel/Motel
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2018 | Other
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	17	17
Year of Origination 2018 | Mixed Use
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2018 | Total
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	202	206
Year of Origination 2017 and prior
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	2,890	3,114
Year of Origination 2017 and prior | Retail
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	806	888
Year of Origination 2017 and prior | Industrial
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	700	757
Year of Origination 2017 and prior | Apartments
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	632	679
Year of Origination 2017 and prior | Office
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	485	513
Year of Origination 2017 and prior | Hotel/Motel
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	67	69
Year of Origination 2017 and prior | Other
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	150	156
Year of Origination 2017 and prior | Mixed Use
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	50	52
Year of Origination 2017 and prior | Total
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	2,890	3,114
Total | Retail
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	1,154	1,145
Total | Industrial
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	1,451	1,410
Total | Apartments
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	1,564	1,660
Total | Office
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	854	875
Total | Hotel/Motel
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	89	93
Total | Other
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	195	201
Total | Mixed Use
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	59	61
Total | Total
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	$ 5,366	$ 5,445

Investments (excluding Conso_17

Investments (excluding Consolidated Investment Entities) - Allowance for Losses for Commercial Mortgage Loans (Details) - USD ($) $ in Millions	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	$ 12	$ 58
Credit losses on securities for which credit losses were not previously recorded		9
Increase (decrease) on securities with allowance recorded in previous period	(2)	2
Ending Balance	16	12
Commercial Portfolio Segment
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	18	15
Credit losses on securities for which credit losses were not previously recorded	1	3
Increase (decrease) on securities with allowance recorded in previous period	8	0
Provision for expected credit losses	27	18
Write-offs	0	0
Recoveries of amounts previously written-off	0	0
Ending Balance	$ 27	$ 18

Investments (excluding Conso_18

Investments (excluding Consolidated Investment Entities) - Past due commercial mortgage loans (Details) - USD ($)	6 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Financing Receivable, Past Due [Line Items]
Financing Receivable, 90 Days or More Past Due, Still Accruing	$ 0
Financing Receivable, Nonaccrual, Interest Income	0
Current
Financing Receivable, Past Due [Line Items]
Past due commercial mortgage loans	5,366,000,000	$ 5,445,000,000
30-59 days past due
Financing Receivable, Past Due [Line Items]
Past due commercial mortgage loans	0	0
60-89 days past due
Financing Receivable, Past Due [Line Items]
Past due commercial mortgage loans	0	0
Greater than 90 days past due
Financing Receivable, Past Due [Line Items]
Past due commercial mortgage loans	0	0
Total
Financing Receivable, Past Due [Line Items]
Past due commercial mortgage loans	$ 5,366,000,000	$ 5,445,000,000

Investments (excluding Conso_19

Investments (excluding Consolidated Investment Entities) - Net Investment Income (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Schedule of Investment Income, Reported Amounts, by Category [Line Items]
Gross investment income	$ 563	$ 596	$ 1,126	$ 1,241
Less: Investment expenses	18	15	36	30
Net investment income	545	581	1,090	1,211
Fixed maturities
Schedule of Investment Income, Reported Amounts, by Category [Line Items]
Gross investment income	440	495	898	974
Investments in fixed maturities that did not produce net investment income	17		17		$ 11
Equity securities
Schedule of Investment Income, Reported Amounts, by Category [Line Items]
Gross investment income	7	5	14	9
Mortgage loans on real estate
Schedule of Investment Income, Reported Amounts, by Category [Line Items]
Gross investment income	62	60	123	119
Policy loans
Schedule of Investment Income, Reported Amounts, by Category [Line Items]
Gross investment income	5	5	11	11
Short-term investments and cash equivalents
Schedule of Investment Income, Reported Amounts, by Category [Line Items]
Gross investment income	9	2	18	3
Limited partnerships and other
Schedule of Investment Income, Reported Amounts, by Category [Line Items]
Gross investment income	$ 40	$ 29	$ 62	$ 125

Investments (excluding Conso_20

Investments (excluding Consolidated Investment Entities) - Net Realized Capital Gains (Losses) (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Realized Gain/(Losses) [Line Items]
Net gains (losses)	$ (56)	$ (226)	$ (72)	$ (514)
Fixed maturities
Realized Gain/(Losses) [Line Items]
Net gains (losses)	(2)	(2)	(1)	(6)
Other derivatives, net
Realized Gain/(Losses) [Line Items]
Net gains (losses)	0	12	0	17
Standalone derivatives
Realized Gain/(Losses) [Line Items]
Net gains (losses)	0	0	0	1
Managed custody guarantees
Realized Gain/(Losses) [Line Items]
Net gains (losses)	0	1	3	(2)
Derivatives
Realized Gain/(Losses) [Line Items]
Net gains (losses)	119	32	65	126
Mortgage loans on real estate
Realized Gain/(Losses) [Line Items]
Net gains (losses)	(10)	1	(10)	5
Other investments
Realized Gain/(Losses) [Line Items]
Net gains (losses)	0	5	(1)	6
Fixed maturities, available-for-sale, including securities pledged
Realized Gain/(Losses) [Line Items]
Net gains (losses)	(18)	(6)	(17)	(79)
Fixed maturities, at fair value option
Realized Gain/(Losses) [Line Items]
Net gains (losses)	(144)	(245)	(108)	(550)
Equity securities, at fair value
Realized Gain/(Losses) [Line Items]
Net gains (losses)	$ (1)	$ (24)	$ (3)	$ (32)

Investments (excluding Conso_21

Investments (excluding Consolidated Investment Entities) (Details) - Gross Gains/(Losses) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Investments, Debt and Equity Securities [Abstract]
Proceeds on sales	$ 2,331	$ 971	$ 3,637	$ 2,220
Gross gains	23	15		30
Gross losses	$ 30	$ 12		$ 44
Gross gains			43
Gross losses			$ 55

Derivative Financial Instrume_3

Derivative Financial Instruments - Notional and Fair Values (Details) - USD ($) $ in Millions	Jun. 30, 2023	Dec. 31, 2022
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	$ 524	$ 520
Derivative Liability, Fair Value, Gross Liability	450	441
Credit contracts
Derivative [Line Items]
Notional Amount	177	174
Not Designated as Hedging Instrument | Credit contracts
Derivative [Line Items]
Notional Amount	177	174
Not Designated as Hedging Instrument | Derivatives | Credit contracts
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	0	0
Derivative Liability, Fair Value, Gross Liability	4	2
Foreign exchange contracts
Derivative [Line Items]
Notional Amount	1,097	959
Foreign exchange contracts | Not Designated as Hedging Instrument
Derivative [Line Items]
Notional Amount	249	160
Foreign exchange contracts | Not Designated as Hedging Instrument | Derivatives
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	4	9
Derivative Liability, Fair Value, Gross Liability	1	2
Foreign exchange contracts | Fair Value Hedging | Designated as Hedging Instrument
Derivative [Line Items]
Notional Amount	103	81
Foreign exchange contracts | Fair Value Hedging | Designated as Hedging Instrument | Derivatives
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	1	0
Derivative Liability, Fair Value, Gross Liability	0	6
Foreign exchange contracts | Cash Flow Hedging | Designated as Hedging Instrument
Derivative [Line Items]
Notional Amount	745	718
Foreign exchange contracts | Cash Flow Hedging | Designated as Hedging Instrument | Derivatives
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	54	71
Derivative Liability, Fair Value, Gross Liability	3	2
Interest rate contracts
Derivative [Line Items]
Notional Amount	24,444	13,328
Interest rate contracts | Not Designated as Hedging Instrument
Derivative [Line Items]
Notional Amount	27,506	18,304
Interest rate contracts | Not Designated as Hedging Instrument | Derivatives
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	374	341
Derivative Liability, Fair Value, Gross Liability	390	376
Interest rate contracts | Cash Flow Hedging | Designated as Hedging Instrument
Derivative [Line Items]
Notional Amount	44	22
Interest rate contracts | Cash Flow Hedging | Designated as Hedging Instrument | Derivatives
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	0	0
Derivative Liability, Fair Value, Gross Liability	0	0
Equity contracts
Derivative [Line Items]
Notional Amount	225	201
Equity contracts | Not Designated as Hedging Instrument
Derivative [Line Items]
Notional Amount	255	248
Equity contracts | Not Designated as Hedging Instrument | Derivatives
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	11	1
Derivative Liability, Fair Value, Gross Liability	2	1
Fixed maturities | Not Designated as Hedging Instrument
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	2	3
Derivative Liability, Fair Value, Gross Liability	0	0
Embedded derivative on reinsurance | Not Designated as Hedging Instrument
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	78	95
Derivative Liability, Fair Value, Gross Liability		46
Derivative Liability, Not Subject to Master Netting Arrangement	47
Managed custody guarantees | Not Designated as Hedging Instrument
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	0	0
Derivative Liability, Fair Value, Gross Liability	$ 3	$ 6

Derivative Financial Instrume_4

Derivative Financial Instruments - Offsetting Assets and Liabilities (Details) - USD ($) $ in Millions	Jun. 30, 2023	Dec. 31, 2022
Offsetting Assets and Liabilities [Line Items]
Asset Fair Value	$ 444	$ 420
Liability Fair Value	399	389
Counterparty netting, Assets	(341)	(295)
Counterparty netting, Liabilities	(341)	(295)
Cash collateral netting, Assets	(96)	(64)
Cash collateral netting, Liabilities	(52)	(88)
Securities collateral netting, Assets	(5)	(6)
Securities collateral netting, Liabilities	(5)	(1)
Net receivables/payables, Assets	2	55
Net receivables/payables, Liabilities	1	5
Equity contracts
Offsetting Assets and Liabilities [Line Items]
Notional Amount	225	201
Asset Fair Value	11	1
Liability Fair Value	2	1
Foreign exchange contracts
Offsetting Assets and Liabilities [Line Items]
Notional Amount	1,097	959
Asset Fair Value	59	80
Liability Fair Value	4	10
Interest rate contracts
Offsetting Assets and Liabilities [Line Items]
Notional Amount	24,444	13,328
Asset Fair Value	374	339
Liability Fair Value	389	376
Credit contracts
Offsetting Assets and Liabilities [Line Items]
Notional Amount	177	174
Asset Fair Value	0	0
Liability Fair Value	$ 4	$ 2

Derivative Financial Instrume_5

Derivative Financial Instruments - Collateral and Credit Default Swaps (Details) - USD ($) $ in Millions	Jun. 30, 2023	Dec. 31, 2022
Securities pledged as collateral
Derivatives, Fair Value [Line Items]
Securities held as collateral	$ 6	$ 7
Collateral Securities Repledged, Delivered, or Used	175	142
Over the counter | Cash collateral, included in Payables
Derivatives, Fair Value [Line Items]
Securities held as collateral	98	56
Cleared derivative contract | Cash collateral, included in Payables
Derivatives, Fair Value [Line Items]
Securities held as collateral	$ 55	$ 79

Derivative Financial Instrume_6

Derivative Financial Instruments - Effect of Derivatives (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Derivative Instruments, Gain (Loss) [Line Items]
Net investment income	$ 545	$ 581	$ 1,090	$ 1,211
Net gains (losses)	(56)	(226)	(72)	(514)
Gain (loss) on derivative, net	125	110	50	286
Not Designated as Hedging Instrument | Credit contracts
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	0	(4)	(1)	(4)
Interest rate contracts | Not Designated as Hedging Instrument
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	114	52	58	152
Interest rate contracts | Cash Flow Hedging | Designated as Hedging Instrument | Other Comprehensive Income (Loss)
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Income	0	(1)	0	(2)
Interest rate contracts | Cash Flow Hedging | Designated as Hedging Instrument | Net investment income
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Income	0	0	0	0
Foreign exchange contracts | Not Designated as Hedging Instrument
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	0	(1)	1	(2)
Foreign exchange contracts | Cash Flow Hedging | Designated as Hedging Instrument | Other Comprehensive Income (Loss)
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Income	(6)	55	(18)	62
Foreign exchange contracts | Cash Flow Hedging | Designated as Hedging Instrument | Net investment income
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Income	2	2	5	5
Gain (loss) on derivative, net	2	2	5	5
Foreign exchange contracts | Cash Flow Hedging | Designated as Hedging Instrument | Net gains/(losses)
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	0	0	0	0
Foreign exchange contracts | Fair Value Hedging | Net investment income
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	0	0	0	0
Foreign exchange contracts | Fair Value Hedging | Net gains/(losses)
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	0	(5)	2	(7)
Foreign exchange contracts | Fair Value Hedging | Designated as Hedging Instrument | Net investment income
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	0	0	0	0
Foreign exchange contracts | Fair Value Hedging | Designated as Hedging Instrument | Net gains/(losses)
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	0	6	(1)	8
Embedded derivative on reinsurance
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	8	84	(18)	176
Embedded derivative on reinsurance | Level 3 | Measured at fair value on a recurring basis
Derivative Instruments, Gain (Loss) [Line Items]
Fair Value, Assets and Liabilities Measured on Recurring Basis, Gain (Loss) Included in Earnings			1	1
Total Realized/Unrealized Gains (Losses) Included in Net income	0	0	0	1
Equity contracts | Not Designated as Hedging Instrument
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	5	(20)	8	(28)
Fixed maturities
Derivative Instruments, Gain (Loss) [Line Items]
Net gains (losses)	(2)	(2)	(1)	(6)
Gain (loss) on derivative, net	(2)	(2)	(1)	(6)
Managed Custody Guarantees
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net			3	(2)
Managed custody guarantees
Derivative Instruments, Gain (Loss) [Line Items]
Net gains (losses)	0	1	3	(2)
Gain (loss) on derivative, net	0	1
Managed custody guarantees | Level 3 | Measured at fair value on a recurring basis
Derivative Instruments, Gain (Loss) [Line Items]
Total Realized/Unrealized Gains (Losses) Included in Net income	$ 0	$ 11	$ 4	$ 17

Fair Value Measurements (excl_3

Fair Value Measurements (excluding Consolidated Investment Entities) - Fair Value Measurement (Details) - USD ($) $ in Millions	Jun. 30, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets held in separate accounts	$ 88,851	$ 80,174
Total assets	154,616	146,606
Derivatives	400	389
Total liabilities	149,088	141,609
Fixed maturities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	29,193	30,357
U.S. Treasuries
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	425	581
U.S. Government agencies and authorities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	56	59
State, municipalities and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	822	845
U.S. corporate public securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	7,878	8,201
U.S. corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	4,735	4,692
Foreign corporate public securities and foreign governments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	2,767	2,949
Foreign corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	2,915	3,034
Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	3,628	3,977
Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	3,676	3,883
Other asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	2,291	2,136
Measured at fair value on a recurring basis
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	29,193	30,357
Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements	2,333	2,454
Assets held in separate accounts	88,851	80,174
Total assets	$ 121,208	$ 113,838
Percentage of Level to total	100%	100%
Contingent consideration	$ 112	$ 112
Total liabilities	562	553
Measured at fair value on a recurring basis | Managed custody guarantees
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	3	6
Measured at fair value on a recurring basis | Interest rate contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	374	341
Derivatives	390	376
Measured at fair value on a recurring basis | Foreign exchange contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	59	80
Derivatives	4	10
Measured at fair value on a recurring basis | Equity contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	11	1
Derivatives	2	1
Measured at fair value on a recurring basis | Embedded derivative on reinsurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	78	95
Embedded derivative on reinsurance	47	46
Measured at fair value on a recurring basis | Credit contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	4	2
Measured at fair value on a recurring basis | U.S. Treasuries
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	425	581
Measured at fair value on a recurring basis | U.S. Government agencies and authorities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	56	59
Measured at fair value on a recurring basis | State, municipalities and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	822	845
Measured at fair value on a recurring basis | U.S. corporate public securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	7,878	8,201
Measured at fair value on a recurring basis | U.S. corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	4,735	4,692
Measured at fair value on a recurring basis | Foreign corporate public securities and foreign governments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	2,767	2,949
Measured at fair value on a recurring basis | Foreign corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	2,915	3,034
Measured at fair value on a recurring basis | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	3,628	3,977
Measured at fair value on a recurring basis | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	3,676	3,883
Measured at fair value on a recurring basis | Other asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	2,291	2,136
Measured at fair value on a recurring basis | Equity securities, at fair value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity securities	309	336
Measured at fair value on a recurring basis | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	367	433
Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements	2,297	2,430
Assets held in separate accounts	83,005	74,600
Total assets	$ 85,786	$ 77,605
Percentage of Level to total	71%	68%
Contingent consideration	$ 0	$ 0
Total liabilities	4	3
Measured at fair value on a recurring basis | Level 1 | Managed custody guarantees
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	0	0
Measured at fair value on a recurring basis | Level 1 | Interest rate contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	2
Derivatives	4	3
Measured at fair value on a recurring basis | Level 1 | Foreign exchange contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Derivatives	0	0
Measured at fair value on a recurring basis | Level 1 | Equity contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Derivatives	0	0
Measured at fair value on a recurring basis | Level 1 | Embedded derivative on reinsurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Embedded derivative on reinsurance	0	0
Measured at fair value on a recurring basis | Level 1 | Credit contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Measured at fair value on a recurring basis | Level 1 | U.S. Treasuries
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	367	433
Measured at fair value on a recurring basis | Level 1 | U.S. Government agencies and authorities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	0
Measured at fair value on a recurring basis | Level 1 | State, municipalities and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	0
Measured at fair value on a recurring basis | Level 1 | U.S. corporate public securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	0
Measured at fair value on a recurring basis | Level 1 | U.S. corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	0
Measured at fair value on a recurring basis | Level 1 | Foreign corporate public securities and foreign governments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	0
Measured at fair value on a recurring basis | Level 1 | Foreign corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	0
Measured at fair value on a recurring basis | Level 1 | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	0
Measured at fair value on a recurring basis | Level 1 | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	0
Measured at fair value on a recurring basis | Level 1 | Other asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	0
Measured at fair value on a recurring basis | Level 1 | Equity securities, at fair value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity securities	117	140
Measured at fair value on a recurring basis | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	26,558	27,575
Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements	36	24
Assets held in separate accounts	5,502	5,227
Total assets	$ 32,618	$ 33,341
Percentage of Level to total	27%	29%
Contingent consideration	$ 0	$ 0
Total liabilities	385	374
Measured at fair value on a recurring basis | Level 2 | Managed custody guarantees
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	0	0
Measured at fair value on a recurring basis | Level 2 | Interest rate contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	374	339
Derivatives	386	373
Measured at fair value on a recurring basis | Level 2 | Foreign exchange contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	59	80
Derivatives	4	10
Measured at fair value on a recurring basis | Level 2 | Equity contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	11	1
Derivatives	2	1
Measured at fair value on a recurring basis | Level 2 | Embedded derivative on reinsurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	78	95
Embedded derivative on reinsurance	(11)	(12)
Measured at fair value on a recurring basis | Level 2 | Credit contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	4	2
Measured at fair value on a recurring basis | Level 2 | U.S. Treasuries
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	58	148
Measured at fair value on a recurring basis | Level 2 | U.S. Government agencies and authorities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	55	58
Measured at fair value on a recurring basis | Level 2 | State, municipalities and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	822	845
Measured at fair value on a recurring basis | Level 2 | U.S. corporate public securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	7,858	8,181
Measured at fair value on a recurring basis | Level 2 | U.S. corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	3,003	2,891
Measured at fair value on a recurring basis | Level 2 | Foreign corporate public securities and foreign governments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	2,767	2,946
Measured at fair value on a recurring basis | Level 2 | Foreign corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	2,502	2,602
Measured at fair value on a recurring basis | Level 2 | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	3,571	3,949
Measured at fair value on a recurring basis | Level 2 | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	3,676	3,883
Measured at fair value on a recurring basis | Level 2 | Other asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	2,246	2,072
Measured at fair value on a recurring basis | Level 2 | Equity securities, at fair value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity securities	0	0
Measured at fair value on a recurring basis | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	2,268	2,349
Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements	0	0
Assets held in separate accounts	344	347
Total assets	$ 2,804	$ 2,892
Percentage of Level to total	2%	3%
Contingent consideration	$ 112	$ 112
Total liabilities	173	176
Measured at fair value on a recurring basis | Level 3 | Managed custody guarantees
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	3	6
Measured at fair value on a recurring basis | Level 3 | Interest rate contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Derivatives	0	0
Measured at fair value on a recurring basis | Level 3 | Foreign exchange contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Derivatives	0	0
Measured at fair value on a recurring basis | Level 3 | Equity contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Derivatives	0	0
Measured at fair value on a recurring basis | Level 3 | Embedded derivative on reinsurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Embedded derivative on reinsurance	58	58
Measured at fair value on a recurring basis | Level 3 | Credit contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Measured at fair value on a recurring basis | Level 3 | U.S. Treasuries
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	0
Measured at fair value on a recurring basis | Level 3 | U.S. Government agencies and authorities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	1	1
Measured at fair value on a recurring basis | Level 3 | State, municipalities and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	0
Measured at fair value on a recurring basis | Level 3 | U.S. corporate public securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	20	20
Measured at fair value on a recurring basis | Level 3 | U.S. corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	1,732	1,801
Measured at fair value on a recurring basis | Level 3 | Foreign corporate public securities and foreign governments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	3
Measured at fair value on a recurring basis | Level 3 | Foreign corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	413	432
Measured at fair value on a recurring basis | Level 3 | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	57	28
Measured at fair value on a recurring basis | Level 3 | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	0
Measured at fair value on a recurring basis | Level 3 | Other asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	45	64
Measured at fair value on a recurring basis | Level 3 | Equity securities, at fair value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity securities	$ 192	$ 196

Fair Value Measurements (excl_4

Fair Value Measurements (excluding Consolidated Investment Entities) - Level 3 Financial Instruments (Details) - Measured at fair value on a recurring basis - Level 3 - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Embedded derivative on reinsurance
Derivatives Rollforward:
Fair Value, Derivatives, beginning balance	$ (58)	$ (86)	$ (58)	$ (87)
Total Realized/Unrealized Gains (Losses) Included in Net income	0	0	0	1
Total Realized/Unrealized Gains (Losses) Included in OCI	0	0	0	0
Purchases	0	0	0	0
Issuances	0	0	0	0
Sales	0	0	0	0
Settlements	0	0	0	0
Transfers out of Level 3	0	0	0	0
Fair Value, Derivatives, ending balance	(58)	(86)	(58)	(86)
Change In Unrealized Gains (Losses) Included in Earnings	0	0	0	0
Change In Unrealized Gains (Losses) Included in OCI	0	0	0	0
Transfers in to Level 3	0	0	0	0
Managed custody guarantees
Derivatives Rollforward:
Fair Value, Derivatives, beginning balance	(3)	(15)	(6)	(20)
Total Realized/Unrealized Gains (Losses) Included in Net income	0	11	4	17
Total Realized/Unrealized Gains (Losses) Included in OCI	0	0	0	0
Purchases	0	0	0	0
Issuances	0	0	(1)	(1)
Sales	0	0	0	0
Settlements	0	0	0	0
Transfers out of Level 3	0	0	0	0
Fair Value, Derivatives, ending balance	(3)	(4)	(3)	(4)
Change In Unrealized Gains (Losses) Included in Earnings	0	0	0	0
Change In Unrealized Gains (Losses) Included in OCI	0	0	0	0
Transfers in to Level 3	0	0	0	0
Short-term investments and cash equivalents
Derivatives Rollforward:
Fair Value, Derivatives, beginning balance		8		0
Total Realized/Unrealized Gains (Losses) Included in Net income		0		0
Total Realized/Unrealized Gains (Losses) Included in OCI		0		0
Purchases		0		8
Issuances		0		0
Sales		0		0
Settlements		(8)		(8)
Transfers out of Level 3		0		0
Fair Value, Derivatives, ending balance		0		0
Change In Unrealized Gains (Losses) Included in Earnings		0		0
Change In Unrealized Gains (Losses) Included in OCI		0		0
Transfers in to Level 3		0		0
U.S. corporate public securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance		71		16
Total Realized/Unrealized Gains (Losses) Included in Net income		0		0
Total Realized/Unrealized Gains (Losses) Included in OCI		(1)		(1)
Purchases		1		5
Issuances		0		0
Sales		0		0
Settlements		0		0
Transfers out of Level 3		(52)		(1)
Fair Value, Assets, ending balance		19		19
Change In Unrealized Gains (Losses) Included in Earnings		0		0
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI		1		(1)
Transfers in to Level 3		0		0
U.S. corporate public securities | Available-for-sale Securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance	21		20
Total Realized/Unrealized Gains (Losses) Included in Net income	0		0
Total Realized/Unrealized Gains (Losses) Included in OCI	(1)		0
Purchases	0		0
Issuances	0		0
Sales	0		0
Settlements	0		0
Transfers out of Level 3	0		0
Fair Value, Assets, ending balance	20		20
Change In Unrealized Gains (Losses) Included in Earnings	0		0
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI	0		0
Transfers in to Level 3	0		0
U.S. corporate private securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance		1,925		1,910
Total Realized/Unrealized Gains (Losses) Included in Net income		(1)		(2)
Total Realized/Unrealized Gains (Losses) Included in OCI		(134)		(277)
Purchases		89		158
Issuances		0		0
Sales		0		0
Settlements		(58)		(120)
Transfers out of Level 3		(41)		(10)
Fair Value, Assets, ending balance		1,780		1,780
Change In Unrealized Gains (Losses) Included in Earnings		(1)		(2)
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI		(133)		(276)
Transfers in to Level 3		0		121
U.S. corporate private securities | Available-for-sale Securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance	1,800		1,801
Total Realized/Unrealized Gains (Losses) Included in Net income	0		0
Total Realized/Unrealized Gains (Losses) Included in OCI	(29)		6
Purchases	20		61
Issuances	0		0
Sales	(3)		(3)
Settlements	(56)		(133)
Transfers out of Level 3	0		0
Fair Value, Assets, ending balance	1,732		1,732
Change In Unrealized Gains (Losses) Included in Earnings	0		1
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI	(29)		5
Transfers in to Level 3	0		0
Foreign corporate public securities and foreign governments | Available-for-sale Securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance		11	3	0
Total Realized/Unrealized Gains (Losses) Included in Net income		0	0	0
Total Realized/Unrealized Gains (Losses) Included in OCI		0	0	0
Purchases		4	0	4
Issuances		0	0	0
Sales		0	0	0
Settlements		0	0	0
Transfers out of Level 3		(11)	(3)	0
Fair Value, Assets, ending balance	0	4	0	4
Change In Unrealized Gains (Losses) Included in Earnings		0	0	0
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI		0	0	0
Transfers in to Level 3		0	0	0
Foreign corporate private securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance		496		353
Total Realized/Unrealized Gains (Losses) Included in Net income		(3)		(22)
Total Realized/Unrealized Gains (Losses) Included in OCI		(7)		(31)
Purchases		51		97
Issuances		0		0
Sales		0		0
Settlements		(15)		(28)
Transfers out of Level 3		(119)		(114)
Fair Value, Assets, ending balance		403		403
Change In Unrealized Gains (Losses) Included in Earnings		(4)		(4)
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI		(7)		(31)
Transfers in to Level 3		0		148
Foreign corporate private securities | Available-for-sale Securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance	441		432
Total Realized/Unrealized Gains (Losses) Included in Net income	1		3
Total Realized/Unrealized Gains (Losses) Included in OCI	0		7
Purchases	19		75
Issuances	0		0
Sales	0		0
Settlements	(93)		(181)
Transfers out of Level 3	0		0
Fair Value, Assets, ending balance	413		413
Change In Unrealized Gains (Losses) Included in Earnings	1		3
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI	0		6
Transfers in to Level 3	45		77
Residential mortgage-backed securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance		45		43
Total Realized/Unrealized Gains (Losses) Included in Net income		(6)		(15)
Total Realized/Unrealized Gains (Losses) Included in OCI		0		0
Purchases		2		4
Issuances		0		0
Sales		0		0
Settlements		(9)		0
Transfers out of Level 3		(2)		(2)
Fair Value, Assets, ending balance		31		31
Change In Unrealized Gains (Losses) Included in Earnings		(6)		(15)
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI		0		0
Transfers in to Level 3		1		1
Residential mortgage-backed securities | Available-for-sale Securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance	56		28
Total Realized/Unrealized Gains (Losses) Included in Net income	(3)		(3)
Total Realized/Unrealized Gains (Losses) Included in OCI	0		0
Purchases	4		32
Issuances	0		0
Sales	0		0
Settlements	0		0
Transfers out of Level 3	0		0
Fair Value, Assets, ending balance	57		57
Change In Unrealized Gains (Losses) Included in Earnings	(3)		(3)
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI	0		0
Transfers in to Level 3	0		0
Commercial mortgage-backed securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance		49		44
Total Realized/Unrealized Gains (Losses) Included in Net income		0		0
Total Realized/Unrealized Gains (Losses) Included in OCI		(2)		(4)
Purchases		35		39
Issuances		0		0
Sales		0		(10)
Settlements		(5)		(6)
Transfers out of Level 3		(14)		0
Fair Value, Assets, ending balance		63		63
Change In Unrealized Gains (Losses) Included in Earnings		0		0
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI		(2)		(4)
Transfers in to Level 3		0		0
Asset-backed Securities [Member]
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance		2,597		2,366
Total Realized/Unrealized Gains (Losses) Included in Net income		(10)		(39)
Total Realized/Unrealized Gains (Losses) Included in OCI		(144)		(313)
Purchases		182		307
Issuances		0		0
Sales		0		(10)
Settlements		(87)		(154)
Transfers out of Level 3		(239)		(127)
Fair Value, Assets, ending balance		2,300		2,300
Change In Unrealized Gains (Losses) Included in Earnings		(11)		(21)
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI		(143)		(312)
Transfers in to Level 3		1		270
Asset-backed Securities [Member] | Available-for-sale Securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance	77		64
Total Realized/Unrealized Gains (Losses) Included in Net income	0		0
Total Realized/Unrealized Gains (Losses) Included in OCI	0		0
Purchases	4		4
Issuances	0		0
Sales	0		0
Settlements	(1)		(1)
Transfers out of Level 3	(35)		(22)
Fair Value, Assets, ending balance	45		45
Change In Unrealized Gains (Losses) Included in Earnings	0		0
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI	0		0
Transfers in to Level 3	0		0
Fixed maturities | Available-for-sale Securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance	2,396		2,349
Total Realized/Unrealized Gains (Losses) Included in Net income	(2)		0
Total Realized/Unrealized Gains (Losses) Included in OCI	(30)		13
Purchases	47		172
Issuances	0		0
Sales	(3)		(3)
Settlements	(150)		(315)
Transfers out of Level 3	(35)		(25)
Fair Value, Assets, ending balance	2,268		2,268
Change In Unrealized Gains (Losses) Included in Earnings	(2)		1
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI	(29)		11
Transfers in to Level 3	45		77
Equity securities, at fair value
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance	192	203	196	203
Total Realized/Unrealized Gains (Losses) Included in Net income	0	(17)	(4)	(26)
Total Realized/Unrealized Gains (Losses) Included in OCI	0	0	0	0
Purchases	0	26	0	26
Issuances	0	0	0	0
Sales	0	0	0	0
Settlements	0	0	0	0
Transfers out of Level 3	0	(9)	0	0
Fair Value, Assets, ending balance	192	203	192	203
Change In Unrealized Gains (Losses) Included in Earnings	0	(17)	(3)	(26)
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI	0	0	0	0
Transfers in to Level 3	0	0	0	0
US Government Agencies Debt Securities | Available-for-sale Securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance	1		1
Total Realized/Unrealized Gains (Losses) Included in Net income	0		0
Total Realized/Unrealized Gains (Losses) Included in OCI	0		0
Purchases	0		0
Issuances	0		0
Sales	0		0
Settlements	0		0
Transfers out of Level 3	0		0
Fair Value, Assets, ending balance	1		1
Change In Unrealized Gains (Losses) Included in Earnings	0		0
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI	0		0
Transfers in to Level 3	0		0
Contingent Consideration
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance	(112)	(11)	(112)	(11)
Total Realized/Unrealized Gains (Losses) Included in Net income	0	0	0	0
Total Realized/Unrealized Gains (Losses) Included in OCI	0	0	0	0
Purchases	0	0	0	0
Issuances	0	0	0	0
Sales	0	0	0	0
Settlements	0	0	0	0
Transfers out of Level 3	0	0	0	0
Fair Value, Assets, ending balance	(112)	(11)	(112)	(11)
Change In Unrealized Gains (Losses) Included in Earnings	0	0	0	0
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI	0	0	0	0
Transfers in to Level 3	0	0	0	0
Assets held in separate accounts
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance	349	334	347	316
Total Realized/Unrealized Gains (Losses) Included in Net income	(8)	(12)	(4)	(26)
Total Realized/Unrealized Gains (Losses) Included in OCI	0	0	0	0
Purchases	7	67	7	132
Issuances	0	0	0	0
Sales	(7)	(3)	(9)	(4)
Settlements	0	0	0	0
Transfers out of Level 3	0	(37)	0	(75)
Fair Value, Assets, ending balance	344	349	344	349
Change In Unrealized Gains (Losses) Included in Earnings	0	0	0	0
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI	0	0	0	0
Transfers in to Level 3	$ 3	$ 0	$ 3	$ 6

Fair Value Measurements (excl_5

Fair Value Measurements (excluding Consolidated Investment Entities) - Other Financial Instruments (Details) - USD ($) $ in Millions	Jun. 30, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets held in separate accounts	$ 88,851	$ 80,174
Derivatives	400	389
Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	29,193	30,357
Equity securities	309	336
Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements	2,333	2,454
Derivatives	444	422
Other investments	69	68
Assets held in separate accounts	88,851	80,174
Short-term debt	143	141
Long-term debt	2,095	2,094
Carrying Value | Derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	400	389
Carrying Value | Embedded derivative on reinsurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	78	95
Derivatives	47	46
Carrying Value | Managed custody guarantees
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	3	6
Carrying Value | Funding agreements without fixed maturities and deferred annuities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	34,335	35,707
Carrying Value | Funding agreements with fixed maturities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	1,290	1,285
Carrying Value | Supplementary contracts, immediate annuities and other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	673	727
Carrying Value | Mortgage loans on real estate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans Receivable, Fair Value Disclosure	5,366	5,445
Carrying Value | Policy loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans Receivable, Fair Value Disclosure	358	363
Estimate of Fair Value Measurement
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	29,193	30,357
Equity securities	309	336
Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements	2,333	2,454
Derivatives	444	422
Other investments	69	68
Assets held in separate accounts	88,851	80,174
Short-term debt	143	142
Long-term debt	1,941	1,935
Estimate of Fair Value Measurement | Derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	400	389
Estimate of Fair Value Measurement | Embedded derivative on reinsurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	78	95
Derivatives	47	46
Estimate of Fair Value Measurement | Managed custody guarantees
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	3	6
Estimate of Fair Value Measurement | Funding agreements without fixed maturities and deferred annuities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	35,615	36,385
Estimate of Fair Value Measurement | Funding agreements with fixed maturities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	1,298	1,281
Estimate of Fair Value Measurement | Supplementary contracts, immediate annuities and other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	614	636
Estimate of Fair Value Measurement | Mortgage loans on real estate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans Receivable, Fair Value Disclosure	4,998	5,149
Estimate of Fair Value Measurement | Policy loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans Receivable, Fair Value Disclosure	$ 358	$ 363

Deferred Policy Acquisition C_3

Deferred Policy Acquisition Costs and Value of Business Acquired - DAC and VOBA Activity (Details) - USD ($) $ in Millions	3 Months Ended	6 Months Ended		12 Months Ended
	Jun. 30, 2023	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Beginning balance		$ 2,363
Ending balance	$ 2,304	2,304		$ 2,363
Movement Analysis Of Value of Business Acquired VOBA [Roll Forward]
Beginning balance		439	$ 473	473
Deferrals of commissions and expenses		2		5
Net amortization included in Condensed Consolidated Statements of Operations	(19)			(39)
Ending balance	422	422		439
Present Value of Future Insurance Profits, Impairment Loss		0	0
Wealth Solutions
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Beginning balance		691	691	691
Deferrals of commissions and expenses	29			59
Net amortization included in the Consolidated Statements of Operations	(28)			(59)
Ending balance	692	692		691
business exited
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Beginning balance		1,043	$ 1,158	1,158
Deferrals of commissions and expenses		0		0
Net amortization included in the Consolidated Statements of Operations	(53)			(115)
Ending balance	990	990		1,043
Other Segments
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Beginning balance		190
Ending balance	$ 200	$ 200		$ 190

Financial Services, Insurance_3

Financial Services, Insurance, ASU 2018-12 Transition (Details) $ in Millions	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2023 USD ($) yr	Jun. 30, 2022 USD ($)	Jun. 30, 2023 USD ($) yr	Jun. 30, 2022 USD ($)	Dec. 31, 2022 USD ($) yr	Dec. 31, 2021 USD ($)
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Net liability for future policy benefits	$ 9,653		$ 9,653		$ 9,719
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			42,455
Interest credited	244	$ 243	485	$ 476
Policyholder Account Balance, Ending Balance	40,930		40,930		42,455
Policyholder Account Balance	40,930		40,930		42,455
Up to 1.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			13,398
Policyholder Account Balance, Ending Balance	12,904		12,904		13,398
Policyholder Account Balance	12,904		12,904		13,398
1.01% - 2.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			805
Policyholder Account Balance, Ending Balance	781		781		805
Policyholder Account Balance	781		781		805
2.01% - 3.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			12,892
Policyholder Account Balance, Ending Balance	12,173		12,173		12,892
Policyholder Account Balance	12,173		12,173		12,892
3.01% - 4.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			9,601
Policyholder Account Balance, Ending Balance	9,475		9,475		9,601
Policyholder Account Balance	9,475		9,475		9,601
4.01% and Above
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			1,730
Policyholder Account Balance, Ending Balance	1,685		1,685		1,730
Policyholder Account Balance	1,685		1,685		1,730
Renewable beyond 12 months (MYGA)
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			405
Policyholder Account Balance, Ending Balance	424		424		405
Policyholder Account Balance	424		424		405
Total discretionary rate setting products
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			38,831
Policyholder Account Balance, Ending Balance	37,441		37,441		38,831
Policyholder Account Balance	37,441		37,441		38,831
At GMIR
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			30,725
Policyholder Account Balance, Ending Balance	24,008		24,008		30,725
Policyholder Account Balance	24,008		24,008		30,725
At GMIR | Up to 1.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			5,848
Policyholder Account Balance, Ending Balance	162		162		5,848
Policyholder Account Balance	162		162		5,848
At GMIR | 1.01% - 2.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			707
Policyholder Account Balance, Ending Balance	575		575		707
Policyholder Account Balance	575		575		707
At GMIR | 2.01% - 3.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			12,677
Policyholder Account Balance, Ending Balance	11,930		11,930		12,677
Policyholder Account Balance	11,930		11,930		12,677
At GMIR | 3.01% - 4.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			9,448
Policyholder Account Balance, Ending Balance	9,320		9,320		9,448
Policyholder Account Balance	9,320		9,320		9,448
At GMIR | 4.01% and Above
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			1,643
Policyholder Account Balance, Ending Balance	1,601		1,601		1,643
Policyholder Account Balance	1,601		1,601		1,643
At GMIR | Renewable beyond 12 months (MYGA)
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			402
Policyholder Account Balance, Ending Balance	421		421		402
Policyholder Account Balance	421		421		402
Up to .50% Above GMIR
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			3,315
Policyholder Account Balance, Ending Balance	7,032		7,032		3,315
Policyholder Account Balance	7,032		7,032		3,315
Up to .50% Above GMIR | Up to 1.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			2,967
Policyholder Account Balance, Ending Balance	6,577		6,577		2,967
Policyholder Account Balance	6,577		6,577		2,967
Up to .50% Above GMIR | 1.01% - 2.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			52
Policyholder Account Balance, Ending Balance	142		142		52
Policyholder Account Balance	142		142		52
Up to .50% Above GMIR | 2.01% - 3.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			56
Policyholder Account Balance, Ending Balance	75		75		56
Policyholder Account Balance	75		75		56
Up to .50% Above GMIR | 3.01% - 4.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			153
Policyholder Account Balance, Ending Balance	153		153		153
Policyholder Account Balance	153		153		153
Up to .50% Above GMIR | 4.01% and Above
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			87
Policyholder Account Balance, Ending Balance	85		85		87
Policyholder Account Balance	85		85		87
Up to .50% Above GMIR | Renewable beyond 12 months (MYGA)
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			0
Policyholder Account Balance, Ending Balance	0		0		0
Policyholder Account Balance	0		0		0
0.51% - 1.00% Above GMIR
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			1,988
Policyholder Account Balance, Ending Balance	2,824		2,824		1,988
Policyholder Account Balance	2,824		2,824		1,988
0.51% - 1.00% Above GMIR | Up to 1.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			1,907
Policyholder Account Balance, Ending Balance	2,721		2,721		1,907
Policyholder Account Balance	2,721		2,721		1,907
0.51% - 1.00% Above GMIR | 1.01% - 2.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			35
Policyholder Account Balance, Ending Balance	52		52		35
Policyholder Account Balance	52		52		35
0.51% - 1.00% Above GMIR | 2.01% - 3.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			46
Policyholder Account Balance, Ending Balance	51		51		46
Policyholder Account Balance	51		51		46
0.51% - 1.00% Above GMIR | 3.01% - 4.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			0
Policyholder Account Balance, Ending Balance	1		1		0
Policyholder Account Balance	1		1		0
0.51% - 1.00% Above GMIR | 4.01% and Above
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			0
Policyholder Account Balance, Ending Balance	0		0		0
Policyholder Account Balance	0		0		0
0.51% - 1.00% Above GMIR | Renewable beyond 12 months (MYGA)
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			0
Policyholder Account Balance, Ending Balance	0		0		0
Policyholder Account Balance	0		0		0
1.01% - 1.50% Above GMIR
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			1,224
Policyholder Account Balance, Ending Balance	1,990		1,990		1,224
Policyholder Account Balance	1,990		1,990		1,224
1.01% - 1.50% Above GMIR | Up to 1.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			1,112
Policyholder Account Balance, Ending Balance	1,872		1,872		1,112
Policyholder Account Balance	1,872		1,872		1,112
1.01% - 1.50% Above GMIR | 1.01% - 2.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			2
Policyholder Account Balance, Ending Balance	4		4		2
Policyholder Account Balance	4		4		2
1.01% - 1.50% Above GMIR | 2.01% - 3.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			110
Policyholder Account Balance, Ending Balance	112		112		110
Policyholder Account Balance	112		112		110
1.01% - 1.50% Above GMIR | 3.01% - 4.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			0
Policyholder Account Balance, Ending Balance	2		2		0
Policyholder Account Balance	2		2		0
1.01% - 1.50% Above GMIR | 4.01% and Above
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			0
Policyholder Account Balance, Ending Balance	0		0		0
Policyholder Account Balance	0		0		0
1.01% - 1.50% Above GMIR | Renewable beyond 12 months (MYGA)
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			0
Policyholder Account Balance, Ending Balance	0		0		0
Policyholder Account Balance	0		0		0
1.51% - 2.00% Above GMIR
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			1,467
Policyholder Account Balance, Ending Balance	836		836		1,467
Policyholder Account Balance	836		836		1,467
1.51% - 2.00% Above GMIR | Up to 1.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			1,462
Policyholder Account Balance, Ending Balance	831		831		1,462
Policyholder Account Balance	831		831		1,462
1.51% - 2.00% Above GMIR | 1.01% - 2.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			2
Policyholder Account Balance, Ending Balance	2		2		2
Policyholder Account Balance	2		2		2
1.51% - 2.00% Above GMIR | 2.01% - 3.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			0
Policyholder Account Balance, Ending Balance	0		0		0
Policyholder Account Balance	0		0		0
1.51% - 2.00% Above GMIR | 3.01% - 4.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			0
Policyholder Account Balance, Ending Balance	0		0		0
Policyholder Account Balance	0		0		0
1.51% - 2.00% Above GMIR | 4.01% and Above
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			0
Policyholder Account Balance, Ending Balance	0		0		0
Policyholder Account Balance	0		0		0
1.51% - 2.00% Above GMIR | Renewable beyond 12 months (MYGA)
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			3
Policyholder Account Balance, Ending Balance	3		3		3
Policyholder Account Balance	3		3		3
More than 2.00% Above GMIR
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			112
Policyholder Account Balance, Ending Balance	751		751		112
Policyholder Account Balance	751		751		112
More than 2.00% Above GMIR | Up to 1.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			102
Policyholder Account Balance, Ending Balance	741		741		102
Policyholder Account Balance	741		741		102
More than 2.00% Above GMIR | 1.01% - 2.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			7
Policyholder Account Balance, Ending Balance	6		6		7
Policyholder Account Balance	6		6		7
More than 2.00% Above GMIR | 2.01% - 3.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			3
Policyholder Account Balance, Ending Balance	3		3		3
Policyholder Account Balance	3		3		3
More than 2.00% Above GMIR | 3.01% - 4.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			0
Policyholder Account Balance, Ending Balance	0		0		0
Policyholder Account Balance	0		0		0
More than 2.00% Above GMIR | 4.01% and Above
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			0
Policyholder Account Balance, Ending Balance	0		0		0
Policyholder Account Balance	0		0		0
More than 2.00% Above GMIR | Renewable beyond 12 months (MYGA)
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			0
Policyholder Account Balance, Ending Balance	0		0		0
Policyholder Account Balance	0		0		0
Employee Benefits, Group
Liability for Future Policy Benefit, Expected Net Premium [Roll Forward]
Beginning Balance			77	93	93
Beginning balance at original discount rate			84	85	85
Effect of change in cash flow assumptions					0	$ (7)
Effect of actual variances from expected experience					12	23
Adjusted balance at January 1					96	101
Interest accrual			1		2
Net premiums collected			(11)		(19)
Ending balance at original discount rate	86		86		84
Effects of changes in discount rate assumptions	(6)		(6)		(7)
Ending Balance	80		80		77
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Beginning Balance			881	1,048	1,048
Beginning balance at original discount rate			913	952	952
Effect of change in cash flow assumptions					4	(43)
Effect of actual variances from expected experience					(2)	(27)
Adjusted balance at January 1					915	882
Issuances			68		139
Interest accrual			12		25
Benefit payments			(64)		(133)
Ending balance at original discount rate	931		931		913
Effects of changes in discount rate assumptions	(34)		(34)		(32)
Ending Balance	897		897		881
Net liability for future policy benefits	816		816		804
Less: Reinsurance recoverable	299		299		283
Net additional liability, after reinsurance recoverable	$ 517		$ 517		$ 521
Weighted average duration (in years) | yr	7		7		7
Interest accretion rate	4%		4%		4.10%
Current discount rate	5.20%		5.20%		5.20%
undiscounted expected gross premiums and future benefit payments [Line Items]
Expected future benefit payments, Undiscounted	$ 1,160		$ 1,160		$ 1,141
Expected future gross premiums, Undiscounted	288		288		286
Expected future benefit payments, Discounted	931		931		913	952
Expected future gross premiums, Discounted	231		231		231
Employee Benefits, Voluntary
Liability for Future Policy Benefit, Expected Net Premium [Roll Forward]
Beginning Balance			97	105	105
Beginning balance at original discount rate			100	92	92
Effect of change in cash flow assumptions					0	0
Effect of actual variances from expected experience					5	20
Adjusted balance at January 1					105	112
Interest accrual			2		4
Net premiums collected			(8)		(16)
Ending balance at original discount rate	99		99		100
Effects of changes in discount rate assumptions	(3)		(3)		(3)
Ending Balance	96		96		97
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Beginning Balance			285	359	359
Beginning balance at original discount rate			294	290	290
Effect of change in cash flow assumptions					(1)	(2)
Effect of actual variances from expected experience					5	11
Adjusted balance at January 1					298	299
Issuances			0		0
Interest accrual			7		14
Benefit payments			(11)		(19)
Ending balance at original discount rate	294		294		294
Effects of changes in discount rate assumptions	(5)		(5)		(9)
Ending Balance	289		289		285
Net liability for future policy benefits	193		193		188
Less: Reinsurance recoverable	0		0		0
Net additional liability, after reinsurance recoverable	$ 193		$ 193		$ 188
Weighted average duration (in years) | yr	14,000,000		14,000,000		14,000,000
Interest accretion rate	5.30%		5.30%		5.30%
Current discount rate	5.20%		5.20%		5.40%
undiscounted expected gross premiums and future benefit payments [Line Items]
Expected future benefit payments, Undiscounted	$ 589		$ 589		$ 588
Expected future gross premiums, Undiscounted	308		308		307
Expected future benefit payments, Discounted	294		294		294	290
Expected future gross premiums, Discounted	205		205		205
business exited
Liability for Future Policy Benefit, Expected Net Premium [Roll Forward]
Beginning Balance			4,244	5,634	5,634
Beginning balance at original discount rate			4,128	4,226	4,226
Effect of change in cash flow assumptions					0	(69)
Effect of actual variances from expected experience					(37)	86
Adjusted balance at January 1					4,091	4,243
Interest accrual			112		230
Net premiums collected			(161)		(345)
Ending balance at original discount rate	4,042		4,042		4,128
Effects of changes in discount rate assumptions	153		153		116
Ending Balance	4,195		4,195		4,244
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Beginning Balance			8,639	11,444	11,444
Beginning balance at original discount rate			8,644	9,079	9,079
Effect of change in cash flow assumptions					0	(77)
Effect of actual variances from expected experience					(41)	(52)
Adjusted balance at January 1					8,603	8,950
Issuances			9		13
Interest accrual			220		458
Benefit payments			(388)		(777)
Ending balance at original discount rate	8,444		8,444		8,644
Effects of changes in discount rate assumptions	51		51		(5)
Ending Balance	8,495		8,495		8,639
Net liability for future policy benefits	4,300		4,300		4,395
Less: Reinsurance recoverable	4,412		4,412		4,411
Net additional liability, after reinsurance recoverable	$ (112)		$ (112)		$ (16)
Weighted average duration (in years) | yr	8,000,000		8,000,000		8,000,000
Interest accretion rate	4.90%		4.90%		5%
Current discount rate	5.40%		5.40%		5.70%
undiscounted expected gross premiums and future benefit payments [Line Items]
Expected future benefit payments, Discounted	$ 8,444		$ 8,444		$ 8,644	9,079
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			5,146	5,532	5,532
Deposits			147		310
Fee income			(188)		(384)
Surrenders and withdrawals			(230)		(281)
Benefit payments			(81)		(144)
Net transfers from (to) separate accounts			(1)		0
Interest credited			73		150
Other			0		(37)
Policyholder Account Balance, Ending Balance	$ 4,866		$ 4,866		$ 5,146
Weighted-average crediting rate	2.50%		2.50%		2.50%
Net amount at risk	$ 792		$ 792		$ 900
Cash surrender value	1,669		1,669		1,824
Policyholder Account Balance	4,866		4,866		5,146	5,532
business exited, additional liability
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Beginning Balance			2,107	1,715	1,715
Effect of change in cash flow assumptions					0	540
Effect of actual variances from expected experience					(58)	15
Adjusted balance at January 1					2,049	2,270
Interest accrual			43		80
Benefit payments			(209)		(427)
Assessments			191		184
Ending Balance					2,107
Net liability for future policy benefits	2,074		2,074		2,107
Less: Reinsurance recoverable	2,021		2,021		2,054
Net additional liability, after reinsurance recoverable	$ 53		$ 53		$ 53
Current discount rate	4.20%		4.20%		4.30%
Other Segments
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Net liability for future policy benefits	$ 2,270		$ 2,270		$ 2,225
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			3,687
Policyholder Account Balance, Ending Balance	3,588		3,588		3,687
Policyholder Account Balance	3,588		3,588		3,687
Wealth Solutions
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			33,622	$ 33,044	33,044
Deposits			1,171		2,962
Fee income			(4)		(8)
Surrenders and withdrawals			(2,740)		(4,280)
Benefit payments			(88)		(157)
Net transfers from (to) separate accounts			70		1,174
Interest credited			440		874
Other			5		13
Policyholder Account Balance, Ending Balance	$ 32,476		$ 32,476		$ 33,622
Weighted-average crediting rate	2.70%		2.70%		2.60%
Net amount at risk	$ 135		$ 135		$ 199
Cash surrender value	31,995		31,995		33,125
Policyholder Account Balance	$ 32,476		$ 32,476		$ 33,622	$ 33,044

Reinsurance - Assets and Liabil

Reinsurance - Assets and Liabilities (Details) - USD ($) $ in Millions	Jun. 30, 2023	Dec. 31, 2022
Assets
Premiums receivable, direct	$ 172	$ 172
Premiums Receivable, assumed	10	11
Premiums receivable, ceded	(220)	(212)
Premiums Receivable, net	(38)	(29)
Reinsurance recoverable, net of allowance for credit losses, ceded	12,169	12,455
Reinsurance recoverable, net of allowance for credit losses, net	12,169	12,455
Total assets, direct	172	172
Total assets, assumed	10	11
Total assets, ceded	11,949	12,243
Total assets, net	12,131	12,426
Liabilities
Future policy benefits and contract owner account balances, direct	49,574	51,137
Future policy benefits and contract owner account balances, assumed	1,009	1,037
Future policy benefits and contract owner account balances, net	50,583	52,174
Liability for funds withheld under reinsurance agreements, direct	105	104
Liability for funds withheld under reinsurance agreements, net	105	104
Total liabilities, direct	49,679	51,241
Total liabilities, assumed	1,009	1,037
Total liabilities, net	$ 50,688	$ 52,278

Reinsurance - Effect of Reinusa

Reinsurance - Effect of Reinusance (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Premiums Earned, Net [Abstract]
Direct Premiums Earned	$ 902	$ 816	$ 1,810	$ 1,624
Assumed Premiums Earned	5	5	15	14
Ceded Premiums Earned	230	224	463	433
Premiums	677	597	1,362	1,205
Policyholder Benefits and Claims Incurred, Net [Abstract]
Revenue from Contract with Customer, Including Assessed Tax	571	513	1,133	1,045
Assumed Insurance Commissions and Fees	5	4	9	9
Ceded Insurance Commissions And Fees	102	104	204	208
Fee income	474	413	938	846
Policyholder Benefits and Claims Incurred, Assumed and Ceded [Abstract]
Policyholder Benefits and Claims Incurred, Direct	1,014	1,104	2,122	2,080
Policyholder Benefits and Claims Incurred, Assumed	11	14	30	22
Policyholder Benefits and Claims Incurred, Ceded	343	464	719	804
Policyholder Interest and Other Benefits, Net	682	$ 654	1,433	$ 1,298
Deposit asset	$ 1,400		$ 1,400		$ 1,500

Separate Accounts (Details)

Separate Accounts (Details) - USD ($) $ in Millions	3 Months Ended	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets held in separate accounts	$ 88,851	$ 88,851	$ 80,174
Liabilities related to separate accounts	88,851	88,851	80,174
Wealth Solutions Stabilizer
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Separate Account, Liability, Policyholder Behavior		(119)
Wealth Solutions
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Liabilities related to separate accounts	84,793	84,793	76,348	$ 95,018
Separate Account, Liability, Policyholder Behavior		203	(1,377)
Separate Account, Liability, Policy Charge		(223)	(457)
Separate Account, Liability, Increase (Decrease) from Invested Performance		8,465	(16,838)
Separate Account, Liability, Increase (Decrease) from Other Change		0	2
Separate Account, Liability, Cash Surrender Value, Amount	77,548	77,548	69,121
Wealth Solutions | Wealth Solutions Stabilizer
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Liabilities related to separate accounts	7,211	7,211	7,196	8,091
Separate Account, Liability, Policyholder Behavior			(68)
Separate Account, Liability, Policy Charge		(17)	(34)
Separate Account, Liability, Increase (Decrease) from Invested Performance		151	(794)
Separate Account, Liability, Increase (Decrease) from Other Change	0		1
Wealth Solutions | Deferred Variable Annuity
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Liabilities related to separate accounts	77,582	77,582	69,152	$ 86,927
Separate Account, Liability, Policyholder Behavior		322	(1,309)
Separate Account, Liability, Policy Charge		(206)	(423)
Separate Account, Liability, Increase (Decrease) from Invested Performance		8,314	(16,044)
Separate Account, Liability, Increase (Decrease) from Other Change	0		1
Other Segments
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Liabilities related to separate accounts	4,058	4,058	3,826
U.S. Government agencies and authorities
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets held in separate accounts	1,157	1,157	1,586
Corporate Debt Securities
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets held in separate accounts	1,791	1,791	1,647
Separate Account, Cash and Cash Equivalents
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets held in separate accounts	454	454	311
Separate Account, Debt Security
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets held in separate accounts	706	706	660
Separate Account, Mortgage-Backed Security
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets held in separate accounts	3,274	3,274
Separate Account, Mortgage-Backed Security | Mortgage-Backed Securities, Issued by Private Enterprises
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets held in separate accounts			3,434
Separate Account, Equity Security
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets held in separate accounts	81,063	81,063	72,309
Asset-Backed Securities, Securitized Loans and Receivables
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets held in separate accounts	$ 406	$ 406	$ 227

Share-based Incentive Compens_3

Share-based Incentive Compensation Plans - Narrative (Details)	Jun. 30, 2023 shares
2019 Omnibus Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for grant (in shares)	8,881,340

Share-based Incentive Compens_4

Share-based Incentive Compensation Plans - Compensation Cost (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost	$ 26	$ 15	$ 89	$ 61
Income tax benefit	7	3	22	18
After-tax share-based compensation expense	19	12	67	43
Restricted Stock Unit (RSU) awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost	16	8	53	30
Performance Stock Unit (PSU) awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost	$ 10	$ 7	$ 36	$ 31

Share-based Incentive Compens_5

Share-based Incentive Compensation Plans - Awards Outstanding (Details)	6 Months Ended
	Jun. 30, 2023 $ / shares shares
RSU awards
Number of Awards
Outstanding, beginning balance (in shares) | shares	1,500,000
Adjustment for PSU performance factor (in shares) | shares	0
Granted (in shares) | shares	1,700,000
Vested (in shares) | shares	(1,000,000)
Forfeited (in shares) | shares	0
Outstanding, ending balance (in shares) | shares	2,200,000
Weighted Average Grant Date Fair Value
Outstanding, beginning balance (usd per share) | $ / shares	$ 60.91
Adjustment for PSU performance factor (usd per share) | $ / shares	0
Granted (usd per share) | $ / shares	70.49
Vested (usd per share) | $ / shares	63.18
Forfeited (usd per share) | $ / shares	64.54
Outstanding, ending balance (usd per share) | $ / shares	$ 67.06
PSU awards
Number of Awards
Outstanding, beginning balance (in shares) | shares	2,100,000
Adjustment for PSU performance factor (in shares) | shares	(100,000)
Granted (in shares) | shares	800,000
Vested (in shares) | shares	(500,000)
Forfeited (in shares) | shares	0
Outstanding, ending balance (in shares) | shares	2,300,000
Weighted Average Grant Date Fair Value
Outstanding, beginning balance (usd per share) | $ / shares	$ 55.68
Adjustment for PSU performance factor (usd per share) | $ / shares	61.50
Granted (usd per share) | $ / shares	66.10
Vested (usd per share) | $ / shares	63.08
Forfeited (usd per share) | $ / shares	63.48
Outstanding, ending balance (usd per share) | $ / shares	$ 61.27
Stock options
Number of Awards
Outstanding, beginning balance (in shares) | shares	1,600,000
Granted (in shares) | shares	0
Exercised (in shares) | shares	(400,000)
Forfeited (in shares) | shares	0
Outstanding, ending balance (in shares) | shares	1,200,000
Vested, exercisable (in shares) | shares	1,200,000
Weighted Average Exercise Price
Outstanding, beginning balance (usd per share) | $ / shares	$ 43.05
Granted (usd per share) | $ / shares	0
Exercised (usd per share) | $ / shares	38.11
Forfeited (usd per share) | $ / shares	0
Outstanding, ending balance (usd per share) | $ / shares	44.55
Vested, exercisable, weighted average exercise price (usd per share) | $ / shares	$ 44.55

Shareholders' Equity - Common S

Shareholders' Equity - Common Stock Rollforward (Details) - shares	6 Months Ended	9 Months Ended
	Jun. 30, 2023	Sep. 30, 2022
Increase (Decrease) in Stockholders' Equity
Common stock, shares issued, beginning balance (in shares)	97,789,852
Common shares, held in treasury, beginning balance (in shares)	602,882
Common shares, beginning balance (in shares)	97,186,970
Common stock acquired - share repurchase (in shares)	2,300,000	11,700,000
Share-based compensation programs (in shares)	1,200,000	1,000,000
Treasury Stock retirement (in shares)		0
Common stock, shares issued, ending balance (in shares)	109,286,448
Common shares, held in treasury, ending balance (in shares)	3,566,145
Common shares, ending balance (in shares)	105,720,303
Common Stock
Increase (Decrease) in Stockholders' Equity
Common stock, shares issued, beginning balance (in shares)	97,800,000	109,000,000
Common shares, beginning balance (in shares)	97,200,000	107,800,000
Common shares issued (in shares)	9,600,000	100,000
Common stock acquired - share repurchase (in shares)	0	0
Share-based compensation programs (in shares)	1,900,000	1,700,000
Treasury Stock retirement (in shares)		(13,000,000)
Common stock, shares issued, ending balance (in shares)	109,300,000
Treasury Stock, Common
Increase (Decrease) in Stockholders' Equity
Common shares, held in treasury, beginning balance (in shares)	(600,000)	(1,200,000)
Common shares issued (in shares)	0	0
Common stock acquired - share repurchase (in shares)	2,300,000	11,700,000
Share-based compensation programs (in shares)	700,000	700,000
Treasury Stock retirement (in shares)		(13,000,000)
Common shares, held in treasury, ending balance (in shares)	3,600,000

Shareholders' Equity - Common_2

Shareholders' Equity - Common stock Dividends Declared (Details) - $ / shares	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Equity [Abstract]
Dividends declared per share of Common Stock (usd per share)	$ 0.200	$ 0.200	$ 0.400	$ 0.400

Shareholders' Equity - Narrativ

Shareholders' Equity - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions		3 Months Ended		6 Months Ended
	Jul. 27, 2023	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	May 10, 2023	Dec. 31, 2022	May 07, 2013
Equity [Abstract]
Preferred Stock, shares authorized (in shares)		100,000,000		100,000,000			100,000,000
Preferred Stock, amount of preferred dividends in arrears				$ 0
Number of warrants issued and outstanding (in shares)		0		0				26,050,846
Class of Warrant or Right, Number of Securities Called by Warrants or Rights						9,600,000
Warrants issued allowing purchase of shares, percentage of common stock issued and outstanding								9.99%
Class of Stock [Line Items]
Dividends declared per share of Common Stock (usd per share)		$ 0.200	$ 0.200	$ 0.400	$ 0.400
Stock Repurchase Program, Remaining Authorized Repurchase Amount		$ 109		$ 109
Subsequent Event
Class of Stock [Line Items]
Dividends declared per share of Common Stock (usd per share)	$ 0.40
Amount authorized for repurchase	$ 500
Stock Repurchase Program, Remaining Authorized Repurchase Amount	$ 609

Shareholders' Equity - Summary

Shareholders' Equity - Summary of Share Repurchases (Details) - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended		9 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Sep. 30, 2022
Equity [Abstract]
Payment for share repurchases	$ 162	$ 250	$ 162	$ 750
Common stock acquired - share repurchase (in shares)			2.3		11.7

Shareholders' Equity - Preferre

Shareholders' Equity - Preferred Stock (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Class of Stock [Line Items]
Aggregate (in shares)	$ 4	$ 4	$ 18	$ 18
Preferred Stock
Class of Stock [Line Items]
Preferred Stock, shares issued (in shares)	625,000		625,000		625,000
Preferred Stock, shares outstanding (in shares)	625,000		625,000		625,000
Series A Preferred Stock
Class of Stock [Line Items]
Dividend rate, percentage			0.06125%
Preferred Stock, shares issued (in shares)	325,000		325,000		325,000
Preferred Stock, shares outstanding (in shares)	325,000		325,000		325,000
Per Share (usd per share)	$ 0	$ 0	$ 30.625	$ 30.625
Aggregate (in shares)	$ 0	$ 0	$ 10	$ 10
Series B Preferred Stock
Class of Stock [Line Items]
Dividend rate, percentage			0.0535%
Preferred Stock, shares issued (in shares)	300,000		300,000		300,000
Preferred Stock, shares outstanding (in shares)	300,000		300,000		300,000
Per Share (usd per share)	$ 13.375	$ 13.375	$ 26.750	$ 26.750
Aggregate (in shares)	$ 4	$ 4	$ 8	$ 8

Earnings per Common Share (Deta

Earnings per Common Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Net income (loss) available to common shareholders:
Income (loss) from continuing operations	$ 235	$ 143	$ 364	$ 254
Less: Preferred stock dividends	4	4	18	18
Less: Net income (loss) attributable to noncontrolling interest	77	75	123	118
Net income (loss) available to common shareholders	$ 154	$ 64	$ 223	$ 118
Weighted average common shares outstanding
Basic (in shares)	103	101.7	100.4	103.9
Dilutive Effects:
Diluted (in shares)	109.8	110.8	109.7	113.9
Net income (loss) available to Voya Financial, Inc.'s common shareholders per common share:
Basic (usd per share)	$ 1.50	$ 0.62	$ 2.22	$ 1.13
Diluted (usd per share)	$ 1.41	$ 0.57	$ 2.03	$ 1.03
Warrant
Dilutive Effects:
Dilutive Effects (in shares)	4	7.1	6.5	7.7
RSU awards
Dilutive Effects:
Dilutive Effects (in shares)	1.1	0.8	1.1	0.9
PSU awards
Dilutive Effects:
Dilutive Effects (in shares)	1.2	0.6	1.2	0.8
Stock options
Dilutive Effects:
Dilutive Effects (in shares)	0.5	0.6	0.5	0.6

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Income (Loss) - Components of AOCI (Details) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2023	Dec. 31, 2022	Jun. 30, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]
Fixed maturities, net of impairment	$ (2,963)		$ (1,926)
DAC/VOBA adjustment on available-for-sale securities	98		129
AOCI, Liability for Future Policy Benefit, before Tax	(827)		(951)
Deferred income tax asset (liability)	898		700
Total	(2,794)		(2,048)
Pension and other postretirement benefits liability, net of tax	3		3
AOCI	(2,791)	$ (3,055)	$ (2,045)
Other Contract
Accumulated Other Comprehensive Income (Loss) [Line Items]
Portion of AOCI expected to be reclassified into earnings within next 12 months	$ 17

Accumulated Other Comprehensi_4

Accumulated Other Comprehensive Income (Loss) - Changes in AOCI, including Reclassification Adjustments (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Available-for-sale securities, Before-Tax Amount:
Fixed maturities	$ (343)	$ (2,548)	$ 318	$ (5,211)
Adjustments for amounts recognized in Net realized capital gains (losses) in the Condensed Consolidated Statements of Operations	15	20	14	90
Change in unrealized gains/losses on available-for-sale securities	(328)	(2,528)	332	(5,121)
Available-for-sale securities, Income Tax:
Fixed maturities	72	535	(67)	1,094
Adjustments for amounts recognized in Net realized capital gains (losses) in the Condensed Consolidated Statements of Operations	(3)	(4)	(3)	(19)
Change in unrealized gains/losses on available-for-sale securities	69	531	(70)	1,075
Available-for-sale securities, After-Tax Amount:
Fixed maturities	(271)	(2,013)	251	(4,117)
Adjustments for amounts recognized in Net realized capital gains (losses) in the Condensed Consolidated Statements of Operations	12	16	11	71
Change in unrealized gains/losses on available-for-sale securities	(259)	(1,997)	262	(4,046)
Derivatives, Before-Tax Amount:
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax	(6)	54	(18)	59
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax	(5)	(5)	(10)	(10)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax, Total	(11)	49	(28)	49
Derivatives, Income Tax:
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax	1	(11)	4	(12)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax	1	1	2	2
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax, Total	(2)	10	(6)	10
Derivatives, After-Tax Amount:
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax	(5)	43	(14)	47
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax	(4)	(4)	(8)	(8)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Total	(9)	39	(22)	39
AOCI, Liability for Future Policy Benefit, Expected Future Policy Benefit, before Tax	28	92	30	196
AOCI, Liability for Future Policy Benefit, Expected Future Policy Benefit, before Tax	(6)	(19)	(6)	(41)
OCI, Liability for Future Policy Benefit, Gain (Loss), after Reclassification Adjustment and Tax	22	73	24	155
Other Comprehensive Income (Loss), before Tax, Total	(311)	(2,387)	334	(4,876)
Other comprehensive income (loss), tax	65	502	(70)	1,024
Other Comprehensive Income (Loss), Net of Tax, Total	$ (246)	$ (1,885)	$ 264	$ (3,852)

Revenue from Contracts with C_2

Revenue from Contracts with Customers (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Mar. 31, 2023	Dec. 31, 2022
Disaggregation of Revenue [Line Items]
Total financial services and software subscriptions and services revenue	$ 481,000,000	$ 377,000,000	$ 971,000,000	$ 780,000,000
Revenue from other sources	79,000,000	80,000,000	131,000,000	150,000,000
Total fee income and other revenue	560,000,000	457,000,000	$ 1,102,000,000	930,000,000
Financial Service
Disaggregation of Revenue [Line Items]
Contract term			1 year
Software Subscription and Service | Minimum
Disaggregation of Revenue [Line Items]
Contract term			1 year
Software Subscription and Service | Maximum
Disaggregation of Revenue [Line Items]
Contract term			3 years
Wealth Solutions
Disaggregation of Revenue [Line Items]
Total financial services and software subscriptions and services revenue	124,000,000	127,000,000	$ 244,000,000	260,000,000
Wealth Solutions | DistributionFeesMember [Member]
Disaggregation of Revenue [Line Items]
Total financial services and software subscriptions and services revenue	30,000,000	31,000,000	59,000,000	64,000,000
Investment Management
Disaggregation of Revenue [Line Items]
Total financial services and software subscriptions and services revenue	232,000,000	159,000,000	462,000,000	329,000,000
Investment Management | DistributionFeesMember [Member]
Disaggregation of Revenue [Line Items]
Total financial services and software subscriptions and services revenue	32,000,000	38,000,000	64,000,000	80,000,000
Health Solutions
Disaggregation of Revenue [Line Items]
Total financial services and software subscriptions and services revenue	4,000,000	5,000,000	11,000,000	9,000,000
Benefitfocus
Disaggregation of Revenue [Line Items]
Total financial services and software subscriptions and services revenue	54,000,000	0	114,000,000	0
Corporate
Disaggregation of Revenue [Line Items]
Total financial services and software subscriptions and services revenue	$ 5,000,000	$ 17,000,000	$ 17,000,000	$ 38,000,000
Accounting Standards Update 2014-09 [Member]
Disaggregation of Revenue [Line Items]
Net receivables					$ 357,000,000	$ 299

Income Taxes (Details)

Income Taxes (Details)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Income Tax Disclosure [Abstract]
Effective tax rate	10.60%	5.90%	9.90%	7.30%

Financing Agreements - Schedule

Financing Agreements - Schedule of Long-term Debt (Details) - USD ($) $ in Millions	3 Months Ended
	Jun. 30, 2023	Dec. 31, 2022	Mar. 17, 2015	May 16, 2013
Debt Instrument [Line Items]
Long-term debt	$ 2,238	$ 2,235
Less: Current portion of long-term debt	143	141
Total long-term debt, excluding current portion	$ 2,095	2,094
7.25% Voya Holdings Inc. debentures, due 2023 | Debentures
Debt Instrument [Line Items]
Annual interest rate on debt	7.25%
One Point Two Five Percent Convertible Senior Notes, due 2023 | Senior Notes
Debt Instrument [Line Items]
Annual interest rate on debt	1.25%
Senior Notes
Debt Instrument [Line Items]
Annual interest rate on debt			1.875%
Senior Notes | 3.976% Senior Notes, Due 2025
Debt Instrument [Line Items]
Long-term debt	$ 389	0
Annual interest rate on debt	3.976%
Senior Notes | 3.65% Senior Notes, due 2026
Debt Instrument [Line Items]
Long-term debt	$ 445	445
Annual interest rate on debt	3.65%
Senior Notes | 5.7% Senior Notes, due 2043
Debt Instrument [Line Items]
Long-term debt	$ 396	396
Annual interest rate on debt	5.70%
Senior Notes | 4.8% Senior Notes, due 2046
Debt Instrument [Line Items]
Long-term debt	$ 297	297
Annual interest rate on debt	4.80%
Senior Notes | One Point Two Five Percent Convertible Senior Notes, due 2023
Debt Instrument [Line Items]
Long-term debt	$ 2	0
Junior Subordinated Notes | 4.7% Fixed-to-Floating Rate Junior Subordinated Notes, due 2048(1)
Debt Instrument [Line Items]
Long-term debt	$ 336	336
Annual interest rate on debt	4.70%
Junior Subordinated Notes | 5.65% Fixed-to-Floating Rate Junior Subordinated Notes, due 2053
Debt Instrument [Line Items]
Long-term debt	$ 0	388
Annual interest rate on debt	5.65%			5.65%
Debt Instrument, Face Amount	$ 393
Debentures | 7.25% Voya Holdings Inc. debentures, due 2023
Debt Instrument [Line Items]
Long-term debt	140	140
Debentures | 7.63% Voya Holdings Inc. debentures, due 2026
Debt Instrument [Line Items]
Long-term debt	$ 139	139
Annual interest rate on debt	7.63%
Debentures | 6.97% Voya Holdings Inc. debentures, due 2036
Debt Instrument [Line Items]
Long-term debt	$ 79	79
Annual interest rate on debt	6.97%
Notes payable, other | 8.42% Equitable of Iowa Companies Capital Trust II Notes, due 2027
Debt Instrument [Line Items]
Long-term debt	$ 13	13
Annual interest rate on debt	8.42%
Loans payable | 1.00% Windsor Property Loan
Debt Instrument [Line Items]
Long-term debt	$ 2	$ 2
Annual interest rate on debt	1%
Debt Securities | Interest Expense
Debt Instrument [Line Items]
Income (loss) related to early extinguishment of debt	$ (5)

Financing Agreements - Narrativ

Financing Agreements - Narrative (Details) - USD ($) $ in Millions		6 Months Ended
	Mar. 17, 2015	Jun. 30, 2023	May 03, 2023	May 01, 2023	Dec. 31, 2022	May 16, 2013
Debt Instrument [Line Items]
Outstanding par amount of guaranteed debentures		$ 2,238			$ 2,235
Maximum borrowing capacity		700
Line of Credit		163
Business Agreement, Processing and Operation Services Period	10 years
Put Option Agreement, Face Amount	$ 500
Line of Credit Facility, Remaining Borrowing Capacity		537
Payments of Financing Costs		0
Aetna Notes
Debt Instrument [Line Items]
Amount of letters of credit outstanding		163
Revolving Credit agreement
Debt Instrument [Line Items]
Maximum borrowing capacity		500
Minimum net worth required for compliance				$ 4,998
Unsecured and Committed [Member] | Voya Financial, Inc.
Debt Instrument [Line Items]
Maximum borrowing capacity		500
Line of Credit		0
Line of Credit Facility, Remaining Borrowing Capacity		500
Unsecured and Committed [Member] | Voya Financial, Inc. Three
Debt Instrument [Line Items]
Maximum borrowing capacity		200
Line of Credit		163
Line of Credit Facility, Remaining Borrowing Capacity		37
Voya Holdings Debentures | Aetna Notes
Debt Instrument [Line Items]
Amount of collateral for credit facility		372
Amount of collateral deposited to a control account		209
Short-term Debt | Revolving Credit agreement
Debt Instrument [Line Items]
Maximum borrowing capacity				25
Revolving Credit agreement
Debt Instrument [Line Items]
Line of Credit		0
Debentures | Voya Holdings Debentures
Debt Instrument [Line Items]
Outstanding par amount of guaranteed debentures		358
Revolving Credit agreement
Debt Instrument [Line Items]
Amount of letters of credit outstanding		0
Line of Credit		0
Senior Notes
Debt Instrument [Line Items]
Annual interest rate on debt	1.875%
Senior Notes | Pre-Capitalized Trust
Debt Instrument [Line Items]
Annual interest rate on debt	3.976%
Debt Instrument, Face Amount			$ 400	$ 400
Junior Subordinated Notes | 5.65% Fixed-to-Floating Rate Junior Subordinated Notes, due 2053
Debt Instrument [Line Items]
Outstanding par amount of guaranteed debentures		$ 0			$ 388
Annual interest rate on debt		5.65%				5.65%
Debt Instrument, Face Amount		$ 393

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) - USD ($) $ in Millions	3 Months Ended	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Loss Contingencies [Line Items]
Possible losses in excess of amounts accrued	$ 25	$ 25
Potential future loss	131	131
Pledged Collateral	1,851	1,851		$ 1,791
Impairment of right-of-use asset	12	14	$ 3
Liability for Unpaid Claims and Claims Adjustment Expense, Net	47	47
Payments for Legal Settlements		$ 39
Policy period		7 years
Securities Loaned
Loss Contingencies [Line Items]
Securities Owned and Pledged as Collateral	175	$ 175		142
Federal Home Loan Bank | Line of Credit
Loss Contingencies [Line Items]
Non-putable funding agreements issued to FHLB	1,290	1,290		1,279
Pledged Collateral	$ 1,851	1,851		$ 1,791
Acquisition of mortgage loans
Loss Contingencies [Line Items]
Amount of purchase commitments		145
Purchase of limited partnership and private placement investments
Loss Contingencies [Line Items]
Amount of purchase commitments		1,005
Purchase of limited partnership and private placement investments | VOEs
Loss Contingencies [Line Items]
Amount of purchase commitments		$ 352

Commitments and Contingencies_2

Commitments and Contingencies - Restricted Assets (Details) - USD ($) $ in Millions	Jun. 30, 2023	Dec. 31, 2022
Loss Contingencies [Line Items]
Fixed maturity collateral pledged to FHLB	$ 1,851	$ 1,791
FHLB restricted stock	68	67
Other fixed maturities-state deposits	39	38
Cash and cash equivalents	33	27
Total restricted assets	3,139	3,085
Collateral Pledged
Loss Contingencies [Line Items]
Securities pledged	1,148	1,162
Securities pledged as collateral
Loss Contingencies [Line Items]
Fair value of loaned securities	857	907
Securities pledged under repurchase agreements, carrying value	$ 116	$ 113

Consolidated and Nonconsolida_3

Consolidated and Nonconsolidated Investment Entities - General and Consolidated VIEs and VOEs and Nonconsolidated VIEs (Details) $ in Millions	6 Months Ended
	Jun. 30, 2023 USD ($) CLO fund	Dec. 31, 2022 USD ($)
Variable Interest Entity [Line Items]
Consolidated collateral loan obligations | CLO	7
Limited Partnerships life	10 years
Consolidated funds | fund	10
Noncontrolling interest	$ 1,660	$ 1,482
Consolidated Investment Entities
Variable Interest Entity [Line Items]
Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount	$ 346	$ 288

Consolidated and Nonconsolida_4

Consolidated and Nonconsolidated Investment Entities - Components of the Consolidated Investment Entities (Details) - USD ($) $ in Millions	Jun. 30, 2023	Dec. 31, 2022
Assets of Consolidated Investment Entities
Assets	$ 154,616	$ 146,606
Liabilities and Shareholders' Equity of Consolidated Investment Entities
Liabilities	149,088	141,609
Noncontrolling interest	1,660	1,482
Total liabilities, mezzanine equity and shareholders' equity	$ 154,616	$ 146,606

Consolidated and Nonconsolida_5

Consolidated and Nonconsolidated Investment Entities - Fair Value Measurement (Details) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Variable Interest Entity [Line Items]
Revolving lines of credit capacity	$ 700
Outstanding borrowings	163
VOEs | Private Equity Funds
Variable Interest Entity [Line Items]
Revolving lines of credit capacity	$ 1,354	$ 1,366
Renewal period for term loan	3 years
Outstanding borrowings	$ 1,295	1,143
VOEs | Minimum | Private Equity Funds
Variable Interest Entity [Line Items]
Basis spread on notes	1.55%
Term of debt	18 months
VOEs | Maximum | Private Equity Funds
Variable Interest Entity [Line Items]
Basis spread on notes	2%
Term of debt	12 months
VOEs | LIBOR | Private Equity Funds
Variable Interest Entity [Line Items]
Description of variable rate basis	LIBOR
VOEs | EURIBOR | Private Equity Funds
Variable Interest Entity [Line Items]
Description of variable rate basis	EURIBOR
Senior secured corporate loans | VIEs
Variable Interest Entity [Line Items]
Unpaid principal exceeds fair value, amount	$ 72	$ 85
Default of collateral assets, percentage	1%
Weighted average maturity	12 years
Senior secured corporate loans | VIEs | Maximum
Variable Interest Entity [Line Items]
Basis spread on loans	8.50%
Senior secured corporate loans | VIEs | LIBOR
Variable Interest Entity [Line Items]
Description of variable rate basis	LIBOR
Senior secured corporate loans | VIEs | LIBOR | Minimum
Variable Interest Entity [Line Items]
Basis spread on notes	1%
Senior secured corporate loans | VIEs | LIBOR | Maximum
Variable Interest Entity [Line Items]
Basis spread on notes	9.60%
Senior secured corporate loans | VIEs | EURIBOR
Variable Interest Entity [Line Items]
Description of variable rate basis	EURIBOR
Senior secured corporate loans | VIEs | PRIME
Variable Interest Entity [Line Items]
Description of variable rate basis	PRIME
Senior secured corporate loans | VIEs | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Variable Interest Entity [Line Items]
Description of variable rate basis	SOFR

Consolidated and Nonconsolida_6

Consolidated and Nonconsolidated Investment Entities - Fair Value Hierarchy (Details) - Measured at fair value on a recurring basis - USD ($) $ in Millions	Jun. 30, 2023	Dec. 31, 2022
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets, Net Asset Value (NAV)	$ 3,120	$ 2,802
Assets, Including NAV	4,706	4,183
Liabilities	1,331	1,234
VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets, Net Asset Value (NAV)	0	0
Cash and cash equivalents | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	154	88
Assets, Net Asset Value (NAV)	0	0
Corporate loans | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	1,407	1,293
Assets, Net Asset Value (NAV)	0	0
Corporate loans | Consolidated Entity, Excluding Consolidated VIE
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	25
Assets, Net Asset Value (NAV)	0
Limited partnerships/corporations | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets, Net Asset Value (NAV)	3,120	2,802
Assets, Including NAV	3,120	2,802
CLO notes | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets, Net Asset Value (NAV)	0	0
Liabilities	1,331	1,234
Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	154	88
Liabilities	0	0
Level 1 | Cash and cash equivalents | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	154	88
Level 1 | Corporate loans | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0	0
Level 1 | Corporate loans | Consolidated Entity, Excluding Consolidated VIE
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0
Level 1 | Limited partnerships/corporations | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0	0
Level 1 | CLO notes | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	0	0
Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	1,432	1,293
Liabilities	1,331	1,234
Level 2 | Cash and cash equivalents | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0	0
Level 2 | Corporate loans | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	1,407	1,293
Level 2 | Corporate loans | Consolidated Entity, Excluding Consolidated VIE
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	25
Level 2 | Limited partnerships/corporations | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0	0
Level 2 | CLO notes | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	1,331	1,234
Level 3
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0	0
Liabilities	0	0
Level 3 | Cash and cash equivalents | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0	0
Level 3 | Corporate loans | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0	0
Level 3 | Corporate loans | Consolidated Entity, Excluding Consolidated VIE
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0
Level 3 | Limited partnerships/corporations | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0	0
Level 3 | CLO notes | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	$ 0	$ 0

Consolidated and Nonconsolida_7

Consolidated and Nonconsolidated Investment Entities - Deconsolidation and Nonconsolidated VIEs (Details) $ in Millions	6 Months Ended
	Jun. 30, 2023 USD ($) loan	Jun. 30, 2022 loan	Dec. 31, 2022 USD ($)
Variable Interest Entity [Line Items]
Number of deconsolidated investment entities | loan	1	0
Total assets	$ 154,616		$ 146,606
VIEs, Not Primary Beneficiary
Variable Interest Entity [Line Items]
Amount of ownership interest in unconsolidated CLOs	$ 371		$ 364

Goodwill and Other Intangible_2

Goodwill and Other Intangible Assets - Goodwill (Details) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Goodwill [Roll Forward]
Goodwill, Beginning Balance	$ 327	$ 72
Additions from business combinations	319	255
Goodwill, Ending Balance	646
Wealth
Goodwill [Roll Forward]
Goodwill, Beginning Balance	17	17
Additions from business combinations	0	0
Goodwill, Ending Balance	17
Health Solutions
Goodwill [Roll Forward]
Goodwill, Beginning Balance	24	24
Additions from business combinations	319	0
Goodwill, Ending Balance	343
Investment Management
Goodwill [Roll Forward]
Goodwill, Beginning Balance	286	31
Additions from business combinations	0	$ 255
Goodwill, Ending Balance	$ 286

Goodwill and Other Intangible_3

Goodwill and Other Intangible Assets - Other Intangible Assets (Details) - USD ($) $ in Millions	3 Months Ended	6 Months Ended		12 Months Ended
	Jun. 30, 2023	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Indefinite-life intangibles, Gross Carrying Amount		$ 350		$ 350
Finite-life intangibles, Gross Carrying Amount	$ 1,363	1,363		1,728
Finite-life intangibles, Accumulated Amortization	455	455		1,097
Finite-life intangibles, Net Carrying Amount	$ 908	908		631
Amortization of intangible assets		$ 42	$ 22
Contractual Rights
Finite-Lived Intangible Assets [Line Items]
Finite-life intangibles, Weighted Average Amortization Lives	17 years	17 years
Finite-life intangibles, Gross Carrying Amount	$ 190	$ 190		741
Finite-life intangibles, Accumulated Amortization	10	10		554
Finite-life intangibles, Net Carrying Amount	$ 180	$ 180		187
Customer Relationships
Finite-Lived Intangible Assets [Line Items]
Finite-life intangibles, Weighted Average Amortization Lives	8 years	8 years
Finite-life intangibles, Gross Carrying Amount	$ 325	$ 325		135
Finite-life intangibles, Accumulated Amortization	119	119		111
Finite-life intangibles, Net Carrying Amount	$ 206	$ 206		24
Computer Software, Intangible Asset
Finite-Lived Intangible Assets [Line Items]
Finite-life intangibles, Weighted Average Amortization Lives	4 years	4 years
Finite-life intangibles, Gross Carrying Amount	$ 483	$ 483		502
Finite-life intangibles, Accumulated Amortization	325	325		432
Finite-life intangibles, Net Carrying Amount	$ 158	$ 158		70
Trademarks
Finite-Lived Intangible Assets [Line Items]
Finite-life intangibles, Weighted Average Amortization Lives	8 years	8 years
Finite-life intangibles, Gross Carrying Amount	$ 15	$ 15		0
Finite-life intangibles, Accumulated Amortization	1	1		0
Finite-life intangibles, Net Carrying Amount	14	14		0
Customer Lists
Finite-Lived Intangible Assets [Line Items]
Indefinite-life intangibles, Gross Carrying Amount		345		345
Contractual Rights
Finite-Lived Intangible Assets [Line Items]
Indefinite-life intangibles, Gross Carrying Amount		$ 5		$ 5
Gross Intangibles written off	550
Accumulated amortization for intangibles written off	$ 550

Segments - Narrative (Details)

Segments - Narrative (Details)	6 Months Ended
	Jun. 30, 2023 segment
Segment Reporting [Abstract]
Number of operating segments	3

Segments - Operating Earnings B

Segments - Operating Earnings Before Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Segment Reporting Information [Line Items]
Income (loss) attributable to noncontrolling interests	$ 77	$ 75	$ 123	$ 118
Less: Preferred stock dividends	4	4	18	18
Total adjustments to income (loss) before income taxes	263	152	404	274
Adjustments
Segment Reporting Information [Line Items]
Net investment gains (losses) and related charges and adjustments	(38)	(59)	(47)	(171)
Income (loss) related to businesses exited or to be exited through reinsurance or divestment	(21)	(55)	(54)	(91)
Other adjustments	(52)	(40)	(122)	(48)
Total adjustments to income (loss) before income taxes	(31)	(75)	(82)	(174)
Operating Segments
Segment Reporting Information [Line Items]
Adjusted operating earnings before income taxes	294	228	486	448
Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax	307	228	507	448
Net Income (Loss) Attributable to Redeemable Noncontrolling Interest	13	0	21	0
Operating Segments | Wealth Solutions
Segment Reporting Information [Line Items]
Adjusted operating earnings before income taxes	174	197	306	425
Operating Segments | Investment Management
Segment Reporting Information [Line Items]
Adjusted operating earnings before income taxes	63	40	105	79
Operating Segments | Health Solutions
Segment Reporting Information [Line Items]
Adjusted operating earnings before income taxes	124	50	218	72
Operating Segments | Corporate
Segment Reporting Information [Line Items]
Adjusted operating earnings before income taxes	$ (54)	$ (60)	$ (123)	$ (128)

Segments - Operating Revenues (

Segments - Operating Revenues (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Segment Reporting Information [Line Items]
Total revenues	$ 1,871	$ 1,524	$ 3,706	$ 3,030
Adjustments
Segment Reporting Information [Line Items]
Total revenues	151	(14)	288	(111)
Net investment gains (losses) and related charges and adjustments	(46)	(60)	(60)	(180)
Revenues related to businesses exited or to be exited through reinsurance or divestment	2	(55)	32	(109)
Revenues attributable to noncontrolling interests	128	93	188	142
Other adjustments	67	8	127	36
Operating Segments
Segment Reporting Information [Line Items]
Total revenues	1,721	1,537	3,419	3,140
Operating Segments | Wealth Solutions
Segment Reporting Information [Line Items]
Total revenues	705	709	1,389	1,465
Operating Segments | Investment Management
Segment Reporting Information [Line Items]
Total revenues	226	171	455	349
Operating Segments | Health Solutions
Segment Reporting Information [Line Items]
Total revenues	775	641	1,549	1,288
Operating Segments | Corporate
Segment Reporting Information [Line Items]
Total revenues	15	17	26	39
Intersegment | Investment Management
Segment Reporting Information [Line Items]
Total revenues	$ 22	$ 23	$ 44	$ 45

Segments - Total Assets (Detail

Segments - Total Assets (Details) - USD ($) $ in Millions	Jun. 30, 2023	Dec. 31, 2022
Segment Reporting Information [Line Items]
Total assets	$ 154,616	$ 146,606
Noncontrolling Interest
Segment Reporting Information [Line Items]
Total assets	4,406	3,914
Total | Parent
Segment Reporting Information [Line Items]
Total assets	150,210	142,692
Corporate
Segment Reporting Information [Line Items]
Total assets	26,241	26,712
Operating Segments | Wealth Solutions
Segment Reporting Information [Line Items]
Total assets	118,943	111,701
Operating Segments | Investment Management
Segment Reporting Information [Line Items]
Total assets	1,648	1,611
Operating Segments | Health Solutions
Segment Reporting Information [Line Items]
Total assets	$ 3,378	$ 2,668

Uncategorized Items - voya-2023

Label	Element	Value
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents	us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	$ 1,007,000,000